Information Center
Your Health. Your Family. Your Choice.
|
|
National Vaccine Information Center Your Health. Your Family. Your Choice. |
MedAlerts Home |
| Table |
 |   | |
| Symptoms | Count | Percent |
| Abdomen scan | 2 | 0% |
| Abdomen scan normal | 3 | 0.01% |
| Abdominal discomfort | 419 | 0.89% |
| Abdominal distension | 136 | 0.29% |
| Abdominal exploration | 1 | 0% |
| Abdominal mass | 4 | 0.01% |
| Abdominal pain | 726 | 1.54% |
| Abdominal pain lower | 67 | 0.14% |
| Abdominal pain upper | 834 | 1.76% |
| Abdominal rigidity | 5 | 0.01% |
| Abdominal tenderness | 12 | 0.03% |
| Abdominal wall operation | 1 | 0% |
| Abdominal X-ray | 12 | 0.03% |
| Abdominoplasty | 1 | 0% |
| Abnormal behaviour | 20 | 0.04% |
| Abnormal clotting factor | 2 | 0% |
| Abnormal dreams | 56 | 0.12% |
| Abnormal faeces | 12 | 0.03% |
| Abnormal loss of weight | 3 | 0.01% |
| Abnormal sensation in eye | 8 | 0.02% |
| Abnormal sleep-related event | 1 | 0% |
| Abnormal uterine bleeding | 1 | 0% |
| Abortion induced | 1 | 0% |
| Abortion missed | 2 | 0% |
| Abortion spontaneous | 47 | 0.1% |
| Abscess | 4 | 0.01% |
| Abscess drainage | 2 | 0% |
| Abscess limb | 2 | 0% |
| Absence of immediate treatment response | 1 | 0% |
| Abstains from alcohol | 1 | 0% |
| Abulia | 1 | 0% |
| Acarodermatitis | 2 | 0% |
| Accident | 2 | 0% |
| Accidental exposure to product | 15 | 0.03% |
| Accidental overdose | 3 | 0.01% |
| Accident at home | 2 | 0% |
| Acid base balance | 1 | 0% |
| Acid fast bacilli infection | 1 | 0% |
| Acidosis | 1 | 0% |
| Acne | 23 | 0.05% |
| Acne cystic | 1 | 0% |
| Acoustic stimulation tests | 31 | 0.07% |
| Acoustic stimulation tests abnormal | 17 | 0.04% |
| Acoustic stimulation tests normal | 13 | 0.03% |
| Acquired diaphragmatic eventration | 2 | 0% |
| Acquired dysfibrinogenaemia | 2 | 0% |
| Acrochordon | 1 | 0% |
| Activated partial thromboplastin time | 45 | 0.1% |
| Activated partial thromboplastin time normal | 13 | 0.03% |
| Activated partial thromboplastin time prolonged | 10 | 0.02% |
| Activated partial thromboplastin time shortened | 22 | 0.05% |
| Activated protein C resistance test | 1 | 0% |
| Acupuncture | 2 | 0% |
| Acute cardiac event | 3 | 0.01% |
| Acute coronary syndrome | 4 | 0.01% |
| Acute disseminated encephalomyelitis | 4 | 0.01% |
| Acute generalised exanthematous pustulosis | 1 | 0% |
| Acute hepatic failure | 4 | 0.01% |
| Acute kidney injury | 45 | 0.1% |
| Acute left ventricular failure | 1 | 0% |
| Acute megakaryocytic leukaemia | 1 | 0% |
| Acute myocardial infarction | 50 | 0.11% |
| Acute polyneuropathy | 2 | 0% |
| Acute pulmonary oedema | 2 | 0% |
| Acute respiratory distress syndrome | 10 | 0.02% |
| Acute respiratory failure | 36 | 0.08% |
| Acute sinusitis | 3 | 0.01% |
| Acute stress disorder | 1 | 0% |
| ADAMTS13 activity abnormal | 1 | 0% |
| ADAMTS13 activity assay | 2 | 0% |
| ADAMTS13 activity normal | 1 | 0% |
| Addison's disease | 1 | 0% |
| Adenocarcinoma | 1 | 0% |
| Adenoidal disorder | 1 | 0% |
| Adenoma benign | 1 | 0% |
| Adenovirus test | 2 | 0% |
| Administration site haematoma | 1 | 0% |
| Administration site pain | 3 | 0.01% |
| Adnexa uteri pain | 7 | 0.01% |
| Adrenal adenoma | 1 | 0% |
| Adrenal disorder | 2 | 0% |
| Adrenal haemorrhage | 3 | 0.01% |
| Adrenal mass | 1 | 0% |
| Adrenocortical insufficiency acute | 3 | 0.01% |
| Adverse drug reaction | 134 | 0.28% |
| Adverse event | 329 | 0.7% |
| Adverse event following immunisation | 2 | 0% |
| Adverse food reaction | 1 | 0% |
| Adverse reaction | 57 | 0.12% |
| Affective disorder | 1 | 0% |
| Affect lability | 8 | 0.02% |
| Afterbirth pain | 1 | 0% |
| Ageusia | 242 | 0.51% |
| Aggression | 8 | 0.02% |
| Agitation | 23 | 0.05% |
| Agonal respiration | 3 | 0.01% |
| Agonal rhythm | 1 | 0% |
| Airway secretion clearance therapy | 1 | 0% |
| Akathisia | 2 | 0% |
| Akinesia | 1 | 0% |
| Alanine aminotransferase | 12 | 0.03% |
| Alanine aminotransferase increased | 38 | 0.08% |
| Alanine aminotransferase normal | 29 | 0.06% |
| Albumin globulin ratio | 8 | 0.02% |
| Albumin globulin ratio decreased | 1 | 0% |
| Albumin globulin ratio increased | 1 | 0% |
| Albumin globulin ratio normal | 7 | 0.01% |
| Albuminuria | 1 | 0% |
| Albumin urine | 3 | 0.01% |
| Alcohol intolerance | 1 | 0% |
| Alcohol test | 1 | 0% |
| Alcohol test negative | 3 | 0.01% |
| Alcohol use | 3 | 0.01% |
| Alcohol withdrawal syndrome | 2 | 0% |
| Aldolase | 1 | 0% |
| Alice in wonderland syndrome | 2 | 0% |
| Allergy test | 12 | 0.03% |
| Allergy test negative | 1 | 0% |
| Allergy test positive | 1 | 0% |
| Allergy to metals | 1 | 0% |
| Allergy to vaccine | 10 | 0.02% |
| Allodynia | 5 | 0.01% |
| Alopecia | 59 | 0.12% |
| Alopecia areata | 2 | 0% |
| Alpha-1 anti-trypsin increased | 1 | 0% |
| Alpha 1 globulin normal | 1 | 0% |
| Altered pitch perception | 1 | 0% |
| Altered state of consciousness | 19 | 0.04% |
| Altered visual depth perception | 5 | 0.01% |
| Alveolar-arterial oxygen gradient | 1 | 0% |
| Alveolitis | 1 | 0% |
| Amblyopia | 1 | 0% |
| Amenorrhoea | 23 | 0.05% |
| Ammonia | 1 | 0% |
| Ammonia increased | 1 | 0% |
| Ammonia normal | 1 | 0% |
| Amnesia | 99 | 0.21% |
| Amphetamines | 1 | 0% |
| Amylase | 6 | 0.01% |
| Amylase decreased | 1 | 0% |
| Amylase normal | 7 | 0.01% |
| Amyotrophic lateral sclerosis | 1 | 0% |
| Anaemia | 34 | 0.07% |
| Anaemia macrocytic | 1 | 0% |
| Anaesthesia oral | 2 | 0% |
| Analgesic drug level | 1 | 0% |
| Analgesic therapy | 1 | 0% |
| Anal haemorrhage | 3 | 0.01% |
| Anal incontinence | 19 | 0.04% |
| Anal pruritus | 1 | 0% |
| Anaphylactic reaction | 126 | 0.27% |
| Anaphylactic shock | 24 | 0.05% |
| Anaphylactoid reaction | 20 | 0.04% |
| Anaplastic thyroid cancer | 1 | 0% |
| Androgenetic alopecia | 1 | 0% |
| Aneurysm | 4 | 0.01% |
| Aneurysm ruptured | 1 | 0% |
| Anger | 15 | 0.03% |
| Anginal equivalent | 1 | 0% |
| Angina pectoris | 51 | 0.11% |
| Angina unstable | 1 | 0% |
| Angiocardiogram | 7 | 0.01% |
| Angiocentric lymphoma | 1 | 0% |
| Angioedema | 49 | 0.1% |
| Angiogram | 120 | 0.25% |
| Angiogram abnormal | 16 | 0.03% |
| Angiogram cerebral | 9 | 0.02% |
| Angiogram cerebral abnormal | 57 | 0.12% |
| Angiogram cerebral normal | 25 | 0.05% |
| Angiogram normal | 17 | 0.04% |
| Angiogram peripheral | 2 | 0% |
| Angiogram peripheral abnormal | 3 | 0.01% |
| Angiogram pulmonary | 11 | 0.02% |
| Angiogram pulmonary abnormal | 117 | 0.25% |
| Angiogram pulmonary normal | 17 | 0.04% |
| Angiogram retina | 1 | 0% |
| Angiopathy | 2 | 0% |
| Angioplasty | 5 | 0.01% |
| Angiotensin converting enzyme | 5 | 0.01% |
| Anhedonia | 1 | 0% |
| Anhidrosis | 2 | 0% |
| Animal bite | 1 | 0% |
| Anion gap | 22 | 0.05% |
| Anion gap decreased | 6 | 0.01% |
| Anion gap normal | 9 | 0.02% |
| Anisocytosis | 1 | 0% |
| Anisomastia | 1 | 0% |
| Ankle brachial index | 2 | 0% |
| Ankle brachial index normal | 1 | 0% |
| Ankle fracture | 3 | 0.01% |
| Anosmia | 165 | 0.35% |
| Anosognosia | 1 | 0% |
| Anti-cyclic citrullinated peptide antibody | 2 | 0% |
| Anti-cyclic citrullinated peptide antibody negative | 2 | 0% |
| Anti-erythropoietin antibody negative | 1 | 0% |
| Anti-GAD antibody | 1 | 0% |
| Anti-ganglioside antibody | 2 | 0% |
| Anti-glomerular basement membrane disease | 1 | 0% |
| Anti-insulin antibody | 1 | 0% |
| Anti-islet cell antibody | 1 | 0% |
| Anti-muscle specific kinase antibody | 1 | 0% |
| Anti-muscle specific kinase antibody negative | 1 | 0% |
| Anti-myelin-associated glycoprotein antibodies positive | 1 | 0% |
| Anti-neutrophil cytoplasmic antibody positive vasculitis | 1 | 0% |
| Anti-platelet antibody | 4 | 0.01% |
| Anti-RNA polymerase III antibody | 1 | 0% |
| Anti-RNA polymerase III antibody negative | 2 | 0% |
| Anti-saccharomyces cerevisiae antibody | 1 | 0% |
| Anti-thyroid antibody | 7 | 0.01% |
| Anti-thyroid antibody positive | 1 | 0% |
| Anti-transglutaminase antibody | 1 | 0% |
| Anti-transglutaminase antibody negative | 1 | 0% |
| Antiacetylcholine receptor antibody | 3 | 0.01% |
| Antibody test | 114 | 0.24% |
| Antibody test abnormal | 1 | 0% |
| Antibody test negative | 5 | 0.01% |
| Antibody test normal | 2 | 0% |
| Anticoagulant therapy | 184 | 0.39% |
| Anticoagulation drug level | 1 | 0% |
| Anticonvulsant drug level therapeutic | 1 | 0% |
| Anti factor VIII antibody test | 1 | 0% |
| Anti factor Xa assay normal | 1 | 0% |
| Anti factor X activity increased | 1 | 0% |
| Antimitochondrial antibody normal | 1 | 0% |
| Antineutrophil cytoplasmic antibody | 5 | 0.01% |
| Antineutrophil cytoplasmic antibody negative | 7 | 0.01% |
| Antinuclear antibody | 28 | 0.06% |
| Antinuclear antibody increased | 1 | 0% |
| Antinuclear antibody negative | 16 | 0.03% |
| Antinuclear antibody positive | 18 | 0.04% |
| Antiphospholipid antibodies | 9 | 0.02% |
| Antiphospholipid antibodies negative | 5 | 0.01% |
| Antiphospholipid antibodies positive | 2 | 0% |
| Antiphospholipid syndrome | 1 | 0% |
| Antiplatelet therapy | 3 | 0.01% |
| Antipsychotic drug level | 1 | 0% |
| Antisocial behaviour | 1 | 0% |
| Antithrombin III | 4 | 0.01% |
| Antithrombin III decreased | 3 | 0.01% |
| Anuria | 3 | 0.01% |
| Anxiety | 600 | 1.27% |
| Anxiety disorder | 1 | 0% |
| Aortic aneurysm | 3 | 0.01% |
| Aortic aneurysm repair | 2 | 0% |
| Aortic aneurysm rupture | 1 | 0% |
| Aortic arteriosclerosis | 1 | 0% |
| Aortic dilatation | 1 | 0% |
| Aortic disorder | 1 | 0% |
| Aortic dissection | 3 | 0.01% |
| Aortic occlusion | 2 | 0% |
| Aortic rupture | 1 | 0% |
| Aortic thrombosis | 4 | 0.01% |
| Aortic valve incompetence | 7 | 0.01% |
| Aortic valve replacement | 2 | 0% |
| Apallic syndrome | 2 | 0% |
| Apathy | 11 | 0.02% |
| Aphasia | 136 | 0.29% |
| Aphonia | 20 | 0.04% |
| Aphthous ulcer | 20 | 0.04% |
| Apical granuloma | 1 | 0% |
| Aplastic anaemia | 2 | 0% |
| Apnoea | 3 | 0.01% |
| Apnoeic attack | 3 | 0.01% |
| Apparent life threatening event | 1 | 0% |
| Appendicectomy | 23 | 0.05% |
| Appendicitis | 28 | 0.06% |
| Appendicitis perforated | 6 | 0.01% |
| Appetite disorder | 5 | 0.01% |
| Application site bruise | 1 | 0% |
| Application site discolouration | 4 | 0.01% |
| Application site discomfort | 2 | 0% |
| Application site erythema | 3 | 0.01% |
| Application site haemorrhage | 1 | 0% |
| Application site induration | 1 | 0% |
| Application site nodule | 2 | 0% |
| Application site pain | 8 | 0.02% |
| Application site rash | 2 | 0% |
| Apraxia | 1 | 0% |
| Aptyalism | 2 | 0% |
| Arachnoid cyst | 1 | 0% |
| Arachnoid web | 1 | 0% |
| Areflexia | 5 | 0.01% |
| Arrhythmia | 47 | 0.1% |
| Arrhythmia supraventricular | 1 | 0% |
| Arterial catheterisation | 1 | 0% |
| Arterial occlusive disease | 5 | 0.01% |
| Arterial rupture | 1 | 0% |
| Arterial stenosis | 1 | 0% |
| Arterial thrombosis | 4 | 0.01% |
| Arteriogram | 1 | 0% |
| Arteriogram abnormal | 1 | 0% |
| Arteriogram carotid | 13 | 0.03% |
| Arteriogram carotid abnormal | 17 | 0.04% |
| Arteriogram carotid normal | 18 | 0.04% |
| Arteriogram coronary abnormal | 8 | 0.02% |
| Arteriogram coronary normal | 5 | 0.01% |
| Arteriogram normal | 1 | 0% |
| Arteriosclerosis | 8 | 0.02% |
| Arteriosclerosis coronary artery | 2 | 0% |
| Arteriosclerotic retinopathy | 1 | 0% |
| Arteriospasm coronary | 3 | 0.01% |
| Arteriovenous fistula | 1 | 0% |
| Arteritis | 1 | 0% |
| Artery dissection | 1 | 0% |
| Arthralgia | 2,913 | 6.16% |
| Arthritis | 77 | 0.16% |
| Arthritis viral | 1 | 0% |
| Arthropathy | 15 | 0.03% |
| Arthropod bite | 8 | 0.02% |
| Arthropod sting | 1 | 0% |
| Arthroscopy | 1 | 0% |
| Ascites | 2 | 0% |
| Aspartate aminotransferase | 11 | 0.02% |
| Aspartate aminotransferase decreased | 4 | 0.01% |
| Aspartate aminotransferase increased | 36 | 0.08% |
| Aspartate aminotransferase normal | 27 | 0.06% |
| Aspergillus test negative | 1 | 0% |
| Asphyxia | 2 | 0% |
| Aspiration | 7 | 0.01% |
| Aspiration bursa | 1 | 0% |
| Aspiration joint | 1 | 0% |
| Aspiration pleural cavity | 1 | 0% |
| Asterixis | 1 | 0% |
| Asthenia | 2,283 | 4.83% |
| Asthenopia | 39 | 0.08% |
| Asthma | 84 | 0.18% |
| Asthma exercise induced | 2 | 0% |
| Asthmatic crisis | 1 | 0% |
| AST to platelet ratio index increased | 1 | 0% |
| Asymptomatic COVID-19 | 19 | 0.04% |
| Ataxia | 11 | 0.02% |
| Atelectasis | 20 | 0.04% |
| Atrial enlargement | 4 | 0.01% |
| Atrial fibrillation | 104 | 0.22% |
| Atrial flutter | 9 | 0.02% |
| Atrial pressure | 1 | 0% |
| Atrial septal defect | 8 | 0.02% |
| Atrial septal defect repair | 1 | 0% |
| Atrial thrombosis | 3 | 0.01% |
| Atrioventricular block | 4 | 0.01% |
| Atrioventricular block complete | 5 | 0.01% |
| Atrioventricular block first degree | 1 | 0% |
| Atrioventricular block second degree | 4 | 0.01% |
| Atrophy | 1 | 0% |
| Atrophy of globe | 1 | 0% |
| Attention deficit hyperactivity disorder | 5 | 0.01% |
| Atypical pneumonia | 5 | 0.01% |
| Audiogram | 7 | 0.01% |
| Audiogram abnormal | 5 | 0.01% |
| Audiogram normal | 1 | 0% |
| Auditory disorder | 5 | 0.01% |
| Aura | 13 | 0.03% |
| Auscultation | 1 | 0% |
| Autism spectrum disorder | 1 | 0% |
| Autoantibody positive | 1 | 0% |
| Autoantibody test | 1 | 0% |
| Autoimmune demyelinating disease | 2 | 0% |
| Autoimmune dermatitis | 2 | 0% |
| Autoimmune disorder | 20 | 0.04% |
| Autoimmune haemolytic anaemia | 1 | 0% |
| Autoimmune hepatitis | 1 | 0% |
| Autoimmune myocarditis | 1 | 0% |
| Autoimmune thyroiditis | 3 | 0.01% |
| Automatic positive airway pressure | 1 | 0% |
| Autonomic nervous system imbalance | 3 | 0.01% |
| Autopsy | 24 | 0.05% |
| Autoscopy | 5 | 0.01% |
| Axial spondyloarthritis | 1 | 0% |
| Axillary mass | 19 | 0.04% |
| Axillary nerve injury | 1 | 0% |
| Axillary pain | 133 | 0.28% |
| Axillary vein thrombosis | 4 | 0.01% |
| Axonal and demyelinating polyneuropathy | 1 | 0% |
| Azotaemia | 2 | 0% |
| B-cell lymphoma | 1 | 0% |
| Back disorder | 3 | 0.01% |
| Back injury | 5 | 0.01% |
| Back pain | 1,298 | 2.75% |
| Bacteraemia | 2 | 0% |
| Bacterial infection | 7 | 0.01% |
| Bacterial sepsis | 1 | 0% |
| Bacterial test | 7 | 0.01% |
| Bacterial test negative | 6 | 0.01% |
| Bacterial test positive | 6 | 0.01% |
| Bacterial vaginosis | 2 | 0% |
| Bacteroides bacteraemia | 1 | 0% |
| Balance disorder | 285 | 0.6% |
| Balance test | 2 | 0% |
| Band neutrophil count | 1 | 0% |
| Band neutrophil percentage | 1 | 0% |
| Band neutrophil percentage increased | 1 | 0% |
| Band sensation | 1 | 0% |
| Barium enema abnormal | 1 | 0% |
| Barium swallow | 2 | 0% |
| Barium swallow normal | 1 | 0% |
| Bartholin's cyst | 1 | 0% |
| Basal ganglia haemorrhage | 2 | 0% |
| Basal ganglia infarction | 4 | 0.01% |
| Basal ganglia stroke | 2 | 0% |
| Basedow's disease | 6 | 0.01% |
| Base excess | 1 | 0% |
| Base excess increased | 1 | 0% |
| Base excess negative | 1 | 0% |
| Basilar artery occlusion | 1 | 0% |
| Basilar artery stenosis | 1 | 0% |
| Basilar artery thrombosis | 2 | 0% |
| Basophil count | 3 | 0.01% |
| Basophil count decreased | 16 | 0.03% |
| Basophil count increased | 1 | 0% |
| Basophil count normal | 10 | 0.02% |
| Basophil percentage | 14 | 0.03% |
| Basophil percentage decreased | 6 | 0.01% |
| Basophil percentage increased | 2 | 0% |
| Bed rest | 7 | 0.01% |
| Bedridden | 55 | 0.12% |
| Behaviour disorder | 5 | 0.01% |
| Bell's palsy | 184 | 0.39% |
| Benign lymph node neoplasm | 1 | 0% |
| Benign prostatic hyperplasia | 1 | 0% |
| Beta-2 glycoprotein antibody | 3 | 0.01% |
| Beta-2 glycoprotein antibody negative | 1 | 0% |
| Beta 2 microglobulin normal | 1 | 0% |
| Beta globulin decreased | 1 | 0% |
| Beta haemolytic streptococcal infection | 2 | 0% |
| Bicuspid aortic valve | 1 | 0% |
| Bicytopenia | 1 | 0% |
| Bile acid malabsorption | 1 | 0% |
| Bile duct stent insertion | 1 | 0% |
| Bile duct stone | 1 | 0% |
| Bilevel positive airway pressure | 18 | 0.04% |
| Biliary colic | 1 | 0% |
| Biliary dilatation | 2 | 0% |
| Biliary obstruction | 1 | 0% |
| Bilirubin conjugated increased | 1 | 0% |
| Bilirubin conjugated normal | 1 | 0% |
| Bilirubinuria | 1 | 0% |
| Bilirubin urine | 9 | 0.02% |
| Bilirubin urine present | 1 | 0% |
| Biopsy | 27 | 0.06% |
| Biopsy abdominal wall normal | 1 | 0% |
| Biopsy artery | 2 | 0% |
| Biopsy artery abnormal | 1 | 0% |
| Biopsy blood vessel | 1 | 0% |
| Biopsy blood vessel abnormal | 1 | 0% |
| Biopsy bone marrow | 6 | 0.01% |
| Biopsy bone marrow abnormal | 2 | 0% |
| Biopsy bone marrow normal | 2 | 0% |
| Biopsy brain | 2 | 0% |
| Biopsy breast | 1 | 0% |
| Biopsy colon abnormal | 1 | 0% |
| Biopsy endometrium | 3 | 0.01% |
| Biopsy endometrium normal | 1 | 0% |
| Biopsy heart | 2 | 0% |
| Biopsy kidney | 1 | 0% |
| Biopsy liver | 2 | 0% |
| Biopsy liver abnormal | 1 | 0% |
| Biopsy lung | 2 | 0% |
| Biopsy lung abnormal | 1 | 0% |
| Biopsy lymph gland | 1 | 0% |
| Biopsy muscle | 1 | 0% |
| Biopsy muscle abnormal | 2 | 0% |
| Biopsy pericardium | 1 | 0% |
| Biopsy prostate | 1 | 0% |
| Biopsy skin | 14 | 0.03% |
| Biopsy skin abnormal | 3 | 0.01% |
| Biopsy skin normal | 2 | 0% |
| Biopsy small intestine | 1 | 0% |
| Biopsy small intestine normal | 1 | 0% |
| Biopsy soft tissue | 1 | 0% |
| Biopsy stomach normal | 2 | 0% |
| Biopsy uterus | 2 | 0% |
| Biopsy vagina | 1 | 0% |
| Bipolar disorder | 2 | 0% |
| Bladder catheterisation | 10 | 0.02% |
| Bladder dilatation | 1 | 0% |
| Bladder discomfort | 1 | 0% |
| Bladder disorder | 3 | 0.01% |
| Bladder hypertrophy | 1 | 0% |
| Bladder mass | 1 | 0% |
| Bladder pain | 4 | 0.01% |
| Bladder scan | 1 | 0% |
| Bladder stenosis | 1 | 0% |
| Bladder trabeculation | 1 | 0% |
| Bleeding time prolonged | 2 | 0% |
| Bleeding varicose vein | 1 | 0% |
| Blepharitis | 1 | 0% |
| Blepharospasm | 35 | 0.07% |
| Blindness | 115 | 0.24% |
| Blindness transient | 22 | 0.05% |
| Blindness unilateral | 38 | 0.08% |
| Blister | 111 | 0.23% |
| Blister rupture | 4 | 0.01% |
| Blood 25-hydroxycholecalciferol | 3 | 0.01% |
| Blood albumin | 1 | 0% |
| Blood albumin decreased | 17 | 0.04% |
| Blood albumin increased | 2 | 0% |
| Blood albumin normal | 21 | 0.04% |
| Blood alcohol normal | 1 | 0% |
| Blood aldosterone | 1 | 0% |
| Blood alkaline phosphatase | 6 | 0.01% |
| Blood alkaline phosphatase decreased | 2 | 0% |
| Blood alkaline phosphatase increased | 20 | 0.04% |
| Blood alkaline phosphatase normal | 28 | 0.06% |
| Blood beta-D-glucan | 1 | 0% |
| Blood bicarbonate | 2 | 0% |
| Blood bicarbonate abnormal | 1 | 0% |
| Blood bicarbonate decreased | 3 | 0.01% |
| Blood bicarbonate increased | 2 | 0% |
| Blood bicarbonate normal | 8 | 0.02% |
| Blood bilirubin | 8 | 0.02% |
| Blood bilirubin decreased | 2 | 0% |
| Blood bilirubin increased | 17 | 0.04% |
| Blood bilirubin normal | 29 | 0.06% |
| Blood blister | 16 | 0.03% |
| Blood caffeine decreased | 1 | 0% |
| Blood calcitonin normal | 1 | 0% |
| Blood calcium | 9 | 0.02% |
| Blood calcium decreased | 20 | 0.04% |
| Blood calcium increased | 7 | 0.01% |
| Blood calcium normal | 23 | 0.05% |
| Blood cannabinoids | 2 | 0% |
| Blood chloride | 4 | 0.01% |
| Blood chloride decreased | 6 | 0.01% |
| Blood chloride increased | 17 | 0.04% |
| Blood chloride normal | 27 | 0.06% |
| Blood cholesterol | 9 | 0.02% |
| Blood cholesterol abnormal | 1 | 0% |
| Blood cholesterol decreased | 1 | 0% |
| Blood cholesterol increased | 13 | 0.03% |
| Blood cholesterol normal | 11 | 0.02% |
| Blood cholinesterase normal | 1 | 0% |
| Blood copper | 1 | 0% |
| Blood copper increased | 1 | 0% |
| Blood copper normal | 2 | 0% |
| Blood corticotrophin normal | 1 | 0% |
| Blood cortisol | 1 | 0% |
| Blood count | 7 | 0.01% |
| Blood count abnormal | 1 | 0% |
| Blood count normal | 1 | 0% |
| Blood creatine | 5 | 0.01% |
| Blood creatine increased | 1 | 0% |
| Blood creatine normal | 1 | 0% |
| Blood creatine phosphokinase | 24 | 0.05% |
| Blood creatine phosphokinase decreased | 2 | 0% |
| Blood creatine phosphokinase increased | 29 | 0.06% |
| Blood creatine phosphokinase MB | 3 | 0.01% |
| Blood creatine phosphokinase MB increased | 5 | 0.01% |
| Blood creatine phosphokinase MB normal | 2 | 0% |
| Blood creatine phosphokinase normal | 20 | 0.04% |
| Blood creatinine | 20 | 0.04% |
| Blood creatinine decreased | 4 | 0.01% |
| Blood creatinine increased | 47 | 0.1% |
| Blood creatinine normal | 49 | 0.1% |
| Blood culture | 32 | 0.07% |
| Blood culture negative | 26 | 0.05% |
| Blood culture positive | 5 | 0.01% |
| Blood disorder | 8 | 0.02% |
| Blood donor | 1 | 0% |
| Blood electrolytes | 6 | 0.01% |
| Blood electrolytes decreased | 3 | 0.01% |
| Blood electrolytes normal | 10 | 0.02% |
| Blood ethanol | 1 | 0% |
| Blood ethanol increased | 1 | 0% |
| Blood fibrinogen | 19 | 0.04% |
| Blood fibrinogen abnormal | 1 | 0% |
| Blood fibrinogen decreased | 7 | 0.01% |
| Blood fibrinogen increased | 10 | 0.02% |
| Blood fibrinogen normal | 8 | 0.02% |
| Blood folate | 5 | 0.01% |
| Blood folate increased | 1 | 0% |
| Blood folate normal | 9 | 0.02% |
| Blood follicle stimulating hormone | 3 | 0.01% |
| Blood follicle stimulating hormone normal | 1 | 0% |
| Blood gases | 15 | 0.03% |
| Blood gases abnormal | 3 | 0.01% |
| Blood gases normal | 2 | 0% |
| Blood glucose | 122 | 0.26% |
| Blood glucose abnormal | 27 | 0.06% |
| Blood glucose decreased | 46 | 0.1% |
| Blood glucose fluctuation | 4 | 0.01% |
| Blood glucose increased | 123 | 0.26% |
| Blood glucose normal | 140 | 0.3% |
| Blood group B | 1 | 0% |
| Blood grouping | 3 | 0.01% |
| Blood homocysteine | 2 | 0% |
| Blood homocysteine increased | 1 | 0% |
| Blood homocysteine normal | 2 | 0% |
| Blood immunoglobulin A | 2 | 0% |
| Blood immunoglobulin E | 1 | 0% |
| Blood immunoglobulin E normal | 2 | 0% |
| Blood immunoglobulin G | 18 | 0.04% |
| Blood immunoglobulin G decreased | 1 | 0% |
| Blood immunoglobulin G increased | 1 | 0% |
| Blood immunoglobulin G normal | 5 | 0.01% |
| Blood immunoglobulin M | 9 | 0.02% |
| Blood immunoglobulin M increased | 1 | 0% |
| Blood immunoglobulin M normal | 1 | 0% |
| Blood insulin | 1 | 0% |
| Blood iron | 6 | 0.01% |
| Blood iron decreased | 13 | 0.03% |
| Blood iron increased | 2 | 0% |
| Blood iron normal | 3 | 0.01% |
| Blood ketone body | 2 | 0% |
| Blood lactate dehydrogenase | 8 | 0.02% |
| Blood lactate dehydrogenase decreased | 1 | 0% |
| Blood lactate dehydrogenase increased | 8 | 0.02% |
| Blood lactate dehydrogenase normal | 3 | 0.01% |
| Blood lactic acid | 47 | 0.1% |
| Blood lactic acid decreased | 3 | 0.01% |
| Blood lactic acid increased | 12 | 0.03% |
| Blood lactic acid normal | 7 | 0.01% |
| Blood luteinising hormone | 1 | 0% |
| Blood magnesium | 39 | 0.08% |
| Blood magnesium abnormal | 1 | 0% |
| Blood magnesium decreased | 8 | 0.02% |
| Blood magnesium increased | 6 | 0.01% |
| Blood magnesium normal | 28 | 0.06% |
| Blood oestrogen | 1 | 0% |
| Blood oestrogen increased | 1 | 0% |
| Blood osmolarity | 1 | 0% |
| Blood osmolarity decreased | 3 | 0.01% |
| Blood osmolarity normal | 1 | 0% |
| Blood parathyroid hormone normal | 1 | 0% |
| Blood pH | 3 | 0.01% |
| Blood pH decreased | 7 | 0.01% |
| Blood pH increased | 2 | 0% |
| Blood pH normal | 2 | 0% |
| Blood phosphorus | 10 | 0.02% |
| Blood phosphorus decreased | 1 | 0% |
| Blood phosphorus increased | 2 | 0% |
| Blood phosphorus normal | 3 | 0.01% |
| Blood potassium | 13 | 0.03% |
| Blood potassium decreased | 45 | 0.1% |
| Blood potassium increased | 11 | 0.02% |
| Blood potassium normal | 45 | 0.1% |
| Blood pressure abnormal | 26 | 0.05% |
| Blood pressure decreased | 131 | 0.28% |
| Blood pressure diastolic | 8 | 0.02% |
| Blood pressure diastolic decreased | 1 | 0% |
| Blood pressure diastolic increased | 3 | 0.01% |
| Blood pressure fluctuation | 20 | 0.04% |
| Blood pressure immeasurable | 1 | 0% |
| Blood pressure increased | 355 | 0.75% |
| Blood pressure management | 1 | 0% |
| Blood pressure measurement | 370 | 0.78% |
| Blood pressure normal | 17 | 0.04% |
| Blood pressure orthostatic | 1 | 0% |
| Blood pressure systolic | 12 | 0.03% |
| Blood pressure systolic increased | 2 | 0% |
| Blood pressure systolic normal | 1 | 0% |
| Blood product transfusion dependent | 1 | 0% |
| Blood prolactin | 2 | 0% |
| Blood smear test | 4 | 0.01% |
| Blood smear test abnormal | 2 | 0% |
| Blood smear test normal | 3 | 0.01% |
| Blood sodium | 10 | 0.02% |
| Blood sodium decreased | 28 | 0.06% |
| Blood sodium increased | 2 | 0% |
| Blood sodium normal | 39 | 0.08% |
| Blood test | 1,269 | 2.68% |
| Blood test abnormal | 81 | 0.17% |
| Blood test normal | 335 | 0.71% |
| Blood testosterone | 1 | 0% |
| Blood testosterone decreased | 1 | 0% |
| Blood testosterone increased | 1 | 0% |
| Blood thromboplastin normal | 1 | 0% |
| Blood thyroid stimulating hormone | 81 | 0.17% |
| Blood thyroid stimulating hormone abnormal | 3 | 0.01% |
| Blood thyroid stimulating hormone decreased | 15 | 0.03% |
| Blood thyroid stimulating hormone increased | 3 | 0.01% |
| Blood thyroid stimulating hormone normal | 26 | 0.05% |
| Blood triglycerides | 6 | 0.01% |
| Blood triglycerides abnormal | 1 | 0% |
| Blood triglycerides increased | 5 | 0.01% |
| Blood triglycerides normal | 7 | 0.01% |
| Blood urea | 12 | 0.03% |
| Blood urea decreased | 7 | 0.01% |
| Blood urea increased | 22 | 0.05% |
| Blood urea nitrogen/creatinine ratio | 7 | 0.01% |
| Blood urea normal | 37 | 0.08% |
| Blood uric acid | 6 | 0.01% |
| Blood uric acid increased | 1 | 0% |
| Blood uric acid normal | 2 | 0% |
| Blood urine | 4 | 0.01% |
| Blood urine absent | 4 | 0.01% |
| Blood urine present | 56 | 0.12% |
| Bloody discharge | 3 | 0.01% |
| Blood zinc normal | 1 | 0% |
| Blue toe syndrome | 3 | 0.01% |
| Body height | 9 | 0.02% |
| Body mass index | 12 | 0.03% |
| Body mass index increased | 1 | 0% |
| Body temperature | 1,261 | 2.67% |
| Body temperature abnormal | 13 | 0.03% |
| Body temperature decreased | 52 | 0.11% |
| Body temperature fluctuation | 19 | 0.04% |
| Body temperature increased | 688 | 1.46% |
| Body temperature normal | 2 | 0% |
| Bone contusion | 1 | 0% |
| Bone densitometry | 3 | 0.01% |
| Bone lesion | 1 | 0% |
| Bone marrow failure | 1 | 0% |
| Bone marrow oedema | 2 | 0% |
| Bone pain | 213 | 0.45% |
| Bone scan | 1 | 0% |
| Bordetella test positive | 1 | 0% |
| Borrelia test | 14 | 0.03% |
| Borrelia test negative | 11 | 0.02% |
| Borrelia test positive | 6 | 0.01% |
| Bowel movement irregularity | 10 | 0.02% |
| Brachial plexopathy | 1 | 0% |
| Brachial plexus injury | 1 | 0% |
| Bradycardia | 62 | 0.13% |
| Bradykinesia | 16 | 0.03% |
| Bradyphrenia | 16 | 0.03% |
| Brain compression | 1 | 0% |
| Brain death | 4 | 0.01% |
| Brain herniation | 2 | 0% |
| Brain injury | 10 | 0.02% |
| Brain natriuretic peptide | 27 | 0.06% |
| Brain natriuretic peptide increased | 15 | 0.03% |
| Brain natriuretic peptide normal | 13 | 0.03% |
| Brain oedema | 15 | 0.03% |
| Brain operation | 3 | 0.01% |
| Brain scan abnormal | 3 | 0.01% |
| Brain scan normal | 4 | 0.01% |
| Brain stem auditory evoked response | 1 | 0% |
| Brain stem haemorrhage | 3 | 0.01% |
| Brain stem infarction | 2 | 0% |
| Brain stem stroke | 2 | 0% |
| Brain stem syndrome | 3 | 0.01% |
| Brain stem thrombosis | 2 | 0% |
| Breast cancer | 1 | 0% |
| Breast cancer female | 3 | 0.01% |
| Breast cancer male | 1 | 0% |
| Breast cyst | 6 | 0.01% |
| Breast discolouration | 1 | 0% |
| Breast discomfort | 5 | 0.01% |
| Breast engorgement | 1 | 0% |
| Breast enlargement | 1 | 0% |
| Breast feeding | 8 | 0.02% |
| Breast inflammation | 2 | 0% |
| Breast mass | 13 | 0.03% |
| Breast neoplasm | 2 | 0% |
| Breast operation | 1 | 0% |
| Breast pain | 85 | 0.18% |
| Breast prosthesis removal | 2 | 0% |
| Breast swelling | 27 | 0.06% |
| Breast tenderness | 34 | 0.07% |
| Breath holding | 1 | 0% |
| Breath odour | 3 | 0.01% |
| Breath sounds abnormal | 8 | 0.02% |
| Breath sounds absent | 1 | 0% |
| Breath sounds normal | 1 | 0% |
| Bronchial disorder | 1 | 0% |
| Bronchial hyperreactivity | 1 | 0% |
| Bronchial irritation | 1 | 0% |
| Bronchial secretion retention | 1 | 0% |
| Bronchiectasis | 1 | 0% |
| Bronchitis | 27 | 0.06% |
| Bronchitis bacterial | 1 | 0% |
| Bronchitis chronic | 3 | 0.01% |
| Bronchoalveolar lavage abnormal | 1 | 0% |
| Bronchogenic cyst | 1 | 0% |
| Bronchoscopy | 2 | 0% |
| Bronchoscopy abnormal | 2 | 0% |
| Bronchoscopy normal | 2 | 0% |
| Bronchospasm | 3 | 0.01% |
| Bruxism | 8 | 0.02% |
| Bulbar palsy | 2 | 0% |
| Bundle branch block | 2 | 0% |
| Bundle branch block left | 1 | 0% |
| Bundle branch block right | 9 | 0.02% |
| Burning sensation | 496 | 1.05% |
| Burning sensation mucosal | 1 | 0% |
| Bursa disorder | 1 | 0% |
| Bursa injury | 1 | 0% |
| Bursal fluid accumulation | 2 | 0% |
| Bursitis | 20 | 0.04% |
| Butterfly rash | 2 | 0% |
| Buttock injury | 2 | 0% |
| C-reactive protein | 71 | 0.15% |
| C-reactive protein decreased | 2 | 0% |
| C-reactive protein increased | 58 | 0.12% |
| C-reactive protein normal | 28 | 0.06% |
| C3 glomerulopathy | 1 | 0% |
| Cachexia | 1 | 0% |
| Caesarean section | 4 | 0.01% |
| Caffeine consumption | 2 | 0% |
| Calcinosis | 1 | 0% |
| Calcium ionised | 2 | 0% |
| Calcium ionised decreased | 1 | 0% |
| Calcium ionised normal | 1 | 0% |
| Calculus urethral | 1 | 0% |
| Campylobacter infection | 1 | 0% |
| Canalith repositioning procedure | 2 | 0% |
| Candida infection | 3 | 0.01% |
| Candida test negative | 1 | 0% |
| Capillary disorder | 1 | 0% |
| Capillary fragility | 8 | 0.02% |
| Capillary leak syndrome | 3 | 0.01% |
| Capillary nail refill test | 2 | 0% |
| Capillary nail refill test abnormal | 3 | 0.01% |
| Carbohydrate antigen 125 increased | 1 | 0% |
| Carbon dioxide | 2 | 0% |
| Carbon dioxide abnormal | 1 | 0% |
| Carbon dioxide decreased | 16 | 0.03% |
| Carbon dioxide increased | 4 | 0.01% |
| Carbon dioxide normal | 23 | 0.05% |
| Carbuncle | 1 | 0% |
| Cardiac ablation | 3 | 0.01% |
| Cardiac arrest | 70 | 0.15% |
| Cardiac assistance device user | 4 | 0.01% |
| Cardiac discomfort | 13 | 0.03% |
| Cardiac disorder | 29 | 0.06% |
| Cardiac dysfunction | 1 | 0% |
| Cardiac failure | 16 | 0.03% |
| Cardiac failure acute | 5 | 0.01% |
| Cardiac failure chronic | 1 | 0% |
| Cardiac failure congestive | 34 | 0.07% |
| Cardiac flutter | 29 | 0.06% |
| Cardiac function test | 9 | 0.02% |
| Cardiac function test normal | 2 | 0% |
| Cardiac hypertrophy | 1 | 0% |
| Cardiac imaging procedure | 4 | 0.01% |
| Cardiac imaging procedure abnormal | 4 | 0.01% |
| Cardiac infection | 1 | 0% |
| Cardiac monitoring | 44 | 0.09% |
| Cardiac monitoring abnormal | 4 | 0.01% |
| Cardiac monitoring normal | 15 | 0.03% |
| Cardiac murmur | 6 | 0.01% |
| Cardiac operation | 1 | 0% |
| Cardiac pacemaker insertion | 7 | 0.01% |
| Cardiac perfusion defect | 1 | 0% |
| Cardiac pharmacologic stress test | 1 | 0% |
| Cardiac septal defect repair | 1 | 0% |
| Cardiac stress test | 50 | 0.11% |
| Cardiac stress test abnormal | 7 | 0.01% |
| Cardiac stress test normal | 16 | 0.03% |
| Cardiac tamponade | 3 | 0.01% |
| Cardiac telemetry | 3 | 0.01% |
| Cardiac telemetry abnormal | 1 | 0% |
| Cardiac telemetry normal | 4 | 0.01% |
| Cardiac valve disease | 2 | 0% |
| Cardiac valve vegetation | 2 | 0% |
| Cardiac ventricular disorder | 1 | 0% |
| Cardiac ventricular thrombosis | 4 | 0.01% |
| Cardiac ventriculogram left | 1 | 0% |
| Cardiac ventriculogram left normal | 1 | 0% |
| Cardio-respiratory arrest | 19 | 0.04% |
| Cardio-respiratory distress | 1 | 0% |
| Cardiogenic shock | 3 | 0.01% |
| Cardiolipin antibody | 7 | 0.01% |
| Cardiolipin antibody negative | 6 | 0.01% |
| Cardiomegaly | 14 | 0.03% |
| Cardiomyopathy | 9 | 0.02% |
| Cardiopulmonary bypass | 1 | 0% |
| Cardiopulmonary exercise test | 1 | 0% |
| Cardiopulmonary exercise test abnormal | 1 | 0% |
| Cardiovascular disorder | 11 | 0.02% |
| Cardiovascular evaluation | 9 | 0.02% |
| Cardiovascular examination | 3 | 0.01% |
| Cardiovascular function test | 3 | 0.01% |
| Cardiovascular symptom | 4 | 0.01% |
| Cardioversion | 17 | 0.04% |
| Carditis | 2 | 0% |
| Carotid angioplasty | 1 | 0% |
| Carotid arteriosclerosis | 1 | 0% |
| Carotid artery aneurysm | 1 | 0% |
| Carotid artery disease | 2 | 0% |
| Carotid artery dissection | 1 | 0% |
| Carotid artery occlusion | 9 | 0.02% |
| Carotid artery stenosis | 9 | 0.02% |
| Carotid artery thrombosis | 4 | 0.01% |
| Carotid endarterectomy | 3 | 0.01% |
| Carotid revascularisation | 1 | 0% |
| Carotidynia | 1 | 0% |
| Carpal tunnel syndrome | 7 | 0.01% |
| Cartilage atrophy | 1 | 0% |
| Cataplexy | 1 | 0% |
| Cataract | 7 | 0.01% |
| Catatonia | 4 | 0.01% |
| Catheter directed thrombolysis | 7 | 0.01% |
| Catheterisation cardiac | 29 | 0.06% |
| Catheterisation cardiac abnormal | 24 | 0.05% |
| Catheterisation cardiac normal | 16 | 0.03% |
| Catheter placement | 5 | 0.01% |
| Catheter site erythema | 1 | 0% |
| Catheter site haematoma | 1 | 0% |
| Catheter site haemorrhage | 1 | 0% |
| Catheter site swelling | 1 | 0% |
| Catheter site thrombosis | 1 | 0% |
| Catheter site warmth | 1 | 0% |
| Cauda equina syndrome | 2 | 0% |
| Cautery to nose | 1 | 0% |
| Cavernous sinus thrombosis | 3 | 0.01% |
| CD4 lymphocytes abnormal | 1 | 0% |
| CD8 lymphocytes abnormal | 1 | 0% |
| Cell-mediated cytotoxicity | 1 | 0% |
| Cell marker | 1 | 0% |
| Cell marker increased | 1 | 0% |
| Cellulitis | 111 | 0.23% |
| Cellulitis orbital | 1 | 0% |
| Central nervous system immune reconstitution inflammatory response | 1 | 0% |
| Central nervous system infection | 1 | 0% |
| Central nervous system inflammation | 2 | 0% |
| Central nervous system lesion | 8 | 0.02% |
| Central nervous system stimulation | 2 | 0% |
| Central venous catheterisation | 7 | 0.01% |
| Central venous catheter removal | 1 | 0% |
| Central vision loss | 1 | 0% |
| Cerebellar artery occlusion | 1 | 0% |
| Cerebellar embolism | 1 | 0% |
| Cerebellar haemorrhage | 2 | 0% |
| Cerebellar infarction | 3 | 0.01% |
| Cerebellar stroke | 6 | 0.01% |
| Cerebral artery embolism | 3 | 0.01% |
| Cerebral artery occlusion | 16 | 0.03% |
| Cerebral artery stenosis | 1 | 0% |
| Cerebral artery thrombosis | 8 | 0.02% |
| Cerebral atrophy | 4 | 0.01% |
| Cerebral calcification | 1 | 0% |
| Cerebral congestion | 2 | 0% |
| Cerebral disorder | 4 | 0.01% |
| Cerebral endovascular aneurysm repair | 1 | 0% |
| Cerebral haematoma | 9 | 0.02% |
| Cerebral haemorrhage | 76 | 0.16% |
| Cerebral hypoperfusion | 1 | 0% |
| Cerebral infarction | 33 | 0.07% |
| Cerebral ischaemia | 3 | 0.01% |
| Cerebral mass effect | 14 | 0.03% |
| Cerebral revascularisation | 1 | 0% |
| Cerebral small vessel ischaemic disease | 4 | 0.01% |
| Cerebral thrombosis | 34 | 0.07% |
| Cerebral venous sinus thrombosis | 59 | 0.12% |
| Cerebral venous thrombosis | 15 | 0.03% |
| Cerebral ventricle dilatation | 1 | 0% |
| Cerebrospinal fluid drainage | 1 | 0% |
| Cerebrospinal fluid leakage | 2 | 0% |
| Cerebrospinal fluid retention | 1 | 0% |
| Cerebrovascular accident | 296 | 0.63% |
| Cerebrovascular disorder | 3 | 0.01% |
| Cerumen removal | 4 | 0.01% |
| Cervical discharge | 1 | 0% |
| Cervical dysplasia | 1 | 0% |
| Cervical neuritis | 1 | 0% |
| Cervical polyp | 1 | 0% |
| Cervical radiculopathy | 4 | 0.01% |
| Cervical spinal stenosis | 2 | 0% |
| Cervicitis trichomonal | 1 | 0% |
| Cervix operation | 1 | 0% |
| Change in sustained attention | 2 | 0% |
| Change of bowel habit | 1 | 0% |
| Chapped lips | 10 | 0.02% |
| Cheilitis | 7 | 0.01% |
| Chemotherapy | 6 | 0.01% |
| Chest discomfort | 906 | 1.92% |
| Chest injury | 2 | 0% |
| Chest pain | 1,387 | 2.93% |
| Chest scan | 2 | 0% |
| Chest tube insertion | 2 | 0% |
| Chest wall haematoma | 3 | 0.01% |
| Chest wall mass | 1 | 0% |
| Chest X-ray | 438 | 0.93% |
| Chest X-ray abnormal | 102 | 0.22% |
| Chest X-ray normal | 187 | 0.4% |
| Childhood asthma | 5 | 0.01% |
| Child maltreatment syndrome | 6 | 0.01% |
| Chills | 9,980 | 21.11% |
| Chiropractic | 1 | 0% |
| Chlamydia test | 1 | 0% |
| Chlamydia test negative | 1 | 0% |
| Choking | 10 | 0.02% |
| Choking sensation | 6 | 0.01% |
| Cholangiocarcinoma | 1 | 0% |
| Cholangiogram | 2 | 0% |
| Cholangitis | 1 | 0% |
| Cholangitis sclerosing | 1 | 0% |
| Cholecystectomy | 4 | 0.01% |
| Cholecystitis | 1 | 0% |
| Cholecystitis acute | 3 | 0.01% |
| Cholecystitis infective | 1 | 0% |
| Cholelithiasis | 9 | 0.02% |
| Cholera | 1 | 0% |
| Cholestasis | 1 | 0% |
| Cholestasis of pregnancy | 1 | 0% |
| Cholinergic syndrome | 1 | 0% |
| Chondritis | 1 | 0% |
| Chondrocalcinosis | 1 | 0% |
| Chondrocalcinosis pyrophosphate | 1 | 0% |
| Chondrodystrophy | 1 | 0% |
| Chromaturia | 32 | 0.07% |
| Chronic inflammatory demyelinating polyradiculoneuropathy | 4 | 0.01% |
| Chronic kidney disease | 2 | 0% |
| Chronic lymphocytic leukaemia | 2 | 0% |
| Chronic obstructive pulmonary disease | 14 | 0.03% |
| Chronic respiratory failure | 1 | 0% |
| Chronic sinusitis | 3 | 0.01% |
| Chronic spontaneous urticaria | 2 | 0% |
| Circadian rhythm sleep disorder | 2 | 0% |
| Circulatory collapse | 10 | 0.02% |
| Circumoral oedema | 1 | 0% |
| Circumoral swelling | 7 | 0.01% |
| Circumstance or information capable of leading to medication error | 3 | 0.01% |
| Circumstantiality | 1 | 0% |
| Clamping of blood vessel | 1 | 0% |
| Claustrophobia | 2 | 0% |
| Clinically isolated syndrome | 1 | 0% |
| Clonic convulsion | 1 | 0% |
| Clostridium difficile colitis | 2 | 0% |
| Clostridium test | 3 | 0.01% |
| Clostridium test negative | 1 | 0% |
| Clostridium test positive | 1 | 0% |
| Clumsiness | 1 | 0% |
| Cluster headache | 9 | 0.02% |
| Coagulation factor | 2 | 0% |
| Coagulation factor increased | 2 | 0% |
| Coagulation factor level normal | 1 | 0% |
| Coagulation factor V level normal | 1 | 0% |
| Coagulation test | 19 | 0.04% |
| Coagulation test abnormal | 4 | 0.01% |
| Coagulation test normal | 10 | 0.02% |
| Coagulation time | 4 | 0.01% |
| Coagulation time prolonged | 2 | 0% |
| Coagulation time shortened | 2 | 0% |
| Coagulopathy | 21 | 0.04% |
| Coating in mouth | 1 | 0% |
| Coccydynia | 7 | 0.01% |
| Coeliac artery stenosis | 1 | 0% |
| Coeliac disease | 2 | 0% |
| Cognitive disorder | 45 | 0.1% |
| Cognitive test | 3 | 0.01% |
| Cold-stimulus headache | 1 | 0% |
| Cold agglutinins | 1 | 0% |
| Cold agglutinins positive | 1 | 0% |
| Cold sweat | 508 | 1.07% |
| Cold urticaria | 2 | 0% |
| Colitis | 20 | 0.04% |
| Colitis ischaemic | 6 | 0.01% |
| Colitis ulcerative | 5 | 0.01% |
| Colon cancer metastatic | 1 | 0% |
| Colonoscopy | 23 | 0.05% |
| Colonoscopy abnormal | 5 | 0.01% |
| Colonoscopy normal | 2 | 0% |
| Colorectal cancer | 1 | 0% |
| Colostomy | 1 | 0% |
| Colour blindness | 1 | 0% |
| Coma | 9 | 0.02% |
| Coma scale | 6 | 0.01% |
| Coma scale abnormal | 2 | 0% |
| Communication disorder | 9 | 0.02% |
| Complement factor C3 | 3 | 0.01% |
| Complement factor C4 | 3 | 0.01% |
| Completed suicide | 2 | 0% |
| Complex regional pain syndrome | 2 | 0% |
| Complication associated with device | 2 | 0% |
| Compression fracture | 2 | 0% |
| Compression garment application | 2 | 0% |
| Computerised tomogram | 782 | 1.65% |
| Computerised tomogram abdomen | 80 | 0.17% |
| Computerised tomogram abdomen abnormal | 42 | 0.09% |
| Computerised tomogram abdomen normal | 14 | 0.03% |
| Computerised tomogram abnormal | 114 | 0.24% |
| Computerised tomogram coronary artery | 4 | 0.01% |
| Computerised tomogram coronary artery abnormal | 2 | 0% |
| Computerised tomogram coronary artery normal | 2 | 0% |
| Computerised tomogram head | 244 | 0.52% |
| Computerised tomogram head abnormal | 139 | 0.29% |
| Computerised tomogram head normal | 99 | 0.21% |
| Computerised tomogram kidney | 1 | 0% |
| Computerised tomogram kidney abnormal | 1 | 0% |
| Computerised tomogram kidney normal | 1 | 0% |
| Computerised tomogram liver | 1 | 0% |
| Computerised tomogram neck | 40 | 0.08% |
| Computerised tomogram normal | 204 | 0.43% |
| Computerised tomogram pancreas normal | 1 | 0% |
| Computerised tomogram pelvis | 17 | 0.04% |
| Computerised tomogram pelvis abnormal | 15 | 0.03% |
| Computerised tomogram spine | 13 | 0.03% |
| Computerised tomogram thorax | 130 | 0.27% |
| Computerised tomogram thorax abnormal | 147 | 0.31% |
| Computerised tomogram thorax normal | 30 | 0.06% |
| Concussion | 18 | 0.04% |
| Condition aggravated | 693 | 1.47% |
| Confabulation | 1 | 0% |
| Confusional state | 448 | 0.95% |
| Congenital skin dimples | 1 | 0% |
| Congestive cardiomyopathy | 2 | 0% |
| Conjunctival haemorrhage | 18 | 0.04% |
| Conjunctival hyperaemia | 1 | 0% |
| Conjunctival oedema | 1 | 0% |
| Conjunctivitis | 12 | 0.03% |
| Consciousness fluctuating | 11 | 0.02% |
| Constipation | 67 | 0.14% |
| Contact lens intolerance | 1 | 0% |
| Continuous glucose monitoring | 1 | 0% |
| Continuous haemodiafiltration | 1 | 0% |
| Continuous positive airway pressure | 2 | 0% |
| Contraception | 4 | 0.01% |
| Contraindicated product administered | 1 | 0% |
| Contraindication to vaccination | 1 | 0% |
| Contrast media reaction | 1 | 0% |
| Contusion | 486 | 1.03% |
| Convalescent plasma transfusion | 2 | 0% |
| Conversion disorder | 9 | 0.02% |
| Cooling therapy | 1 | 0% |
| Coombs direct test | 2 | 0% |
| Coombs direct test positive | 1 | 0% |
| Coombs indirect test | 1 | 0% |
| Coombs test negative | 1 | 0% |
| Coordination abnormal | 36 | 0.08% |
| Corneal abrasion | 1 | 0% |
| Corneal reflex decreased | 4 | 0.01% |
| Coronary angioplasty | 4 | 0.01% |
| Coronary arterial stent insertion | 20 | 0.04% |
| Coronary artery bypass | 4 | 0.01% |
| Coronary artery disease | 9 | 0.02% |
| Coronary artery dissection | 3 | 0.01% |
| Coronary artery embolism | 2 | 0% |
| Coronary artery occlusion | 16 | 0.03% |
| Coronary artery stenosis | 6 | 0.01% |
| Coronary artery stent removal | 1 | 0% |
| Coronary artery thrombosis | 12 | 0.03% |
| Coronavirus infection | 1 | 0% |
| Coronavirus test | 10 | 0.02% |
| Coronavirus test positive | 1 | 0% |
| Cor pulmonale | 2 | 0% |
| Cor pulmonale acute | 4 | 0.01% |
| Corrective lens user | 1 | 0% |
| Corticosteroid binding globulin test | 1 | 0% |
| Cortisol free urine | 1 | 0% |
| Cortisol normal | 1 | 0% |
| Costochondritis | 8 | 0.02% |
| Cough | 1,068 | 2.26% |
| Cough decreased | 2 | 0% |
| COVID-19 | 745 | 1.58% |
| COVID-19 immunisation | 6 | 0.01% |
| COVID-19 pneumonia | 71 | 0.15% |
| COVID-19 treatment | 1 | 0% |
| Coxsackie virus test | 1 | 0% |
| Cranial nerve decompression | 1 | 0% |
| Cranial nerve disorder | 4 | 0.01% |
| Cranial nerve paralysis | 1 | 0% |
| Craniectomy | 2 | 0% |
| Craniocerebral injury | 12 | 0.03% |
| Craniotomy | 9 | 0.02% |
| Creatinine renal clearance increased | 1 | 0% |
| Creatinine renal clearance normal | 1 | 0% |
| Crepitations | 1 | 0% |
| Critical illness | 4 | 0.01% |
| Crohn's disease | 5 | 0.01% |
| Croup infectious | 1 | 0% |
| Crying | 84 | 0.18% |
| Cryptococcus test | 3 | 0.01% |
| CSF cell count | 3 | 0.01% |
| CSF cell count decreased | 1 | 0% |
| CSF cell count increased | 1 | 0% |
| CSF cell count normal | 5 | 0.01% |
| CSF culture | 1 | 0% |
| CSF culture negative | 11 | 0.02% |
| CSF glucose | 2 | 0% |
| CSF glucose decreased | 1 | 0% |
| CSF glucose increased | 4 | 0.01% |
| CSF glucose normal | 11 | 0.02% |
| CSF immunoglobulin increased | 1 | 0% |
| CSF lactate | 1 | 0% |
| CSF lymphocyte count abnormal | 1 | 0% |
| CSF lymphocyte count increased | 2 | 0% |
| CSF lymphocyte count normal | 2 | 0% |
| CSF monocyte count increased | 1 | 0% |
| CSF neutrophil count increased | 1 | 0% |
| CSF oligoclonal band | 2 | 0% |
| CSF oligoclonal band absent | 2 | 0% |
| CSF protein | 5 | 0.01% |
| CSF protein decreased | 1 | 0% |
| CSF protein increased | 37 | 0.08% |
| CSF protein normal | 2 | 0% |
| CSF red blood cell count | 2 | 0% |
| CSF red blood cell count positive | 4 | 0.01% |
| CSF test | 1 | 0% |
| CSF test abnormal | 7 | 0.01% |
| CSF test normal | 1 | 0% |
| CSF virus no organisms observed | 2 | 0% |
| CSF white blood cell count | 6 | 0.01% |
| CSF white blood cell count decreased | 1 | 0% |
| CSF white blood cell count increased | 5 | 0.01% |
| CSF white blood cell count negative | 1 | 0% |
| CSF white blood cell differential | 2 | 0% |
| Cubital tunnel syndrome | 1 | 0% |
| Culture | 14 | 0.03% |
| Culture cervix negative | 1 | 0% |
| Culture negative | 9 | 0.02% |
| Culture stool | 7 | 0.01% |
| Culture stool negative | 5 | 0.01% |
| Culture throat | 1 | 0% |
| Culture throat negative | 1 | 0% |
| Culture tissue specimen | 1 | 0% |
| Culture urine | 35 | 0.07% |
| Culture urine negative | 12 | 0.03% |
| Culture urine positive | 8 | 0.02% |
| Culture wound negative | 1 | 0% |
| Culture wound positive | 1 | 0% |
| Cutaneous sarcoidosis | 1 | 0% |
| Cutaneous vasculitis | 5 | 0.01% |
| Cyanosis | 52 | 0.11% |
| Cyanosis central | 1 | 0% |
| Cyclic vomiting syndrome | 1 | 0% |
| Cyst | 14 | 0.03% |
| Cystic fibrosis | 1 | 0% |
| Cystitis | 13 | 0.03% |
| Cystoid macular oedema | 1 | 0% |
| Cystoscopy | 1 | 0% |
| Cystoscopy normal | 1 | 0% |
| Cyst removal | 2 | 0% |
| Cytogenetic abnormality | 2 | 0% |
| Cytokine abnormal | 1 | 0% |
| Cytology normal | 1 | 0% |
| Cytomegalovirus test | 1 | 0% |
| Cytomegalovirus test negative | 2 | 0% |
| Dacryostenosis acquired | 1 | 0% |
| Dark circles under eyes | 3 | 0.01% |
| Daydreaming | 2 | 0% |
| Deafness | 87 | 0.18% |
| Deafness bilateral | 2 | 0% |
| Deafness neurosensory | 10 | 0.02% |
| Deafness permanent | 1 | 0% |
| Deafness transitory | 1 | 0% |
| Deafness unilateral | 40 | 0.08% |
| Death | 468 | 0.99% |
| Debridement | 2 | 0% |
| Decerebrate posture | 1 | 0% |
| Decorticate posture | 1 | 0% |
| Decreased activity | 10 | 0.02% |
| Decreased appetite | 950 | 2.01% |
| Decreased bronchial secretion | 1 | 0% |
| Decreased eye contact | 2 | 0% |
| Decreased immune responsiveness | 5 | 0.01% |
| Decreased interest | 2 | 0% |
| Decreased vibratory sense | 1 | 0% |
| Decubitus ulcer | 2 | 0% |
| Deep vein thrombosis | 416 | 0.88% |
| Defaecation urgency | 7 | 0.01% |
| Deformity | 1 | 0% |
| Dehydration | 263 | 0.56% |
| Delayed delivery | 1 | 0% |
| Delirium | 36 | 0.08% |
| Delirium febrile | 1 | 0% |
| Delivery | 2 | 0% |
| Delusion | 15 | 0.03% |
| Dementia | 2 | 0% |
| Dementia Alzheimer's type | 1 | 0% |
| Demyelinating polyneuropathy | 4 | 0.01% |
| Demyelination | 8 | 0.02% |
| Dengue fever | 1 | 0% |
| Dengue virus test negative | 1 | 0% |
| Dental caries | 1 | 0% |
| Dental discomfort | 3 | 0.01% |
| Dental examination normal | 1 | 0% |
| Dependence on oxygen therapy | 1 | 0% |
| Dependence on respirator | 7 | 0.01% |
| Depersonalisation/derealisation disorder | 2 | 0% |
| Depressed level of consciousness | 28 | 0.06% |
| Depressed mood | 26 | 0.05% |
| Depression | 73 | 0.15% |
| Depression suicidal | 1 | 0% |
| Depressive symptom | 1 | 0% |
| Derealisation | 3 | 0.01% |
| Dermal cyst | 1 | 0% |
| Dermal filler injection | 2 | 0% |
| Dermatitis | 9 | 0.02% |
| Dermatitis acneiform | 5 | 0.01% |
| Dermatitis allergic | 13 | 0.03% |
| Dermatitis atopic | 1 | 0% |
| Dermatitis bullous | 4 | 0.01% |
| Dermatitis contact | 7 | 0.01% |
| Dermatitis psoriasiform | 1 | 0% |
| Dermatochalasis | 2 | 0% |
| Dermatologic examination | 2 | 0% |
| Dermatologic examination abnormal | 1 | 0% |
| Dermatomyositis | 1 | 0% |
| Dermoid cyst | 1 | 0% |
| Device breakage | 1 | 0% |
| Device connection issue | 7 | 0.01% |
| Device dislocation | 1 | 0% |
| Device extrusion | 1 | 0% |
| Device function test | 1 | 0% |
| Device ineffective shock delivery | 1 | 0% |
| Device infusion issue | 1 | 0% |
| Device issue | 1 | 0% |
| Dexamethasone suppression test | 1 | 0% |
| Diabetes mellitus | 24 | 0.05% |
| Diabetes mellitus inadequate control | 2 | 0% |
| Diabetic complication | 1 | 0% |
| Diabetic foot | 1 | 0% |
| Diabetic hyperosmolar coma | 1 | 0% |
| Diabetic ketoacidosis | 8 | 0.02% |
| Diagnostic procedure | 3 | 0.01% |
| Dialysis | 11 | 0.02% |
| Dialysis device insertion | 1 | 0% |
| Diaphragmalgia | 6 | 0.01% |
| Diaphragmatic disorder | 2 | 0% |
| Diaphragm muscle weakness | 1 | 0% |
| Diarrhoea | 1,663 | 3.52% |
| Diarrhoea haemorrhagic | 18 | 0.04% |
| Diastolic dysfunction | 4 | 0.01% |
| Diet refusal | 4 | 0.01% |
| Differential white blood cell count | 69 | 0.15% |
| Differential white blood cell count abnormal | 2 | 0% |
| Differential white blood cell count normal | 33 | 0.07% |
| Diffuse large B-cell lymphoma | 1 | 0% |
| Diffuse mesangial sclerosis | 1 | 0% |
| Diffuse vasculitis | 1 | 0% |
| Diffusion-weighted brain MRI abnormal | 1 | 0% |
| Diplegia | 10 | 0.02% |
| Diplopia | 81 | 0.17% |
| Disability | 6 | 0.01% |
| Discharge | 3 | 0.01% |
| Discoloured vomit | 6 | 0.01% |
| Discomfort | 324 | 0.69% |
| Discouragement | 1 | 0% |
| Disease recurrence | 1 | 0% |
| Disease risk factor | 1 | 0% |
| Disorder of orbit | 1 | 0% |
| Disorganised speech | 11 | 0.02% |
| Disorientation | 232 | 0.49% |
| Disseminated intravascular coagulation | 8 | 0.02% |
| Disseminated varicella zoster virus infection | 3 | 0.01% |
| Dissociation | 16 | 0.03% |
| Dissociative disorder | 2 | 0% |
| Distractibility | 2 | 0% |
| Distributive shock | 1 | 0% |
| Disturbance in attention | 197 | 0.42% |
| Diuretic therapy | 1 | 0% |
| Diverticular perforation | 1 | 0% |
| Diverticulitis | 24 | 0.05% |
| Dizziness | 6,994 | 14.79% |
| Dizziness exertional | 4 | 0.01% |
| Dizziness postural | 65 | 0.14% |
| DNA antibody negative | 1 | 0% |
| Double stranded DNA antibody | 8 | 0.02% |
| Double stranded DNA antibody positive | 1 | 0% |
| Drainage | 7 | 0.01% |
| Drain placement | 3 | 0.01% |
| Drain removal | 1 | 0% |
| Dreamy state | 4 | 0.01% |
| Drooling | 18 | 0.04% |
| Dropped head syndrome | 1 | 0% |
| Drug abuse | 3 | 0.01% |
| Drug delivery system malfunction | 1 | 0% |
| Drug eruption | 3 | 0.01% |
| Drug exposure before pregnancy | 1 | 0% |
| Drug hypersensitivity | 6 | 0.01% |
| Drug ineffective | 8 | 0.02% |
| Drug interaction | 3 | 0.01% |
| Drug reaction with eosinophilia and systemic symptoms | 1 | 0% |
| Drug screen | 6 | 0.01% |
| Drug screen negative | 10 | 0.02% |
| Drug screen positive | 3 | 0.01% |
| Drug specific antibody absent | 1 | 0% |
| Drug trough level | 1 | 0% |
| Dry eye | 25 | 0.05% |
| Dry mouth | 175 | 0.37% |
| Dry skin | 51 | 0.11% |
| Dry throat | 47 | 0.1% |
| Duodenitis | 1 | 0% |
| Dural arteriovenous fistula | 1 | 0% |
| Dysaesthesia | 8 | 0.02% |
| Dysarthria | 152 | 0.32% |
| Dyschezia | 3 | 0.01% |
| Dyschromatopsia | 9 | 0.02% |
| Dysentery | 1 | 0% |
| Dysgeusia | 284 | 0.6% |
| Dysgraphia | 2 | 0% |
| Dyskinesia | 116 | 0.25% |
| Dyslexia | 1 | 0% |
| Dyslipidaemia | 1 | 0% |
| Dysmenorrhoea | 92 | 0.19% |
| Dysmetria | 1 | 0% |
| Dyspepsia | 142 | 0.3% |
| Dysphagia | 208 | 0.44% |
| Dysphemia | 13 | 0.03% |
| Dysphonia | 97 | 0.21% |
| Dyspnoea | 2,864 | 6.06% |
| Dyspnoea at rest | 4 | 0.01% |
| Dyspnoea exertional | 83 | 0.18% |
| Dysstasia | 223 | 0.47% |
| Dystonia | 6 | 0.01% |
| Dysuria | 42 | 0.09% |
| Ear, nose and throat examination | 5 | 0.01% |
| Ear, nose and throat examination abnormal | 1 | 0% |
| Ear, nose and throat examination normal | 1 | 0% |
| Ear congestion | 24 | 0.05% |
| Ear discomfort | 155 | 0.33% |
| Ear disorder | 10 | 0.02% |
| Ear haemorrhage | 6 | 0.01% |
| Ear infection | 25 | 0.05% |
| Ear injury | 2 | 0% |
| Ear irrigation | 1 | 0% |
| Ear pain | 260 | 0.55% |
| Ear pruritus | 8 | 0.02% |
| Ear swelling | 31 | 0.07% |
| Eating disorder | 32 | 0.07% |
| Eating disorder symptom | 4 | 0.01% |
| Ecchymosis | 16 | 0.03% |
| ECG signs of myocardial infarction | 1 | 0% |
| ECG signs of myocardial ischaemia | 1 | 0% |
| Echocardiogram | 236 | 0.5% |
| Echocardiogram abnormal | 58 | 0.12% |
| Echocardiogram normal | 76 | 0.16% |
| Echovirus test | 1 | 0% |
| Ectopic pregnancy | 3 | 0.01% |
| Eczema | 16 | 0.03% |
| Eczema eyelids | 1 | 0% |
| Eczema nummular | 1 | 0% |
| Effusion | 1 | 0% |
| EGFR status assay | 4 | 0.01% |
| Ehlers-Danlos syndrome | 5 | 0.01% |
| Ehrlichia test | 4 | 0.01% |
| Ejaculation disorder | 2 | 0% |
| Ejection fraction | 6 | 0.01% |
| Ejection fraction decreased | 15 | 0.03% |
| Ejection fraction normal | 10 | 0.02% |
| Electric shock | 1 | 0% |
| Electric shock sensation | 55 | 0.12% |
| Electrocardiogram | 831 | 1.76% |
| Electrocardiogram abnormal | 123 | 0.26% |
| Electrocardiogram ambulatory | 24 | 0.05% |
| Electrocardiogram ambulatory abnormal | 5 | 0.01% |
| Electrocardiogram ambulatory normal | 5 | 0.01% |
| Electrocardiogram change | 2 | 0% |
| Electrocardiogram normal | 339 | 0.72% |
| Electrocardiogram QRS complex prolonged | 2 | 0% |
| Electrocardiogram QT interval | 1 | 0% |
| Electrocardiogram QT prolonged | 1 | 0% |
| Electrocardiogram repolarisation abnormality | 2 | 0% |
| Electrocardiogram S1-S2-S3 pattern | 1 | 0% |
| Electrocardiogram ST-T change | 3 | 0.01% |
| Electrocardiogram ST-T segment abnormal | 3 | 0.01% |
| Electrocardiogram ST segment abnormal | 4 | 0.01% |
| Electrocardiogram ST segment depression | 6 | 0.01% |
| Electrocardiogram ST segment elevation | 17 | 0.04% |
| Electrocardiogram T wave abnormal | 4 | 0.01% |
| Electrocardiogram T wave inversion | 2 | 0% |
| Electrocardiogram U wave present | 1 | 0% |
| Electrocochleogram | 1 | 0% |
| Electrocution | 1 | 0% |
| Electroencephalogram | 41 | 0.09% |
| Electroencephalogram abnormal | 7 | 0.01% |
| Electroencephalogram normal | 16 | 0.03% |
| Electrolyte imbalance | 2 | 0% |
| Electromyogram | 35 | 0.07% |
| Electromyogram abnormal | 8 | 0.02% |
| Electromyogram normal | 6 | 0.01% |
| Electroneurography | 2 | 0% |
| Electroneuromyography | 1 | 0% |
| Electronic cigarette user | 2 | 0% |
| Electronystagmogram normal | 1 | 0% |
| Electrophoresis protein | 2 | 0% |
| Electrophoresis protein abnormal | 2 | 0% |
| Electrophoresis protein normal | 2 | 0% |
| Elliptocytosis | 1 | 0% |
| Embolic stroke | 11 | 0.02% |
| Embolism | 12 | 0.03% |
| Embolism arterial | 2 | 0% |
| Embolism venous | 6 | 0.01% |
| Emergency care | 3 | 0.01% |
| Emergency care examination | 1 | 0% |
| Emotional disorder | 19 | 0.04% |
| Emotional distress | 39 | 0.08% |
| Emphysema | 4 | 0.01% |
| Emphysematous cystitis | 1 | 0% |
| Encephalitis | 21 | 0.04% |
| Encephalomalacia | 1 | 0% |
| Encephalomyelitis | 1 | 0% |
| Encephalopathy | 9 | 0.02% |
| Endocarditis | 2 | 0% |
| Endocrine test | 1 | 0% |
| Endodontic procedure | 1 | 0% |
| Endometrial ablation | 2 | 0% |
| Endometrial hyperplasia | 1 | 0% |
| Endometriosis | 1 | 0% |
| Endoscopic retrograde cholangiopancreatography | 2 | 0% |
| Endoscopic ultrasound | 1 | 0% |
| Endoscopy | 19 | 0.04% |
| Endoscopy abnormal | 1 | 0% |
| Endoscopy gastrointestinal | 1 | 0% |
| Endoscopy normal | 2 | 0% |
| Endoscopy small intestine abnormal | 1 | 0% |
| Endoscopy upper gastrointestinal tract normal | 3 | 0.01% |
| Endotracheal intubation | 72 | 0.15% |
| Endotracheal intubation complication | 1 | 0% |
| Energy increased | 12 | 0.03% |
| Enlarged clitoris | 1 | 0% |
| Enlarged uvula | 12 | 0.03% |
| Enteral nutrition | 2 | 0% |
| Enteritis | 2 | 0% |
| Enterococcal bacteraemia | 1 | 0% |
| Enterocolitis | 1 | 0% |
| Enterovirus test | 1 | 0% |
| Enterovirus test negative | 1 | 0% |
| Entropion | 1 | 0% |
| Enuresis | 6 | 0.01% |
| Enzyme level abnormal | 1 | 0% |
| Enzyme level test | 2 | 0% |
| Eosinophil count | 8 | 0.02% |
| Eosinophil count decreased | 14 | 0.03% |
| Eosinophil count increased | 6 | 0.01% |
| Eosinophil count normal | 18 | 0.04% |
| Eosinophilia | 1 | 0% |
| Eosinophilic cellulitis | 1 | 0% |
| Eosinophilic oesophagitis | 1 | 0% |
| Eosinophilic pneumonia chronic | 1 | 0% |
| Eosinophil percentage | 19 | 0.04% |
| Eosinophil percentage decreased | 4 | 0.01% |
| Eosinophil percentage increased | 2 | 0% |
| Eosinophils urine | 1 | 0% |
| Epicondylitis | 5 | 0.01% |
| Epididymitis | 1 | 0% |
| Epidural blood patch | 1 | 0% |
| Epidural injection | 1 | 0% |
| Epiglottic oedema | 1 | 0% |
| Epilepsy | 8 | 0.02% |
| Epinephrine | 3 | 0.01% |
| Epiploic appendagitis | 2 | 0% |
| Epistaxis | 252 | 0.53% |
| Epstein-Barr virus antibody | 1 | 0% |
| Epstein-Barr virus antibody negative | 1 | 0% |
| Epstein-Barr virus antibody positive | 6 | 0.01% |
| Epstein-Barr virus infection | 4 | 0.01% |
| Epstein-Barr virus infection reactivation | 1 | 0% |
| Epstein-Barr virus test | 3 | 0.01% |
| Epstein-Barr virus test negative | 4 | 0.01% |
| Epstein-Barr virus test positive | 2 | 0% |
| Erectile dysfunction | 11 | 0.02% |
| Erection increased | 3 | 0.01% |
| Eructation | 25 | 0.05% |
| Eruptive pseudoangiomatosis | 1 | 0% |
| Erythema | 736 | 1.56% |
| Erythema multiforme | 4 | 0.01% |
| Erythema nodosum | 1 | 0% |
| Erythema of eyelid | 5 | 0.01% |
| Erythroblast count normal | 1 | 0% |
| Erythrocyte osmotic fragility test | 1 | 0% |
| Erythromelalgia | 1 | 0% |
| Escherichia infection | 3 | 0.01% |
| Escherichia test negative | 1 | 0% |
| Escherichia test positive | 1 | 0% |
| Escherichia urinary tract infection | 1 | 0% |
| Essential hypertension | 3 | 0.01% |
| Essential thrombocythaemia | 1 | 0% |
| Essential tremor | 1 | 0% |
| Euphoric mood | 27 | 0.06% |
| Eustachian tube disorder | 1 | 0% |
| Eustachian tube obstruction | 1 | 0% |
| Evans syndrome | 1 | 0% |
| Exaggerated startle response | 2 | 0% |
| Excessive exercise | 1 | 0% |
| Excessive eye blinking | 1 | 0% |
| Exercise electrocardiogram | 2 | 0% |
| Exercise tolerance decreased | 21 | 0.04% |
| Exfoliative rash | 2 | 0% |
| Exophthalmos | 6 | 0.01% |
| Exostosis | 1 | 0% |
| Expired product administered | 205 | 0.43% |
| Explorative laparotomy | 2 | 0% |
| Exposure during pregnancy | 150 | 0.32% |
| Exposure to SARS-CoV-2 | 33 | 0.07% |
| Exposure to toxic agent | 2 | 0% |
| Exposure via breast milk | 21 | 0.04% |
| Exposure via skin contact | 11 | 0.02% |
| Extensive swelling of vaccinated limb | 5 | 0.01% |
| Extra dose administered | 207 | 0.44% |
| Extraocular muscle disorder | 1 | 0% |
| Extraocular muscle paresis | 4 | 0.01% |
| Extrasystoles | 14 | 0.03% |
| Extremity contracture | 2 | 0% |
| Extremity necrosis | 1 | 0% |
| Extubation | 2 | 0% |
| Eye colour change | 2 | 0% |
| Eye contusion | 10 | 0.02% |
| Eye discharge | 15 | 0.03% |
| Eye disorder | 38 | 0.08% |
| Eye haemorrhage | 39 | 0.08% |
| Eye infarction | 3 | 0.01% |
| Eye infection | 7 | 0.01% |
| Eye infection bacterial | 1 | 0% |
| Eye inflammation | 11 | 0.02% |
| Eye injury | 2 | 0% |
| Eye irritation | 84 | 0.18% |
| Eyelid disorder | 10 | 0.02% |
| Eyelid function disorder | 10 | 0.02% |
| Eyelid infection | 2 | 0% |
| Eyelid injury | 1 | 0% |
| Eyelid irritation | 3 | 0.01% |
| Eyelid margin crusting | 2 | 0% |
| Eyelid myoclonus | 1 | 0% |
| Eyelid oedema | 4 | 0.01% |
| Eyelid pain | 4 | 0.01% |
| Eyelid ptosis | 11 | 0.02% |
| Eyelid rash | 6 | 0.01% |
| Eyelid sensory disorder | 1 | 0% |
| Eyelids pruritus | 4 | 0.01% |
| Eye movement disorder | 133 | 0.28% |
| Eye operation | 1 | 0% |
| Eye pain | 326 | 0.69% |
| Eye patch application | 2 | 0% |
| Eye pruritus | 64 | 0.14% |
| Eye swelling | 155 | 0.33% |
| Eye ulcer | 1 | 0% |
| Face and mouth X-ray | 2 | 0% |
| Face and mouth X-ray abnormal | 1 | 0% |
| Face and mouth X-ray normal | 1 | 0% |
| Face injury | 36 | 0.08% |
| Face oedema | 6 | 0.01% |
| Facet joint syndrome | 2 | 0% |
| Facial asymmetry | 3 | 0.01% |
| Facial bones fracture | 6 | 0.01% |
| Facial discomfort | 33 | 0.07% |
| Facial nerve disorder | 2 | 0% |
| Facial neuralgia | 1 | 0% |
| Facial pain | 89 | 0.19% |
| Facial paralysis | 180 | 0.38% |
| Facial paresis | 40 | 0.08% |
| Facial spasm | 5 | 0.01% |
| Factor II mutation | 5 | 0.01% |
| Factor V Leiden carrier | 1 | 0% |
| Factor V Leiden mutation | 8 | 0.02% |
| Faecaloma | 2 | 0% |
| Faecal vomiting | 1 | 0% |
| Faeces discoloured | 15 | 0.03% |
| Faeces hard | 3 | 0.01% |
| Faeces pale | 1 | 0% |
| Faeces soft | 7 | 0.01% |
| Failure to thrive | 6 | 0.01% |
| Fall | 712 | 1.51% |
| Fallopian tube disorder | 1 | 0% |
| Fallopian tube operation | 1 | 0% |
| Familial mediterranean fever | 1 | 0% |
| Family stress | 1 | 0% |
| Fascial rupture | 1 | 0% |
| Fasciotomy | 1 | 0% |
| Fasting | 2 | 0% |
| Fatigue | 8,976 | 18.99% |
| Fat tissue increased | 1 | 0% |
| Fear | 33 | 0.07% |
| Fear of death | 2 | 0% |
| Fear of disease | 1 | 0% |
| Fear of eating | 1 | 0% |
| Fear of injection | 57 | 0.12% |
| Febrile convulsion | 4 | 0.01% |
| Feeding disorder | 82 | 0.17% |
| Feeling abnormal | 1,814 | 3.84% |
| Feeling cold | 931 | 1.97% |
| Feeling drunk | 37 | 0.08% |
| Feeling guilty | 1 | 0% |
| Feeling hot | 1,068 | 2.26% |
| Feeling jittery | 52 | 0.11% |
| Feeling of body temperature change | 164 | 0.35% |
| Feeling of despair | 4 | 0.01% |
| Feeling of relaxation | 1 | 0% |
| Feelings of worthlessness | 1 | 0% |
| Female orgasmic disorder | 1 | 0% |
| Female sex hormone level | 2 | 0% |
| Feminisation acquired | 2 | 0% |
| Femoral artery embolism | 1 | 0% |
| Femur fracture | 1 | 0% |
| Fibrin | 1 | 0% |
| Fibrin D dimer | 251 | 0.53% |
| Fibrin D dimer decreased | 1 | 0% |
| Fibrin D dimer increased | 181 | 0.38% |
| Fibrin D dimer normal | 80 | 0.17% |
| Fibromyalgia | 21 | 0.04% |
| Fibrosis | 1 | 0% |
| Fine motor skill dysfunction | 14 | 0.03% |
| Finger deformity | 2 | 0% |
| First trimester pregnancy | 3 | 0.01% |
| Flank pain | 52 | 0.11% |
| Flat affect | 2 | 0% |
| Flat chest | 1 | 0% |
| Flatulence | 66 | 0.14% |
| Flight of ideas | 2 | 0% |
| Flow cytometry | 1 | 0% |
| Fluctuance | 1 | 0% |
| Fluid intake reduced | 10 | 0.02% |
| Fluid overload | 3 | 0.01% |
| Fluid replacement | 10 | 0.02% |
| Fluid retention | 37 | 0.08% |
| Fluorescence angiogram abnormal | 2 | 0% |
| Flushing | 553 | 1.17% |
| Foaming at mouth | 19 | 0.04% |
| Focal dyscognitive seizures | 2 | 0% |
| Foetal arrhythmia | 1 | 0% |
| Foetal cardiac arrest | 1 | 0% |
| Foetal death | 5 | 0.01% |
| Foetal exposure during pregnancy | 3 | 0.01% |
| Foetal heart rate abnormal | 4 | 0.01% |
| Foetal hypokinesia | 1 | 0% |
| Foetal monitoring | 2 | 0% |
| Foetal non-stress test | 1 | 0% |
| Foetal placental thrombosis | 1 | 0% |
| Folate deficiency | 1 | 0% |
| Follicular lymphoma | 1 | 0% |
| Folliculitis | 2 | 0% |
| Food allergy | 11 | 0.02% |
| Food interaction | 1 | 0% |
| Food intolerance | 5 | 0.01% |
| Food poisoning | 1 | 0% |
| Foot deformity | 3 | 0.01% |
| Foot fracture | 4 | 0.01% |
| Forceps delivery | 1 | 0% |
| Foreign body in ear | 1 | 0% |
| Foreign body in eye | 1 | 0% |
| Foreign body in throat | 1 | 0% |
| Foreign body sensation in eyes | 4 | 0.01% |
| Formication | 25 | 0.05% |
| Fraction of inspired oxygen | 1 | 0% |
| Fracture | 2 | 0% |
| Freezing phenomenon | 4 | 0.01% |
| Frequent bowel movements | 27 | 0.06% |
| Frostbite | 1 | 0% |
| Frustration tolerance decreased | 7 | 0.01% |
| Full blood count | 515 | 1.09% |
| Full blood count abnormal | 28 | 0.06% |
| Full blood count decreased | 1 | 0% |
| Full blood count normal | 219 | 0.46% |
| Functional gastrointestinal disorder | 3 | 0.01% |
| Fundoscopy | 1 | 0% |
| Fundoscopy normal | 1 | 0% |
| Fundus autofluorescence | 2 | 0% |
| Fungal infection | 8 | 0.02% |
| Fungal skin infection | 1 | 0% |
| Fungal test | 2 | 0% |
| Fungal test negative | 1 | 0% |
| Furuncle | 6 | 0.01% |
| Gait disturbance | 580 | 1.23% |
| Gait inability | 170 | 0.36% |
| Galactostasis | 1 | 0% |
| Gallbladder disorder | 2 | 0% |
| Gallbladder mass | 1 | 0% |
| Gamma-glutamyltransferase | 2 | 0% |
| Gamma-glutamyltransferase increased | 1 | 0% |
| Gamma-glutamyltransferase normal | 1 | 0% |
| Gangrene | 2 | 0% |
| Gastric dilatation | 4 | 0.01% |
| Gastric disorder | 24 | 0.05% |
| Gastric emptying study | 3 | 0.01% |
| Gastric haemorrhage | 5 | 0.01% |
| Gastric pH decreased | 1 | 0% |
| Gastric ulcer | 4 | 0.01% |
| Gastritis | 6 | 0.01% |
| Gastrocardiac syndrome | 1 | 0% |
| Gastroenteritis | 5 | 0.01% |
| Gastroenteritis viral | 9 | 0.02% |
| Gastrointestinal arteriovenous malformation | 1 | 0% |
| Gastrointestinal bacterial overgrowth | 1 | 0% |
| Gastrointestinal disorder | 39 | 0.08% |
| Gastrointestinal haemorrhage | 8 | 0.02% |
| Gastrointestinal hypomotility | 1 | 0% |
| Gastrointestinal inflammation | 5 | 0.01% |
| Gastrointestinal injury | 1 | 0% |
| Gastrointestinal motility disorder | 3 | 0.01% |
| Gastrointestinal necrosis | 1 | 0% |
| Gastrointestinal pain | 40 | 0.08% |
| Gastrointestinal pathogen panel | 4 | 0.01% |
| Gastrointestinal sounds abnormal | 7 | 0.01% |
| Gastrointestinal tract irritation | 2 | 0% |
| Gastrointestinal tube insertion | 3 | 0.01% |
| Gastrointestinal wall thickening | 2 | 0% |
| Gastrooesophageal reflux disease | 51 | 0.11% |
| Gastrostomy | 4 | 0.01% |
| Gaze palsy | 73 | 0.15% |
| Gene mutation | 2 | 0% |
| Gene mutation identification test | 1 | 0% |
| Gene mutation identification test negative | 6 | 0.01% |
| Generalised anxiety disorder | 3 | 0.01% |
| Generalised oedema | 5 | 0.01% |
| Generalised onset non-motor seizure | 1 | 0% |
| Generalised tonic-clonic seizure | 44 | 0.09% |
| General physical condition abnormal | 2 | 0% |
| General physical health deterioration | 33 | 0.07% |
| General symptom | 12 | 0.03% |
| Genital abscess | 1 | 0% |
| Genital cyst | 1 | 0% |
| Genital discomfort | 4 | 0.01% |
| Genital disorder | 1 | 0% |
| Genital herpes | 12 | 0.03% |
| Genital hypoaesthesia | 1 | 0% |
| Genital lesion | 3 | 0.01% |
| Genital pain | 5 | 0.01% |
| Genital paraesthesia | 1 | 0% |
| Genital rash | 6 | 0.01% |
| Genital swelling | 1 | 0% |
| Genital ulceration | 3 | 0.01% |
| Genotype drug resistance test | 1 | 0% |
| Giant cell arteritis | 6 | 0.01% |
| Giardia test negative | 1 | 0% |
| Gingival bleeding | 11 | 0.02% |
| Gingival blister | 2 | 0% |
| Gingival discolouration | 1 | 0% |
| Gingival discomfort | 2 | 0% |
| Gingival disorder | 1 | 0% |
| Gingival pain | 23 | 0.05% |
| Gingival swelling | 13 | 0.03% |
| Gingival ulceration | 1 | 0% |
| Gingivitis | 2 | 0% |
| Glassy eyes | 17 | 0.04% |
| Globulin | 5 | 0.01% |
| Globulins decreased | 2 | 0% |
| Globulins increased | 5 | 0.01% |
| Glomerular filtration rate | 22 | 0.05% |
| Glomerular filtration rate decreased | 14 | 0.03% |
| Glomerular filtration rate increased | 3 | 0.01% |
| Glomerular filtration rate normal | 18 | 0.04% |
| Glomerulonephritis | 1 | 0% |
| Glomerulonephritis proliferative | 1 | 0% |
| Glossitis | 6 | 0.01% |
| Glossodynia | 23 | 0.05% |
| Glucose tolerance impaired | 1 | 0% |
| Glucose tolerance test normal | 1 | 0% |
| Glucose urine absent | 9 | 0.02% |
| Glucose urine present | 1 | 0% |
| Gluten sensitivity | 1 | 0% |
| Glycosylated haemoglobin | 27 | 0.06% |
| Glycosylated haemoglobin abnormal | 1 | 0% |
| Glycosylated haemoglobin decreased | 2 | 0% |
| Glycosylated haemoglobin increased | 11 | 0.02% |
| Glycosylated haemoglobin normal | 14 | 0.03% |
| Goitre | 5 | 0.01% |
| Gout | 17 | 0.04% |
| Gram stain | 2 | 0% |
| Gram stain positive | 2 | 0% |
| Granulocyte percentage | 4 | 0.01% |
| Granuloma | 2 | 0% |
| Granuloma annulare | 1 | 0% |
| Grimacing | 2 | 0% |
| Grip strength decreased | 21 | 0.04% |
| Groin pain | 56 | 0.12% |
| Growing pains | 1 | 0% |
| Grunting | 4 | 0.01% |
| Guillain-Barre syndrome | 136 | 0.29% |
| Gynaecological examination | 4 | 0.01% |
| Haemangioma | 1 | 0% |
| Haemangioma of liver | 1 | 0% |
| Haemangioma of skin | 2 | 0% |
| Haemarthrosis | 1 | 0% |
| Haematemesis | 29 | 0.06% |
| Haematochezia | 53 | 0.11% |
| Haematocrit | 18 | 0.04% |
| Haematocrit abnormal | 1 | 0% |
| Haematocrit decreased | 32 | 0.07% |
| Haematocrit increased | 8 | 0.02% |
| Haematocrit normal | 53 | 0.11% |
| Haematology test | 7 | 0.01% |
| Haematology test normal | 2 | 0% |
| Haematoma | 35 | 0.07% |
| Haematoma evacuation | 1 | 0% |
| Haematoma muscle | 1 | 0% |
| Haematospermia | 3 | 0.01% |
| Haematotympanum | 1 | 0% |
| Haematuria | 18 | 0.04% |
| Haemodialysis | 8 | 0.02% |
| Haemodynamic instability | 5 | 0.01% |
| Haemodynamic test | 1 | 0% |
| Haemodynamic test normal | 2 | 0% |
| Haemoglobin | 35 | 0.07% |
| Haemoglobin abnormal | 1 | 0% |
| Haemoglobin decreased | 79 | 0.17% |
| Haemoglobin increased | 6 | 0.01% |
| Haemoglobin normal | 65 | 0.14% |
| Haemolysis | 1 | 0% |
| Haemolytic anaemia | 1 | 0% |
| Haemolytic uraemic syndrome | 1 | 0% |
| Haemoperitoneum | 3 | 0.01% |
| Haemophagocytic lymphohistiocytosis | 1 | 0% |
| Haemophilus test | 1 | 0% |
| Haemophobia | 3 | 0.01% |
| Haemoptysis | 46 | 0.1% |
| Haemorrhage | 52 | 0.11% |
| Haemorrhage in pregnancy | 3 | 0.01% |
| Haemorrhage intracranial | 6 | 0.01% |
| Haemorrhage subcutaneous | 1 | 0% |
| Haemorrhage urinary tract | 11 | 0.02% |
| Haemorrhagic disorder | 1 | 0% |
| Haemorrhagic ovarian cyst | 2 | 0% |
| Haemorrhagic stroke | 13 | 0.03% |
| Haemorrhagic transformation stroke | 2 | 0% |
| Haemorrhoidal haemorrhage | 1 | 0% |
| Haemorrhoid operation | 2 | 0% |
| Haemorrhoids | 9 | 0.02% |
| Haemorrhoids thrombosed | 7 | 0.01% |
| Haemothorax | 1 | 0% |
| Hair colour changes | 2 | 0% |
| Hair disorder | 3 | 0.01% |
| Hair growth abnormal | 2 | 0% |
| Hair texture abnormal | 1 | 0% |
| Hallucination | 92 | 0.19% |
| Hallucination, auditory | 6 | 0.01% |
| Hallucination, visual | 8 | 0.02% |
| Hallucinations, mixed | 2 | 0% |
| Halo vision | 2 | 0% |
| Hand-arm vibration syndrome | 1 | 0% |
| Hand-eye coordination impaired | 1 | 0% |
| Hand deformity | 1 | 0% |
| Hangover | 31 | 0.07% |
| Haptoglobin | 4 | 0.01% |
| Haptoglobin decreased | 1 | 0% |
| Haptoglobin increased | 1 | 0% |
| Haptoglobin normal | 1 | 0% |
| Headache | 13,466 | 28.48% |
| Head discomfort | 275 | 0.58% |
| Head injury | 246 | 0.52% |
| Head titubation | 7 | 0.01% |
| Hearing disability | 1 | 0% |
| Heart injury | 3 | 0.01% |
| Heart rate | 272 | 0.58% |
| Heart rate abnormal | 26 | 0.05% |
| Heart rate decreased | 101 | 0.21% |
| Heart rate increased | 1,048 | 2.22% |
| Heart rate irregular | 80 | 0.17% |
| Heart rate normal | 10 | 0.02% |
| Heart rate variability test | 4 | 0.01% |
| Heart sounds abnormal | 2 | 0% |
| Heavy exposure to ultraviolet light | 1 | 0% |
| Heavy menstrual bleeding | 234 | 0.49% |
| Helicobacter infection | 1 | 0% |
| Helicobacter test | 1 | 0% |
| HELLP syndrome | 1 | 0% |
| Hemianaesthesia | 2 | 0% |
| Hemianopia | 2 | 0% |
| Hemihyperaesthesia | 1 | 0% |
| Hemiparaesthesia | 3 | 0.01% |
| Hemiparesis | 97 | 0.21% |
| Hemiplegia | 26 | 0.05% |
| Hemiplegic migraine | 2 | 0% |
| Henoch-Schonlein purpura | 3 | 0.01% |
| Heparin-induced thrombocytopenia | 3 | 0.01% |
| Heparin-induced thrombocytopenia test | 31 | 0.07% |
| Heparin-induced thrombocytopenia test positive | 11 | 0.02% |
| Hepatic artery thrombosis | 1 | 0% |
| Hepatic cirrhosis | 1 | 0% |
| Hepatic encephalopathy | 1 | 0% |
| Hepatic enzyme | 10 | 0.02% |
| Hepatic enzyme abnormal | 6 | 0.01% |
| Hepatic enzyme increased | 18 | 0.04% |
| Hepatic failure | 5 | 0.01% |
| Hepatic function abnormal | 3 | 0.01% |
| Hepatic lesion | 1 | 0% |
| Hepatic mass | 2 | 0% |
| Hepatic pain | 7 | 0.01% |
| Hepatic perfusion disorder | 1 | 0% |
| Hepatic steatosis | 11 | 0.02% |
| Hepatic vein thrombosis | 4 | 0.01% |
| Hepatitis | 4 | 0.01% |
| Hepatitis A antibody | 1 | 0% |
| Hepatitis A antibody negative | 1 | 0% |
| Hepatitis acute | 2 | 0% |
| Hepatitis alcoholic | 1 | 0% |
| Hepatitis A virus test | 1 | 0% |
| Hepatitis B antibody | 1 | 0% |
| Hepatitis B antibody negative | 1 | 0% |
| Hepatitis B core antibody positive | 1 | 0% |
| Hepatitis B DNA assay negative | 1 | 0% |
| Hepatitis B DNA increased | 1 | 0% |
| Hepatitis B immunisation | 1 | 0% |
| Hepatitis B surface antigen negative | 2 | 0% |
| Hepatitis B surface antigen positive | 1 | 0% |
| Hepatitis B test negative | 2 | 0% |
| Hepatitis B virus test | 3 | 0.01% |
| Hepatitis C antibody | 3 | 0.01% |
| Hepatitis C antibody negative | 2 | 0% |
| Hepatitis C antibody positive | 1 | 0% |
| Hepatitis C RNA negative | 1 | 0% |
| Hepatitis C test negative | 3 | 0.01% |
| Hepatitis C virus test | 2 | 0% |
| Hepatitis viral test | 2 | 0% |
| Hepatitis viral test negative | 5 | 0.01% |
| Hepatocellular carcinoma | 1 | 0% |
| Hepatomegaly | 5 | 0.01% |
| Hepatosplenomegaly | 2 | 0% |
| Hereditary angioedema | 1 | 0% |
| Hereditary angioedema with C1 esterase inhibitor deficiency | 1 | 0% |
| Hereditary ataxia | 1 | 0% |
| Hernia | 2 | 0% |
| Hernia hiatus repair | 1 | 0% |
| Hernial eventration | 1 | 0% |
| Hernia repair | 1 | 0% |
| Herpes ophthalmic | 2 | 0% |
| Herpes simplex | 13 | 0.03% |
| Herpes simplex test | 2 | 0% |
| Herpes simplex test negative | 8 | 0.02% |
| Herpes simplex test positive | 1 | 0% |
| Herpes virus infection | 12 | 0.03% |
| Herpes virus test | 5 | 0.01% |
| Herpes zoster | 279 | 0.59% |
| Herpes zoster oticus | 1 | 0% |
| Hiatus hernia | 3 | 0.01% |
| Hiccups | 4 | 0.01% |
| Hidradenitis | 4 | 0.01% |
| High-pitched crying | 1 | 0% |
| High density lipoprotein | 1 | 0% |
| High density lipoprotein decreased | 6 | 0.01% |
| High density lipoprotein increased | 1 | 0% |
| High density lipoprotein normal | 6 | 0.01% |
| High foetal head | 1 | 0% |
| Hilar lymphadenopathy | 4 | 0.01% |
| Hip arthroplasty | 4 | 0.01% |
| Hip fracture | 6 | 0.01% |
| Histology | 1 | 0% |
| Histone antibody negative | 1 | 0% |
| Histoplasmosis | 1 | 0% |
| HIV antibody negative | 2 | 0% |
| HIV antigen | 1 | 0% |
| HIV antigen negative | 2 | 0% |
| HIV infection | 2 | 0% |
| HIV test | 5 | 0.01% |
| HIV test false positive | 1 | 0% |
| HIV test negative | 16 | 0.03% |
| HLA-B*27 positive | 1 | 0% |
| Homans' sign positive | 1 | 0% |
| Homeless | 2 | 0% |
| Hordeolum | 9 | 0.02% |
| Hormone level abnormal | 6 | 0.01% |
| Hormone replacement therapy | 1 | 0% |
| Hormone therapy | 1 | 0% |
| Horner's syndrome | 1 | 0% |
| Hospitalisation | 19 | 0.04% |
| Hostility | 1 | 0% |
| Hot flush | 375 | 0.79% |
| Human chorionic gonadotropin | 15 | 0.03% |
| Human chorionic gonadotropin decreased | 2 | 0% |
| Human chorionic gonadotropin negative | 9 | 0.02% |
| Human chorionic gonadotropin normal | 2 | 0% |
| Human chorionic gonadotropin positive | 1 | 0% |
| Human ehrlichiosis | 1 | 0% |
| Human rhinovirus test positive | 2 | 0% |
| Humerus fracture | 2 | 0% |
| Hunger | 24 | 0.05% |
| Hunt and Hess scale | 1 | 0% |
| Hydrocephalus | 4 | 0.01% |
| Hydrogen breath test normal | 1 | 0% |
| Hydronephrosis | 5 | 0.01% |
| Hydroureter | 1 | 0% |
| Hyperacusis | 59 | 0.12% |
| Hyperadrenalism | 1 | 0% |
| Hyperaemia | 1 | 0% |
| Hyperaesthesia | 83 | 0.18% |
| Hyperaesthesia teeth | 7 | 0.01% |
| Hyperammonaemia | 1 | 0% |
| Hyperbilirubinaemia | 1 | 0% |
| Hypercalcaemia | 1 | 0% |
| Hypercapnia | 3 | 0.01% |
| Hypercarotinaemia | 1 | 0% |
| Hyperchlorhydria | 3 | 0.01% |
| Hypercoagulation | 2 | 0% |
| Hyperdynamic left ventricle | 1 | 0% |
| Hyperglycaemia | 15 | 0.03% |
| Hyperhidrosis | 2,829 | 5.98% |
| Hyperhomocysteinaemia | 1 | 0% |
| Hyperintensity in brain deep nuclei | 2 | 0% |
| Hyperkalaemia | 8 | 0.02% |
| Hyperlipidaemia | 2 | 0% |
| Hypermetropia | 2 | 0% |
| Hypermobility syndrome | 1 | 0% |
| Hypernatraemia | 1 | 0% |
| Hyperosmolar state | 1 | 0% |
| Hyperplasia | 1 | 0% |
| Hyperpyrexia | 135 | 0.29% |
| Hyperreflexia | 2 | 0% |
| Hypersensitivity | 201 | 0.43% |
| Hypersensitivity vasculitis | 1 | 0% |
| Hypersomnia | 204 | 0.43% |
| Hypertension | 462 | 0.98% |
| Hypertensive crisis | 9 | 0.02% |
| Hypertensive emergency | 5 | 0.01% |
| Hypertensive encephalopathy | 2 | 0% |
| Hypertensive heart disease | 1 | 0% |
| Hypertensive urgency | 3 | 0.01% |
| Hyperthermia | 4 | 0.01% |
| Hyperthyroidism | 7 | 0.01% |
| Hypertonia | 1 | 0% |
| Hypertonic bladder | 2 | 0% |
| Hypertrophic cardiomyopathy | 2 | 0% |
| Hypertrophy | 1 | 0% |
| Hypertrophy of tongue papillae | 1 | 0% |
| Hyperventilation | 67 | 0.14% |
| Hypervigilance | 6 | 0.01% |
| Hypervolaemia | 1 | 0% |
| Hyphaema | 1 | 0% |
| Hypoacusis | 112 | 0.24% |
| Hypoaesthesia | 1,759 | 3.72% |
| Hypoaesthesia eye | 4 | 0.01% |
| Hypoaesthesia oral | 238 | 0.5% |
| Hypoaesthesia teeth | 1 | 0% |
| Hypobarism | 1 | 0% |
| Hypocalcaemia | 1 | 0% |
| Hypochloraemia | 1 | 0% |
| Hypochromasia | 1 | 0% |
| Hypocomplementaemia | 1 | 0% |
| Hypogeusia | 10 | 0.02% |
| Hypoglossal nerve paralysis | 1 | 0% |
| Hypoglycaemia | 13 | 0.03% |
| Hypokalaemia | 11 | 0.02% |
| Hypokinesia | 92 | 0.19% |
| Hypomagnesaemia | 2 | 0% |
| Hypomenorrhoea | 9 | 0.02% |
| Hyponatraemia | 13 | 0.03% |
| Hypoosmolar state | 2 | 0% |
| Hypophagia | 25 | 0.05% |
| Hypopnoea | 52 | 0.11% |
| Hyporeflexia | 7 | 0.01% |
| Hyporesponsive to stimuli | 7 | 0.01% |
| Hyposmia | 2 | 0% |
| Hypotension | 441 | 0.93% |
| Hypothermia | 8 | 0.02% |
| Hypothyroidism | 11 | 0.02% |
| Hypotonia | 24 | 0.05% |
| Hypotonic-hyporesponsive episode | 2 | 0% |
| Hypoventilation | 1 | 0% |
| Hypovitaminosis | 1 | 0% |
| Hypovolaemia | 3 | 0.01% |
| Hypovolaemic shock | 2 | 0% |
| Hypoxia | 69 | 0.15% |
| Hypoxic-ischaemic encephalopathy | 1 | 0% |
| Hysterectomy | 3 | 0.01% |
| Hysteroscopy abnormal | 1 | 0% |
| Idiopathic intracranial hypertension | 3 | 0.01% |
| Idiopathic orbital inflammation | 1 | 0% |
| Idiosyncratic drug reaction | 1 | 0% |
| IIIrd nerve paralysis | 1 | 0% |
| Iliac artery embolism | 2 | 0% |
| Iliac artery occlusion | 2 | 0% |
| Ill-defined disorder | 7 | 0.01% |
| Illiteracy | 5 | 0.01% |
| Illness | 234 | 0.49% |
| Illusion | 4 | 0.01% |
| Imaging procedure | 16 | 0.03% |
| Imaging procedure abnormal | 3 | 0.01% |
| Imaging procedure artifact | 1 | 0% |
| Immature granulocyte count | 13 | 0.03% |
| Immature granulocyte count increased | 6 | 0.01% |
| Immature granulocyte percentage increased | 1 | 0% |
| Immediate post-injection reaction | 604 | 1.28% |
| Immobile | 6 | 0.01% |
| Immune-mediated adverse reaction | 1 | 0% |
| Immune system disorder | 16 | 0.03% |
| Immune thrombocytopenia | 34 | 0.07% |
| Immunisation | 19 | 0.04% |
| Immunisation anxiety related reaction | 2 | 0% |
| Immunodeficiency | 1 | 0% |
| Immunoelectrophoresis | 1 | 0% |
| Immunoglobulins | 1 | 0% |
| Immunoglobulins abnormal | 1 | 0% |
| Immunoglobulins decreased | 1 | 0% |
| Immunoglobulin therapy | 80 | 0.17% |
| Immunohistochemistry | 2 | 0% |
| Immunology test | 22 | 0.05% |
| Immunology test abnormal | 1 | 0% |
| Immunosuppressant drug therapy | 2 | 0% |
| Impaired driving ability | 89 | 0.19% |
| Impaired gastric emptying | 2 | 0% |
| Impaired healing | 1 | 0% |
| Impaired quality of life | 3 | 0.01% |
| Impaired self-care | 1 | 0% |
| Impaired work ability | 420 | 0.89% |
| Impatience | 1 | 0% |
| Implantable cardiac monitor insertion | 1 | 0% |
| Implantable defibrillator insertion | 1 | 0% |
| Imprisonment | 1 | 0% |
| Inability to crawl | 1 | 0% |
| Inappropriate affect | 11 | 0.02% |
| Inappropriate schedule of product administration | 97 | 0.21% |
| Incisional drainage | 3 | 0.01% |
| Incision site pain | 1 | 0% |
| Incoherent | 34 | 0.07% |
| Incomplete course of vaccination | 2 | 0% |
| Incontinence | 15 | 0.03% |
| Incorrect disposal of product | 1 | 0% |
| Incorrect dose administered | 195 | 0.41% |
| Incorrect dose administered by device | 2 | 0% |
| Incorrect product administration duration | 2 | 0% |
| Incorrect product formulation administered | 28 | 0.06% |
| Incorrect route of product administration | 35 | 0.07% |
| Increased appetite | 8 | 0.02% |
| Increased bronchial secretion | 5 | 0.01% |
| Increased insulin requirement | 3 | 0.01% |
| Increased tendency to bruise | 9 | 0.02% |
| Increased upper airway secretion | 4 | 0.01% |
| Increased viscosity of upper respiratory secretion | 7 | 0.01% |
| Indeterminable ABO blood type | 1 | 0% |
| Indifference | 2 | 0% |
| Induced labour | 5 | 0.01% |
| Induration | 61 | 0.13% |
| Infarction | 6 | 0.01% |
| Infected bite | 1 | 0% |
| Infected dermal cyst | 1 | 0% |
| Infection | 30 | 0.06% |
| Infectious mononucleosis | 3 | 0.01% |
| Inferior vena cava dilatation | 1 | 0% |
| Inflammation | 181 | 0.38% |
| Inflammatory marker increased | 4 | 0.01% |
| Inflammatory marker test | 4 | 0.01% |
| Inflammatory pain | 1 | 0% |
| Influenza | 130 | 0.27% |
| Influenza A virus test | 9 | 0.02% |
| Influenza A virus test negative | 24 | 0.05% |
| Influenza A virus test positive | 2 | 0% |
| Influenza B virus test | 28 | 0.06% |
| Influenza like illness | 1,058 | 2.24% |
| Influenza virus test | 27 | 0.06% |
| Influenza virus test negative | 39 | 0.08% |
| Infrequent bowel movements | 1 | 0% |
| Infusion | 9 | 0.02% |
| Infusion related reaction | 1 | 0% |
| Infusion site extravasation | 1 | 0% |
| Initial insomnia | 27 | 0.06% |
| Injected limb mobility decreased | 56 | 0.12% |
| Injection | 4 | 0.01% |
| Injection related reaction | 2 | 0% |
| Injection site abscess | 7 | 0.01% |
| Injection site atrophy | 1 | 0% |
| Injection site bruising | 167 | 0.35% |
| Injection site cellulitis | 13 | 0.03% |
| Injection site coldness | 1 | 0% |
| Injection site cyst | 1 | 0% |
| Injection site discharge | 1 | 0% |
| Injection site discolouration | 20 | 0.04% |
| Injection site discomfort | 53 | 0.11% |
| Injection site erythema | 545 | 1.15% |
| Injection site exfoliation | 1 | 0% |
| Injection site extravasation | 9 | 0.02% |
| Injection site haematoma | 11 | 0.02% |
| Injection site haemorrhage | 69 | 0.15% |
| Injection site hypersensitivity | 5 | 0.01% |
| Injection site hypoaesthesia | 51 | 0.11% |
| Injection site indentation | 7 | 0.01% |
| Injection site induration | 103 | 0.22% |
| Injection site infection | 10 | 0.02% |
| Injection site inflammation | 52 | 0.11% |
| Injection site irritation | 9 | 0.02% |
| Injection site joint pain | 6 | 0.01% |
| Injection site lymphadenopathy | 1 | 0% |
| Injection site macule | 1 | 0% |
| Injection site mass | 160 | 0.34% |
| Injection site movement impairment | 2 | 0% |
| Injection site muscle weakness | 5 | 0.01% |
| Injection site necrosis | 1 | 0% |
| Injection site nodule | 83 | 0.18% |
| Injection site oedema | 4 | 0.01% |
| Injection site pain | 3,059 | 6.47% |
| Injection site papule | 2 | 0% |
| Injection site paraesthesia | 34 | 0.07% |
| Injection site plaque | 1 | 0% |
| Injection site pruritus | 226 | 0.48% |
| Injection site pustule | 1 | 0% |
| Injection site rash | 127 | 0.27% |
| Injection site reaction | 133 | 0.28% |
| Injection site scab | 6 | 0.01% |
| Injection site scar | 2 | 0% |
| Injection site streaking | 3 | 0.01% |
| Injection site swelling | 678 | 1.43% |
| Injection site thrombosis | 4 | 0.01% |
| Injection site urticaria | 21 | 0.04% |
| Injection site vesicles | 21 | 0.04% |
| Injection site warmth | 256 | 0.54% |
| Injury | 21 | 0.04% |
| Injury associated with device | 1 | 0% |
| Inner ear disorder | 4 | 0.01% |
| Inner ear inflammation | 2 | 0% |
| Insomnia | 830 | 1.76% |
| Inspiratory capacity decreased | 1 | 0% |
| Instillation site exfoliation | 1 | 0% |
| Insulin C-peptide | 1 | 0% |
| Intellectual disability | 2 | 0% |
| Intensive care | 157 | 0.33% |
| Intentional product misuse | 12 | 0.03% |
| Intentional product use issue | 1 | 0% |
| Intentional underdose | 1 | 0% |
| Interchange of vaccine products | 372 | 0.79% |
| Interleukin-2 receptor assay | 1 | 0% |
| Interleukin level | 3 | 0.01% |
| Intermenstrual bleeding | 68 | 0.14% |
| Internal carotid artery deformity | 1 | 0% |
| Internal device exposed | 1 | 0% |
| Internal haemorrhage | 2 | 0% |
| International normalised ratio | 53 | 0.11% |
| International normalised ratio abnormal | 1 | 0% |
| International normalised ratio decreased | 7 | 0.01% |
| International normalised ratio increased | 32 | 0.07% |
| International normalised ratio normal | 56 | 0.12% |
| Interstitial lung disease | 1 | 0% |
| Interventional procedure | 1 | 0% |
| Intervertebral disc compression | 1 | 0% |
| Intervertebral disc degeneration | 5 | 0.01% |
| Intervertebral disc disorder | 1 | 0% |
| Intervertebral disc operation | 1 | 0% |
| Intervertebral disc protrusion | 8 | 0.02% |
| Intervertebral disc space narrowing | 2 | 0% |
| Intestinal congestion | 1 | 0% |
| Intestinal ischaemia | 2 | 0% |
| Intestinal obstruction | 4 | 0.01% |
| Intra-abdominal haematoma | 1 | 0% |
| Intra-abdominal pressure increased | 2 | 0% |
| Intra-aortic balloon placement | 1 | 0% |
| Intra-cerebral aneurysm operation | 1 | 0% |
| Intra-ocular injection | 2 | 0% |
| Intracardiac mass | 1 | 0% |
| Intracardiac thrombus | 15 | 0.03% |
| Intracranial aneurysm | 10 | 0.02% |
| Intracranial mass | 1 | 0% |
| Intracranial pressure increased | 4 | 0.01% |
| Intranasal hypoaesthesia | 1 | 0% |
| Intranasal paraesthesia | 1 | 0% |
| Intraocular pressure decreased | 2 | 0% |
| Intraocular pressure increased | 4 | 0.01% |
| Intraocular pressure test | 7 | 0.01% |
| Intrauterine contraception | 1 | 0% |
| Intraventricular haemorrhage | 5 | 0.01% |
| Intrusive thoughts | 1 | 0% |
| Invasive ductal breast carcinoma | 1 | 0% |
| Investigation | 14 | 0.03% |
| Investigation normal | 1 | 0% |
| In vitro fertilisation | 1 | 0% |
| Iodine uptake increased | 1 | 0% |
| Iridocyclitis | 1 | 0% |
| Iritis | 1 | 0% |
| Iron binding capacity total | 1 | 0% |
| Iron binding capacity total decreased | 1 | 0% |
| Iron binding capacity total increased | 1 | 0% |
| Iron binding capacity total normal | 3 | 0.01% |
| Iron deficiency | 3 | 0.01% |
| Iron deficiency anaemia | 2 | 0% |
| Irregular breathing | 7 | 0.01% |
| Irregular sleep phase | 1 | 0% |
| Irritability | 61 | 0.13% |
| Irritable bowel syndrome | 12 | 0.03% |
| Ischaemia | 3 | 0.01% |
| Ischaemic cardiomyopathy | 1 | 0% |
| Ischaemic cerebral infarction | 1 | 0% |
| Ischaemic hepatitis | 4 | 0.01% |
| Ischaemic stroke | 45 | 0.1% |
| ISTH score for disseminated intravascular coagulation | 1 | 0% |
| IVth nerve paralysis | 2 | 0% |
| Jaundice | 7 | 0.01% |
| Jaw disorder | 7 | 0.01% |
| Jaw fracture | 1 | 0% |
| Joint contracture | 8 | 0.02% |
| Joint dislocation | 9 | 0.02% |
| Joint dislocation reduction | 1 | 0% |
| Joint effusion | 10 | 0.02% |
| Joint fluid drainage | 1 | 0% |
| Joint hyperextension | 2 | 0% |
| Joint injection | 1 | 0% |
| Joint injury | 15 | 0.03% |
| Joint instability | 5 | 0.01% |
| Joint lock | 10 | 0.02% |
| Joint noise | 9 | 0.02% |
| Joint range of motion decreased | 66 | 0.14% |
| Joint space narrowing | 1 | 0% |
| Joint stiffness | 88 | 0.19% |
| Joint swelling | 235 | 0.5% |
| Joint warmth | 6 | 0.01% |
| Judgement impaired | 2 | 0% |
| Jugular vein distension | 1 | 0% |
| Jugular vein thrombosis | 11 | 0.02% |
| Keratitis | 1 | 0% |
| Keratosis pilaris | 1 | 0% |
| Kidney fibrosis | 1 | 0% |
| Kidney infection | 7 | 0.01% |
| Klebsiella infection | 1 | 0% |
| Klebsiella test positive | 1 | 0% |
| Knee operation | 1 | 0% |
| Labia enlarged | 1 | 0% |
| Labile blood pressure | 1 | 0% |
| Labile hypertension | 1 | 0% |
| Laboratory test | 618 | 1.31% |
| Laboratory test abnormal | 41 | 0.09% |
| Laboratory test interference | 1 | 0% |
| Laboratory test normal | 167 | 0.35% |
| Labour induction | 1 | 0% |
| Labour pain | 1 | 0% |
| Labyrinthitis | 8 | 0.02% |
| Lack of spontaneous speech | 6 | 0.01% |
| Lacrimation increased | 94 | 0.2% |
| Lactation disorder | 3 | 0.01% |
| Lactic acidosis | 6 | 0.01% |
| Lactose intolerance | 1 | 0% |
| Lacunar infarction | 7 | 0.01% |
| Lacunar stroke | 5 | 0.01% |
| Language disorder | 4 | 0.01% |
| Laparoscopic surgery | 4 | 0.01% |
| Laparoscopy | 1 | 0% |
| Laparotomy | 1 | 0% |
| Large intestine infection | 1 | 0% |
| Large intestine perforation | 1 | 0% |
| Laryngeal oedema | 2 | 0% |
| Laryngeal pain | 1 | 0% |
| Laryngeal ulceration | 1 | 0% |
| Laryngitis | 11 | 0.02% |
| Laryngospasm | 1 | 0% |
| Laser therapy | 2 | 0% |
| Laziness | 5 | 0.01% |
| LDL/HDL ratio | 2 | 0% |
| Left-to-right cardiac shunt | 1 | 0% |
| Left atrial enlargement | 2 | 0% |
| Left ventricular dysfunction | 9 | 0.02% |
| Left ventricular end-diastolic pressure increased | 1 | 0% |
| Left ventricular enlargement | 1 | 0% |
| Left ventricular failure | 3 | 0.01% |
| Left ventricular hypertrophy | 2 | 0% |
| Leg amputation | 2 | 0% |
| Legionella test | 4 | 0.01% |
| Leptospira test | 1 | 0% |
| Leptospirosis | 1 | 0% |
| Lethargy | 586 | 1.24% |
| Leukaemia | 1 | 0% |
| Leukocytosis | 17 | 0.04% |
| Leukopenia | 7 | 0.01% |
| Leukoplakia oral | 1 | 0% |
| Libido decreased | 3 | 0.01% |
| Libido increased | 1 | 0% |
| Lichen planus | 1 | 0% |
| Lichen sclerosus | 1 | 0% |
| Life support | 8 | 0.02% |
| Ligamentitis | 1 | 0% |
| Ligament operation | 1 | 0% |
| Ligament pain | 4 | 0.01% |
| Ligament rupture | 2 | 0% |
| Ligament sprain | 7 | 0.01% |
| Limb discomfort | 348 | 0.74% |
| Limb immobilisation | 5 | 0.01% |
| Limb injury | 18 | 0.04% |
| Limb mass | 31 | 0.07% |
| Lipase | 28 | 0.06% |
| Lipase decreased | 1 | 0% |
| Lipase increased | 5 | 0.01% |
| Lipase normal | 17 | 0.04% |
| Lip blister | 16 | 0.03% |
| Lip discolouration | 8 | 0.02% |
| Lip disorder | 8 | 0.02% |
| Lip dry | 16 | 0.03% |
| Lip erythema | 5 | 0.01% |
| Lip exfoliation | 1 | 0% |
| Lipids | 20 | 0.04% |
| Lipids abnormal | 1 | 0% |
| Lipids increased | 1 | 0% |
| Lipids normal | 11 | 0.02% |
| Lip injury | 13 | 0.03% |
| Lipoatrophy | 2 | 0% |
| Lip oedema | 4 | 0.01% |
| Lipoma | 1 | 0% |
| Lip pain | 14 | 0.03% |
| Lip pruritus | 17 | 0.04% |
| Lip scab | 1 | 0% |
| Lip swelling | 234 | 0.49% |
| Lip ulceration | 3 | 0.01% |
| Liquid product physical issue | 3 | 0.01% |
| Listeria test | 1 | 0% |
| Listless | 5 | 0.01% |
| Lithotripsy | 1 | 0% |
| Livedo reticularis | 9 | 0.02% |
| Liver abscess | 1 | 0% |
| Liver disorder | 2 | 0% |
| Liver function test | 21 | 0.04% |
| Liver function test abnormal | 4 | 0.01% |
| Liver function test decreased | 2 | 0% |
| Liver function test increased | 19 | 0.04% |
| Liver function test normal | 16 | 0.03% |
| Liver injury | 4 | 0.01% |
| Localised infection | 5 | 0.01% |
| Localised oedema | 2 | 0% |
| Local reaction | 5 | 0.01% |
| Locked-in syndrome | 1 | 0% |
| Logorrhoea | 1 | 0% |
| Loose body in joint | 1 | 0% |
| Loose tooth | 1 | 0% |
| Loss of bladder sensation | 1 | 0% |
| Loss of consciousness | 1,485 | 3.14% |
| Loss of control of legs | 2 | 0% |
| Loss of libido | 1 | 0% |
| Loss of personal independence in daily activities | 297 | 0.63% |
| Loss of proprioception | 1 | 0% |
| Low density lipoprotein | 4 | 0.01% |
| Low density lipoprotein decreased | 1 | 0% |
| Low density lipoprotein increased | 9 | 0.02% |
| Low density lipoprotein normal | 8 | 0.02% |
| Lower limb fracture | 2 | 0% |
| Lower respiratory tract congestion | 2 | 0% |
| Lower respiratory tract infection | 9 | 0.02% |
| Lumbar puncture | 93 | 0.2% |
| Lumbar puncture abnormal | 31 | 0.07% |
| Lumbar puncture normal | 11 | 0.02% |
| Lumbar radiculopathy | 1 | 0% |
| Lumbar spinal stenosis | 2 | 0% |
| Lumbar vertebral fracture | 1 | 0% |
| Lumbosacral radiculopathy | 1 | 0% |
| Lung assist device therapy | 3 | 0.01% |
| Lung carcinoma cell type unspecified stage IV | 1 | 0% |
| Lung consolidation | 5 | 0.01% |
| Lung disorder | 17 | 0.04% |
| Lung hyperinflation | 1 | 0% |
| Lung infiltration | 21 | 0.04% |
| Lung neoplasm malignant | 1 | 0% |
| Lung opacity | 37 | 0.08% |
| Lyme disease | 14 | 0.03% |
| Lymphadenitis | 12 | 0.03% |
| Lymphadenopathy | 463 | 0.98% |
| Lymphadenopathy mediastinal | 1 | 0% |
| Lymphatic system neoplasm | 1 | 0% |
| Lymph gland infection | 1 | 0% |
| Lymph node pain | 99 | 0.21% |
| Lymph node palpable | 1 | 0% |
| Lymphocyte count | 21 | 0.04% |
| Lymphocyte count decreased | 10 | 0.02% |
| Lymphocyte count increased | 13 | 0.03% |
| Lymphocyte count normal | 19 | 0.04% |
| Lymphocyte morphology abnormal | 1 | 0% |
| Lymphocyte percentage | 16 | 0.03% |
| Lymphocyte percentage decreased | 17 | 0.04% |
| Lymphocyte percentage increased | 4 | 0.01% |
| Lymphocytosis | 1 | 0% |
| Lymphoedema | 6 | 0.01% |
| Lymphopenia | 4 | 0.01% |
| Macular degeneration | 1 | 0% |
| Macular fibrosis | 1 | 0% |
| Macular oedema | 1 | 0% |
| Madarosis | 1 | 0% |
| Magnetic resonance imaging | 439 | 0.93% |
| Magnetic resonance imaging abdominal | 1 | 0% |
| Magnetic resonance imaging abdominal abnormal | 2 | 0% |
| Magnetic resonance imaging abdominal normal | 1 | 0% |
| Magnetic resonance imaging abnormal | 61 | 0.13% |
| Magnetic resonance imaging head | 157 | 0.33% |
| Magnetic resonance imaging head abnormal | 166 | 0.35% |
| Magnetic resonance imaging head normal | 86 | 0.18% |
| Magnetic resonance imaging heart | 15 | 0.03% |
| Magnetic resonance imaging hepatobiliary | 1 | 0% |
| Magnetic resonance imaging hepatobiliary abnormal | 1 | 0% |
| Magnetic resonance imaging joint | 1 | 0% |
| Magnetic resonance imaging neck | 30 | 0.06% |
| Magnetic resonance imaging normal | 96 | 0.2% |
| Magnetic resonance imaging spinal | 28 | 0.06% |
| Magnetic resonance imaging spinal abnormal | 31 | 0.07% |
| Magnetic resonance imaging spinal normal | 12 | 0.03% |
| Magnetic resonance imaging thoracic | 7 | 0.01% |
| Magnetic resonance imaging thoracic abnormal | 7 | 0.01% |
| Magnetic resonance imaging thoracic normal | 3 | 0.01% |
| Major depression | 2 | 0% |
| Malaise | 1,668 | 3.53% |
| Malaria | 2 | 0% |
| Malaria antigen test | 1 | 0% |
| Male genital examination abnormal | 1 | 0% |
| Malnutrition | 2 | 0% |
| Malocclusion | 1 | 0% |
| Mammogram | 18 | 0.04% |
| Mammogram abnormal | 5 | 0.01% |
| Mammogram normal | 2 | 0% |
| Mammoplasty | 1 | 0% |
| Mania | 3 | 0.01% |
| Manufacturing issue | 1 | 0% |
| Marrow hyperplasia | 1 | 0% |
| Mass | 34 | 0.07% |
| Mastectomy | 1 | 0% |
| Mastication disorder | 12 | 0.03% |
| Mastitis | 3 | 0.01% |
| Mastoid effusion | 1 | 0% |
| Maternal exposure before pregnancy | 6 | 0.01% |
| Maternal exposure during breast feeding | 5 | 0.01% |
| Maternal exposure during pregnancy | 11 | 0.02% |
| Maximal voluntary ventilation | 1 | 0% |
| Mean arterial pressure | 1 | 0% |
| Mean cell haemoglobin | 10 | 0.02% |
| Mean cell haemoglobin concentration | 6 | 0.01% |
| Mean cell haemoglobin concentration decreased | 8 | 0.02% |
| Mean cell haemoglobin concentration increased | 2 | 0% |
| Mean cell haemoglobin concentration normal | 32 | 0.07% |
| Mean cell haemoglobin decreased | 5 | 0.01% |
| Mean cell haemoglobin increased | 13 | 0.03% |
| Mean cell haemoglobin normal | 24 | 0.05% |
| Mean cell volume | 9 | 0.02% |
| Mean cell volume decreased | 4 | 0.01% |
| Mean cell volume increased | 11 | 0.02% |
| Mean cell volume normal | 33 | 0.07% |
| Mean platelet volume | 10 | 0.02% |
| Mean platelet volume decreased | 1 | 0% |
| Mean platelet volume increased | 15 | 0.03% |
| Mean platelet volume normal | 20 | 0.04% |
| Measles | 1 | 0% |
| Mechanical urticaria | 2 | 0% |
| Mechanical ventilation | 46 | 0.1% |
| Medial tibial stress syndrome | 1 | 0% |
| Mediastinal mass | 1 | 0% |
| Medical cannabis therapy | 1 | 0% |
| Medical counselling | 1 | 0% |
| Medical device site burn | 1 | 0% |
| Medical diet | 2 | 0% |
| Medical induction of coma | 2 | 0% |
| Medical observation | 2 | 0% |
| Medical observation normal | 1 | 0% |
| Medication error | 48 | 0.1% |
| Meige's syndrome | 1 | 0% |
| Melaena | 4 | 0.01% |
| Melanocytic naevus | 1 | 0% |
| Memory impairment | 98 | 0.21% |
| Menarche | 1 | 0% |
| Meniere's disease | 4 | 0.01% |
| Meningioma | 4 | 0.01% |
| Meningitis | 4 | 0.01% |
| Meningitis aseptic | 2 | 0% |
| Meningitis viral | 2 | 0% |
| Meniscus injury | 3 | 0.01% |
| Menometrorrhagia | 1 | 0% |
| Menopausal symptoms | 4 | 0.01% |
| Menopause | 10 | 0.02% |
| Menstrual discomfort | 1 | 0% |
| Menstrual disorder | 131 | 0.28% |
| Menstruation delayed | 57 | 0.12% |
| Menstruation irregular | 173 | 0.37% |
| Mental disorder | 16 | 0.03% |
| Mental fatigue | 5 | 0.01% |
| Mental impairment | 64 | 0.14% |
| Mental status changes | 57 | 0.12% |
| Merycism | 1 | 0% |
| Mesenteric artery thrombosis | 2 | 0% |
| Mesenteric haemorrhage | 2 | 0% |
| Mesenteric vein thrombosis | 7 | 0.01% |
| Metabolic acidosis | 7 | 0.01% |
| Metabolic encephalopathy | 5 | 0.01% |
| Metabolic function test | 400 | 0.85% |
| Metabolic function test abnormal | 6 | 0.01% |
| Metabolic function test normal | 52 | 0.11% |
| Metabolic syndrome | 1 | 0% |
| Metamorphopsia | 15 | 0.03% |
| Metamyelocyte count | 1 | 0% |
| Metamyelocyte percentage | 1 | 0% |
| Metamyelocyte percentage increased | 1 | 0% |
| Metanephrine urine | 1 | 0% |
| Metastases to liver | 1 | 0% |
| Metastases to lung | 1 | 0% |
| Metastases to lymph nodes | 2 | 0% |
| Metastases to neck | 1 | 0% |
| Methylenetetrahydrofolate reductase gene mutation | 1 | 0% |
| Microalbuminuria | 1 | 0% |
| Microangiopathic haemolytic anaemia | 1 | 0% |
| Microbiology test | 1 | 0% |
| Microbiology test normal | 1 | 0% |
| Microtia | 1 | 0% |
| Microvascular coronary artery disease | 1 | 0% |
| Microvascular cranial nerve palsy | 1 | 0% |
| Micturition urgency | 18 | 0.04% |
| Middle ear effusion | 13 | 0.03% |
| Middle insomnia | 7 | 0.01% |
| Migraine | 938 | 1.98% |
| Migraine with aura | 13 | 0.03% |
| Migraine without aura | 2 | 0% |
| Miliaria | 7 | 0.01% |
| Miller Fisher syndrome | 3 | 0.01% |
| Mineral supplementation | 2 | 0% |
| Mini-tracheostomy | 1 | 0% |
| Miosis | 7 | 0.01% |
| Mitral valve calcification | 2 | 0% |
| Mitral valve incompetence | 8 | 0.02% |
| Mitral valve prolapse | 1 | 0% |
| Mixed incontinence | 1 | 0% |
| Moaning | 13 | 0.03% |
| Mobility decreased | 621 | 1.31% |
| Monocyte count | 11 | 0.02% |
| Monocyte count decreased | 3 | 0.01% |
| Monocyte count increased | 18 | 0.04% |
| Monocyte count normal | 17 | 0.04% |
| Monocyte percentage | 20 | 0.04% |
| Monocyte percentage increased | 9 | 0.02% |
| Monocytosis | 1 | 0% |
| Monofilament pressure perception test abnormal | 1 | 0% |
| Mononucleosis heterophile test | 4 | 0.01% |
| Mononucleosis heterophile test negative | 7 | 0.01% |
| Mononucleosis heterophile test positive | 3 | 0.01% |
| Monoparesis | 3 | 0.01% |
| Monoplegia | 27 | 0.06% |
| Montreal cognitive assessment abnormal | 1 | 0% |
| Mood altered | 10 | 0.02% |
| Mood swings | 13 | 0.03% |
| Morning sickness | 2 | 0% |
| Morphoea | 1 | 0% |
| Motion sickness | 16 | 0.03% |
| Motor developmental delay | 1 | 0% |
| Motor dysfunction | 29 | 0.06% |
| Mouth haemorrhage | 12 | 0.03% |
| Mouth injury | 1 | 0% |
| Mouth swelling | 37 | 0.08% |
| Mouth ulceration | 25 | 0.05% |
| Movement disorder | 123 | 0.26% |
| Mucosal discolouration | 1 | 0% |
| Mucosal disorder | 8 | 0.02% |
| Mucosal dryness | 4 | 0.01% |
| Mucosal haemorrhage | 2 | 0% |
| Mucosal hypertrophy | 1 | 0% |
| Mucosal inflammation | 1 | 0% |
| Mucous stools | 2 | 0% |
| Multifocal motor neuropathy | 1 | 0% |
| Multipathogen PCR test | 2 | 0% |
| Multiple allergies | 4 | 0.01% |
| Multiple chemical sensitivity | 1 | 0% |
| Multiple fractures | 1 | 0% |
| Multiple injuries | 1 | 0% |
| Multiple organ dysfunction syndrome | 13 | 0.03% |
| Multiple pregnancy | 1 | 0% |
| Multiple sclerosis | 13 | 0.03% |
| Multiple sclerosis relapse | 2 | 0% |
| Multiple use of single-use product | 1 | 0% |
| Multisystem inflammatory syndrome in children | 1 | 0% |
| Mumps | 1 | 0% |
| Muscle atrophy | 9 | 0.02% |
| Muscle contractions involuntary | 28 | 0.06% |
| Muscle contracture | 20 | 0.04% |
| Muscle discomfort | 12 | 0.03% |
| Muscle disorder | 14 | 0.03% |
| Muscle fatigue | 54 | 0.11% |
| Muscle injury | 3 | 0.01% |
| Muscle mass | 2 | 0% |
| Muscle oedema | 2 | 0% |
| Muscle rigidity | 28 | 0.06% |
| Muscle rupture | 3 | 0.01% |
| Muscle spasms | 946 | 2% |
| Muscle spasticity | 5 | 0.01% |
| Muscle strain | 32 | 0.07% |
| Muscle strength abnormal | 2 | 0% |
| Muscle swelling | 11 | 0.02% |
| Muscle tightness | 212 | 0.45% |
| Muscle twitching | 176 | 0.37% |
| Muscular weakness | 601 | 1.27% |
| Musculoskeletal chest pain | 87 | 0.18% |
| Musculoskeletal discomfort | 103 | 0.22% |
| Musculoskeletal disorder | 10 | 0.02% |
| Musculoskeletal injury | 1 | 0% |
| Musculoskeletal pain | 59 | 0.12% |
| Musculoskeletal stiffness | 493 | 1.04% |
| Myalgia | 3,769 | 7.97% |
| Myasthenia gravis | 5 | 0.01% |
| Myasthenia gravis crisis | 1 | 0% |
| Mycobacterium test negative | 1 | 0% |
| Mycobacterium tuberculosis complex test | 3 | 0.01% |
| Mycobacterium tuberculosis complex test negative | 2 | 0% |
| Mycobacterium tuberculosis complex test positive | 1 | 0% |
| Mycoplasma test | 1 | 0% |
| Mycoplasma test negative | 1 | 0% |
| Mydriasis | 32 | 0.07% |
| Myelitis | 4 | 0.01% |
| Myelitis transverse | 16 | 0.03% |
| Myeloblast count | 1 | 0% |
| Myeloblast percentage | 1 | 0% |
| Myelocyte count | 1 | 0% |
| Myelocyte percentage | 1 | 0% |
| Myelomalacia | 1 | 0% |
| Myelopathy | 2 | 0% |
| Myocardial bridging | 1 | 0% |
| Myocardial fibrosis | 1 | 0% |
| Myocardial infarction | 95 | 0.2% |
| Myocardial ischaemia | 6 | 0.01% |
| Myocardial necrosis marker | 10 | 0.02% |
| Myocardial necrosis marker increased | 9 | 0.02% |
| Myocardial necrosis marker normal | 9 | 0.02% |
| Myocardial strain | 16 | 0.03% |
| Myocarditis | 30 | 0.06% |
| Myoclonic epilepsy | 1 | 0% |
| Myoclonus | 3 | 0.01% |
| Myoglobin blood | 2 | 0% |
| Myoglobin blood increased | 1 | 0% |
| Myoglobin blood present | 1 | 0% |
| Myopathy | 2 | 0% |
| Myosclerosis | 2 | 0% |
| Myositis | 10 | 0.02% |
| Myringitis | 1 | 0% |
| N-terminal prohormone brain natriuretic peptide | 8 | 0.02% |
| N-terminal prohormone brain natriuretic peptide increased | 10 | 0.02% |
| Nail bed disorder | 2 | 0% |
| Nail discolouration | 17 | 0.04% |
| Nail growth abnormal | 1 | 0% |
| Nail ridging | 1 | 0% |
| Narcolepsy | 3 | 0.01% |
| Nasal cavity packing | 2 | 0% |
| Nasal congestion | 264 | 0.56% |
| Nasal discomfort | 19 | 0.04% |
| Nasal disorder | 3 | 0.01% |
| Nasal dryness | 5 | 0.01% |
| Nasal herpes | 1 | 0% |
| Nasal inflammation | 3 | 0.01% |
| Nasal injury | 5 | 0.01% |
| Nasal mucosal discolouration | 1 | 0% |
| Nasal obstruction | 1 | 0% |
| Nasal oedema | 7 | 0.01% |
| Nasal polyps | 1 | 0% |
| Nasal pruritus | 8 | 0.02% |
| Nasal ulcer | 2 | 0% |
| Nasoendoscopy | 3 | 0.01% |
| Nasopharyngitis | 293 | 0.62% |
| Nausea | 6,946 | 14.69% |
| Near death experience | 3 | 0.01% |
| Neck injury | 5 | 0.01% |
| Neck mass | 13 | 0.03% |
| Neck pain | 847 | 1.79% |
| Necrosis | 1 | 0% |
| Necrotising fasciitis | 1 | 0% |
| Needle issue | 23 | 0.05% |
| Negative thoughts | 1 | 0% |
| Neisseria test | 1 | 0% |
| Neoplasm | 1 | 0% |
| Nephritis | 1 | 0% |
| Nephrolithiasis | 21 | 0.04% |
| Nephropathy toxic | 1 | 0% |
| Nephrotic syndrome | 2 | 0% |
| Nerve block | 2 | 0% |
| Nerve compression | 12 | 0.03% |
| Nerve conduction studies | 17 | 0.04% |
| Nerve conduction studies abnormal | 5 | 0.01% |
| Nerve conduction studies normal | 2 | 0% |
| Nerve injury | 25 | 0.05% |
| Nerve stimulation test abnormal | 1 | 0% |
| Nerve stimulation test normal | 3 | 0.01% |
| Nervousness | 164 | 0.35% |
| Nervous system cyst | 1 | 0% |
| Nervous system disorder | 26 | 0.05% |
| Neuralgia | 186 | 0.39% |
| Neuritis | 5 | 0.01% |
| Neuro-ophthalmological test | 1 | 0% |
| Neurodevelopment test | 1 | 0% |
| Neuroendocrine tumour | 1 | 0% |
| Neurogenic bladder | 1 | 0% |
| Neurological complication associated with device | 1 | 0% |
| Neurological examination | 26 | 0.05% |
| Neurological examination abnormal | 9 | 0.02% |
| Neurological examination normal | 10 | 0.02% |
| Neurological eyelid disorder | 1 | 0% |
| Neurological symptom | 66 | 0.14% |
| Neuromyelitis optica spectrum disorder | 2 | 0% |
| Neuropathy peripheral | 55 | 0.12% |
| Neuropsychiatric symptoms | 1 | 0% |
| Neurosarcoidosis | 1 | 0% |
| Neutralising antibodies | 2 | 0% |
| Neutropenia | 5 | 0.01% |
| Neutrophil count | 18 | 0.04% |
| Neutrophil count decreased | 12 | 0.03% |
| Neutrophil count increased | 12 | 0.03% |
| Neutrophil count normal | 18 | 0.04% |
| Neutrophilia | 4 | 0.01% |
| Neutrophil percentage | 14 | 0.03% |
| Neutrophil percentage decreased | 6 | 0.01% |
| Neutrophil percentage increased | 17 | 0.04% |
| New daily persistent headache | 10 | 0.02% |
| Nicotine dependence | 1 | 0% |
| Night blindness | 1 | 0% |
| Nightmare | 37 | 0.08% |
| Night sweats | 244 | 0.52% |
| NIH stroke scale | 1 | 0% |
| NIH stroke scale score increased | 4 | 0.01% |
| Nikolsky's sign | 1 | 0% |
| Nipple disorder | 1 | 0% |
| Nipple pain | 5 | 0.01% |
| Nitrite urine | 1 | 0% |
| Nitrite urine absent | 9 | 0.02% |
| Nitrite urine present | 2 | 0% |
| No adverse event | 537 | 1.14% |
| Nocturia | 2 | 0% |
| Nodal rhythm | 2 | 0% |
| Nodule | 100 | 0.21% |
| Non-cardiac chest pain | 2 | 0% |
| Non-high-density lipoprotein cholesterol | 1 | 0% |
| Non-high-density lipoprotein cholesterol increased | 1 | 0% |
| Non-neutralising antibodies negative | 1 | 0% |
| Noninfective encephalitis | 3 | 0.01% |
| Noninfective gingivitis | 4 | 0.01% |
| Noninfective sialoadenitis | 1 | 0% |
| Nonspecific reaction | 13 | 0.03% |
| No reaction on previous exposure to drug | 1 | 0% |
| Normochromic anaemia | 1 | 0% |
| Normocytic anaemia | 1 | 0% |
| Nuchal rigidity | 2 | 0% |
| Nucleated red cells | 6 | 0.01% |
| Nucleic acid test | 6 | 0.01% |
| Numb chin syndrome | 3 | 0.01% |
| Nystagmus | 5 | 0.01% |
| Obesity | 1 | 0% |
| Obsessive-compulsive disorder | 1 | 0% |
| Obstructive airways disorder | 11 | 0.02% |
| Obstructive pancreatitis | 1 | 0% |
| Obstructive shock | 1 | 0% |
| Obturator neuropathy | 1 | 0% |
| Occipital neuralgia | 2 | 0% |
| Occult blood | 4 | 0.01% |
| Occult blood negative | 1 | 0% |
| Occult blood positive | 2 | 0% |
| Occupational exposure to product | 1 | 0% |
| Occupational exposure to SARS-CoV-2 | 2 | 0% |
| Ocular discomfort | 88 | 0.19% |
| Ocular hyperaemia | 97 | 0.21% |
| Ocular icterus | 1 | 0% |
| Odynophagia | 13 | 0.03% |
| Oedema | 28 | 0.06% |
| Oedema mucosal | 1 | 0% |
| Oedema peripheral | 110 | 0.23% |
| Oesophageal achalasia | 1 | 0% |
| Oesophageal discomfort | 1 | 0% |
| Oesophageal disorder | 3 | 0.01% |
| Oesophageal motility disorder | 1 | 0% |
| Oesophageal pain | 2 | 0% |
| Oesophageal rupture | 2 | 0% |
| Oesophageal spasm | 2 | 0% |
| Oesophageal stenosis | 1 | 0% |
| Oesophagitis | 5 | 0.01% |
| Oesophagogastric fundoplasty | 1 | 0% |
| Oesophagogastroduodenoscopy | 1 | 0% |
| Oesophagogastroduodenoscopy normal | 1 | 0% |
| Office visit | 4 | 0.01% |
| Off label use | 147 | 0.31% |
| Oligomenorrhoea | 35 | 0.07% |
| Oliguria | 1 | 0% |
| On and off phenomenon | 16 | 0.03% |
| Onychoclasis | 1 | 0% |
| Onychomadesis | 1 | 0% |
| Open reduction of fracture | 3 | 0.01% |
| Ophthalmic artery thrombosis | 1 | 0% |
| Ophthalmic fluid drainage | 1 | 0% |
| Ophthalmic herpes zoster | 1 | 0% |
| Ophthalmic migraine | 7 | 0.01% |
| Ophthalmic scan | 3 | 0.01% |
| Ophthalmological examination | 35 | 0.07% |
| Ophthalmological examination abnormal | 8 | 0.02% |
| Ophthalmological examination normal | 4 | 0.01% |
| Ophthalmoplegia | 1 | 0% |
| Opisthotonus | 2 | 0% |
| Optical coherence tomography | 2 | 0% |
| Optical coherence tomography abnormal | 3 | 0.01% |
| Optic ischaemic neuropathy | 5 | 0.01% |
| Optic nerve cupping | 1 | 0% |
| Optic nerve disorder | 5 | 0.01% |
| Optic nerve injury | 2 | 0% |
| Optic neuritis | 7 | 0.01% |
| Oral blood blister | 2 | 0% |
| Oral candidiasis | 6 | 0.01% |
| Oral contraception | 4 | 0.01% |
| Oral contusion | 1 | 0% |
| Oral discomfort | 31 | 0.07% |
| Oral disorder | 5 | 0.01% |
| Oral dysaesthesia | 1 | 0% |
| Oral fungal infection | 1 | 0% |
| Oral herpes | 71 | 0.15% |
| Oral lichen planus | 1 | 0% |
| Oral mucosal blistering | 23 | 0.05% |
| Oral mucosal discolouration | 2 | 0% |
| Oral mucosal eruption | 8 | 0.02% |
| Oral mucosal erythema | 2 | 0% |
| Oral mucosal exfoliation | 1 | 0% |
| Oral pain | 36 | 0.08% |
| Oral pruritus | 21 | 0.04% |
| Oral surgery | 1 | 0% |
| Oral viral infection | 1 | 0% |
| Orbital swelling | 1 | 0% |
| Orchitis noninfective | 1 | 0% |
| Organ failure | 2 | 0% |
| Organic erectile dysfunction | 1 | 0% |
| Oropharyngeal blistering | 2 | 0% |
| Oropharyngeal discomfort | 63 | 0.13% |
| Oropharyngeal oedema | 1 | 0% |
| Oropharyngeal pain | 640 | 1.35% |
| Orthopnoea | 2 | 0% |
| Orthostatic hypotension | 10 | 0.02% |
| Oscillopsia | 3 | 0.01% |
| Osteitis | 2 | 0% |
| Osteoarthritis | 6 | 0.01% |
| Osteolysis | 1 | 0% |
| Osteomyelitis | 1 | 0% |
| Osteonecrosis | 1 | 0% |
| Osteoporosis | 1 | 0% |
| Otitis externa | 1 | 0% |
| Otitis media | 4 | 0.01% |
| Otorrhoea | 4 | 0.01% |
| Otoscopy normal | 1 | 0% |
| Ototoxicity | 1 | 0% |
| Ovarian cancer | 1 | 0% |
| Ovarian cyst | 10 | 0.02% |
| Ovarian cyst ruptured | 1 | 0% |
| Ovarian disorder | 2 | 0% |
| Ovarian mass | 1 | 0% |
| Ovarian vein thrombosis | 3 | 0.01% |
| Overdose | 19 | 0.04% |
| Oversensing | 2 | 0% |
| Oxygenation index | 1 | 0% |
| Oxygen consumption | 2 | 0% |
| Oxygen consumption decreased | 1 | 0% |
| Oxygen saturation | 123 | 0.26% |
| Oxygen saturation abnormal | 1 | 0% |
| Oxygen saturation decreased | 74 | 0.16% |
| Oxygen saturation increased | 1 | 0% |
| Oxygen saturation normal | 2 | 0% |
| Oxygen therapy | 5 | 0.01% |
| Pacemaker generated rhythm | 1 | 0% |
| Packed red blood cell transfusion | 4 | 0.01% |
| Pain | 8,775 | 18.56% |
| Pain assessment | 56 | 0.12% |
| Painful respiration | 58 | 0.12% |
| Pain in extremity | 4,978 | 10.53% |
| Pain in jaw | 147 | 0.31% |
| Pain of skin | 139 | 0.29% |
| Palatal disorder | 2 | 0% |
| Palatal swelling | 2 | 0% |
| Pallor | 735 | 1.55% |
| Palmar-plantar erythrodysaesthesia syndrome | 1 | 0% |
| Palmar erythema | 2 | 0% |
| Palpable purpura | 2 | 0% |
| Palpatory finding abnormal | 1 | 0% |
| Palpitations | 816 | 1.73% |
| Pancreatic cyst | 1 | 0% |
| Pancreatic disorder | 2 | 0% |
| Pancreatic enzymes increased | 3 | 0.01% |
| Pancreatic mass | 1 | 0% |
| Pancreatitis | 9 | 0.02% |
| Pancreatitis acute | 7 | 0.01% |
| Pancytopenia | 3 | 0.01% |
| Panel-reactive antibody | 1 | 0% |
| Panic attack | 103 | 0.22% |
| Panic disorder | 3 | 0.01% |
| Panic reaction | 15 | 0.03% |
| Papillitis | 1 | 0% |
| Papilloedema | 2 | 0% |
| Papule | 2 | 0% |
| Paracentesis | 1 | 0% |
| Paradoxical embolism | 1 | 0% |
| Paraesthesia | 1,759 | 3.72% |
| Paraesthesia mucosal | 1 | 0% |
| Paraesthesia oral | 268 | 0.57% |
| Paralysis | 62 | 0.13% |
| Paranasal sinus discomfort | 81 | 0.17% |
| Paranasal sinus hypersecretion | 2 | 0% |
| Paranasal sinus hyposecretion | 1 | 0% |
| Paranasal sinus inflammation | 5 | 0.01% |
| Paranoia | 10 | 0.02% |
| Paraplegia | 2 | 0% |
| Parasite blood test | 2 | 0% |
| Parasite DNA test | 1 | 0% |
| Parasite stool test negative | 2 | 0% |
| Paresis | 2 | 0% |
| Parkinson's disease | 2 | 0% |
| Paronychia | 1 | 0% |
| Parosmia | 94 | 0.2% |
| Parotitis | 1 | 0% |
| Partial seizures | 7 | 0.01% |
| Parvovirus B19 test | 1 | 0% |
| Passive smoking | 1 | 0% |
| Patella fracture | 1 | 0% |
| Pathology test | 8 | 0.02% |
| Patient uncooperative | 1 | 0% |
| PCO2 | 2 | 0% |
| PCO2 decreased | 3 | 0.01% |
| PCO2 increased | 4 | 0.01% |
| PCO2 normal | 2 | 0% |
| Peak expiratory flow rate decreased | 1 | 0% |
| Pectus excavatum | 1 | 0% |
| Pelvic congestion | 2 | 0% |
| Pelvic discomfort | 1 | 0% |
| Pelvic fluid collection | 1 | 0% |
| Pelvic pain | 30 | 0.06% |
| Pelvic venous thrombosis | 8 | 0.02% |
| Pemphigoid | 2 | 0% |
| Penile erythema | 1 | 0% |
| Penile haemorrhage | 2 | 0% |
| Penile oedema | 2 | 0% |
| Penile pain | 1 | 0% |
| Penile rash | 1 | 0% |
| Peptic ulcer | 1 | 0% |
| Percutaneous coronary intervention | 4 | 0.01% |
| Perforated ulcer | 1 | 0% |
| Perfusion brain scan | 1 | 0% |
| Perfusion brain scan abnormal | 3 | 0.01% |
| Perfusion brain scan normal | 3 | 0.01% |
| Periarthritis | 17 | 0.04% |
| Pericardial drainage | 3 | 0.01% |
| Pericardial effusion | 28 | 0.06% |
| Pericardial excision | 1 | 0% |
| Pericarditis | 58 | 0.12% |
| Perineal pain | 1 | 0% |
| Periodontitis | 1 | 0% |
| Perioral dermatitis | 1 | 0% |
| Periorbital cellulitis | 1 | 0% |
| Periorbital haemorrhage | 1 | 0% |
| Periorbital oedema | 1 | 0% |
| Periorbital pain | 10 | 0.02% |
| Periorbital swelling | 32 | 0.07% |
| Peripheral arterial occlusive disease | 3 | 0.01% |
| Peripheral artery aneurysm | 1 | 0% |
| Peripheral artery occlusion | 5 | 0.01% |
| Peripheral artery stenosis | 2 | 0% |
| Peripheral artery thrombosis | 8 | 0.02% |
| Peripheral circulatory failure | 1 | 0% |
| Peripheral coldness | 156 | 0.33% |
| Peripheral embolism | 16 | 0.03% |
| Peripheral ischaemia | 6 | 0.01% |
| Peripheral nerve injury | 1 | 0% |
| Peripheral pulse decreased | 1 | 0% |
| Peripheral swelling | 966 | 2.04% |
| Peripheral vascular disorder | 4 | 0.01% |
| Peripheral vein occlusion | 8 | 0.02% |
| Peripheral vein thrombus extension | 6 | 0.01% |
| Peripheral venous disease | 6 | 0.01% |
| Peritonitis | 1 | 0% |
| Peritonsillar abscess | 2 | 0% |
| Peroneal nerve palsy | 3 | 0.01% |
| Persistent postural-perceptual dizziness | 1 | 0% |
| Personality change | 2 | 0% |
| Pertussis | 1 | 0% |
| Petechiae | 95 | 0.2% |
| Petit mal epilepsy | 6 | 0.01% |
| Phantom limb syndrome | 3 | 0.01% |
| Pharyngeal disorder | 4 | 0.01% |
| Pharyngeal erythema | 6 | 0.01% |
| Pharyngeal haematoma | 1 | 0% |
| Pharyngeal haemorrhage | 1 | 0% |
| Pharyngeal hypoaesthesia | 20 | 0.04% |
| Pharyngeal inflammation | 1 | 0% |
| Pharyngeal oedema | 3 | 0.01% |
| Pharyngeal paraesthesia | 42 | 0.09% |
| Pharyngeal swelling | 225 | 0.48% |
| Pharyngeal ulceration | 2 | 0% |
| Pharyngitis | 13 | 0.03% |
| Pharyngitis streptococcal | 2 | 0% |
| pH body fluid | 1 | 0% |
| pH body fluid abnormal | 1 | 0% |
| Phlebitis | 5 | 0.01% |
| Phlebitis superficial | 3 | 0.01% |
| Phlebotomy | 2 | 0% |
| Phobia | 3 | 0.01% |
| Phobia of driving | 1 | 0% |
| Photodermatosis | 1 | 0% |
| Photophobia | 198 | 0.42% |
| Photopsia | 29 | 0.06% |
| Photosensitivity reaction | 31 | 0.07% |
| pH urine | 2 | 0% |
| pH urine normal | 8 | 0.02% |
| Physical deconditioning | 2 | 0% |
| Physical disability | 1 | 0% |
| Physical examination | 57 | 0.12% |
| Physical examination abnormal | 2 | 0% |
| Physical examination normal | 3 | 0.01% |
| Physical product label issue | 1 | 0% |
| Physiotherapy | 2 | 0% |
| Pigmentation disorder | 1 | 0% |
| Piloerection | 24 | 0.05% |
| Pinguecula | 1 | 0% |
| Pinta | 1 | 0% |
| Piriformis syndrome | 1 | 0% |
| Pituitary scan | 1 | 0% |
| Pituitary tumour benign | 1 | 0% |
| Pityriasis | 1 | 0% |
| Pityriasis rosea | 11 | 0.02% |
| Placental disorder | 1 | 0% |
| Plantar fasciitis | 3 | 0.01% |
| Plasmapheresis | 12 | 0.03% |
| Plasminogen activator inhibitor | 3 | 0.01% |
| Platelet aggregation test | 2 | 0% |
| Platelet count | 151 | 0.32% |
| Platelet count abnormal | 1 | 0% |
| Platelet count decreased | 202 | 0.43% |
| Platelet count increased | 29 | 0.06% |
| Platelet count normal | 186 | 0.39% |
| Platelet destruction increased | 1 | 0% |
| Platelet disorder | 6 | 0.01% |
| Platelet factor 4 | 19 | 0.04% |
| Platelet factor 4 decreased | 1 | 0% |
| Platelet factor 4 increased | 1 | 0% |
| Platelet morphology | 1 | 0% |
| Platelet morphology normal | 1 | 0% |
| Platelet storage pool deficiency | 1 | 0% |
| Platelet transfusion | 16 | 0.03% |
| Pleocytosis | 3 | 0.01% |
| Pleural effusion | 29 | 0.06% |
| Pleural thickening | 1 | 0% |
| Pleurisy | 9 | 0.02% |
| Pleuritic pain | 22 | 0.05% |
| Pleuropericarditis | 1 | 0% |
| Pneumatosis intestinalis | 2 | 0% |
| Pneumobilia | 1 | 0% |
| Pneumococcal infection | 1 | 0% |
| Pneumonia | 137 | 0.29% |
| Pneumonia aspiration | 3 | 0.01% |
| Pneumonia pseudomonal | 1 | 0% |
| Pneumonia staphylococcal | 1 | 0% |
| Pneumonia viral | 1 | 0% |
| Pneumonitis | 13 | 0.03% |
| Pneumothorax | 7 | 0.01% |
| Pneumothorax traumatic | 1 | 0% |
| PO2 | 2 | 0% |
| PO2 decreased | 5 | 0.01% |
| PO2 increased | 1 | 0% |
| PO2 normal | 1 | 0% |
| Poisoning | 2 | 0% |
| Pollakiuria | 64 | 0.14% |
| Polyarteritis nodosa | 1 | 0% |
| Polyarthritis | 4 | 0.01% |
| Polychromasia | 1 | 0% |
| Polychromic red blood cells present | 1 | 0% |
| Polycythaemia | 2 | 0% |
| Polydipsia | 2 | 0% |
| Polymenorrhagia | 1 | 0% |
| Polymenorrhoea | 30 | 0.06% |
| Polymerase chain reaction | 34 | 0.07% |
| Polymerase chain reaction positive | 2 | 0% |
| Polyneuropathy | 4 | 0.01% |
| Polyp | 2 | 0% |
| Polyuria | 9 | 0.02% |
| Poor peripheral circulation | 15 | 0.03% |
| Poor quality product administered | 240 | 0.51% |
| Poor quality sleep | 54 | 0.11% |
| Poor venous access | 2 | 0% |
| Portal shunt procedure | 1 | 0% |
| Portal vein dilatation | 1 | 0% |
| Portal vein thrombosis | 19 | 0.04% |
| Portal venous gas | 1 | 0% |
| Portosplenomesenteric venous thrombosis | 3 | 0.01% |
| Positron emission tomogram | 10 | 0.02% |
| Positron emission tomogram abnormal | 1 | 0% |
| Positron emission tomogram normal | 1 | 0% |
| Post-acute COVID-19 syndrome | 5 | 0.01% |
| Post-traumatic neck syndrome | 1 | 0% |
| Post-traumatic stress disorder | 1 | 0% |
| Post concussion syndrome | 1 | 0% |
| Posterior reversible encephalopathy syndrome | 2 | 0% |
| Post herpetic neuralgia | 1 | 0% |
| Postictal state | 9 | 0.02% |
| Post lumbar puncture syndrome | 1 | 0% |
| Postmenopausal haemorrhage | 31 | 0.07% |
| Postmenopause | 4 | 0.01% |
| Postoperative thrombosis | 1 | 0% |
| Postoperative wound complication | 1 | 0% |
| Postpartum state | 1 | 0% |
| Postpartum thrombosis | 1 | 0% |
| Postpartum venous thrombosis | 1 | 0% |
| Post procedural complication | 1 | 0% |
| Post procedural haemorrhage | 3 | 0.01% |
| Post stroke depression | 1 | 0% |
| Post thrombotic syndrome | 1 | 0% |
| Postural orthostatic tachycardia syndrome | 7 | 0.01% |
| Posture abnormal | 51 | 0.11% |
| Posturing | 1 | 0% |
| Post vaccination syndrome | 1 | 0% |
| Pre-eclampsia | 3 | 0.01% |
| Pre-existing condition improved | 3 | 0.01% |
| Precancerous skin lesion | 1 | 0% |
| Pregnancy | 10 | 0.02% |
| Pregnancy test | 25 | 0.05% |
| Pregnancy test negative | 14 | 0.03% |
| Pregnancy test positive | 4 | 0.01% |
| Pregnancy test urine | 5 | 0.01% |
| Pregnancy test urine negative | 6 | 0.01% |
| Pregnancy test urine positive | 1 | 0% |
| Premature delivery | 2 | 0% |
| Premature labour | 2 | 0% |
| Premature rupture of membranes | 1 | 0% |
| Premature separation of placenta | 2 | 0% |
| Premenstrual dysphoric disorder | 1 | 0% |
| Premenstrual syndrome | 7 | 0.01% |
| Presyncope | 319 | 0.67% |
| Primigravida | 1 | 0% |
| Primiparous | 1 | 0% |
| Procalcitonin | 6 | 0.01% |
| Procalcitonin decreased | 1 | 0% |
| Procalcitonin increased | 5 | 0.01% |
| Procalcitonin normal | 3 | 0.01% |
| Procedural complication | 1 | 0% |
| Procedural pain | 3 | 0.01% |
| Procedural site reaction | 1 | 0% |
| Procedure aborted | 1 | 0% |
| Proctitis | 3 | 0.01% |
| Product administered at inappropriate site | 24 | 0.05% |
| Product administered to patient of inappropriate age | 786 | 1.66% |
| Product administration error | 67 | 0.14% |
| Product availability issue | 1 | 0% |
| Product barcode issue | 1 | 0% |
| Product colour issue | 4 | 0.01% |
| Product complaint | 2 | 0% |
| Product container issue | 9 | 0.02% |
| Product dispensing error | 9 | 0.02% |
| Product dispensing issue | 5 | 0.01% |
| Product dose omission in error | 1 | 0% |
| Product dose omission issue | 2 | 0% |
| Product intolerance | 1 | 0% |
| Productive cough | 77 | 0.16% |
| Product label confusion | 2 | 0% |
| Product label issue | 4 | 0.01% |
| Product leakage | 2 | 0% |
| Product packaging quantity issue | 4 | 0.01% |
| Product preparation error | 3 | 0.01% |
| Product preparation issue | 6 | 0.01% |
| Product quality issue | 4 | 0.01% |
| Product reconstitution quality issue | 2 | 0% |
| Product storage error | 338 | 0.71% |
| Product temperature excursion issue | 25 | 0.05% |
| Product use in unapproved indication | 1 | 0% |
| Product use issue | 14 | 0.03% |
| Progesterone decreased | 1 | 0% |
| Progressive multifocal leukoencephalopathy | 1 | 0% |
| Prohormone brain natriuretic peptide | 1 | 0% |
| Promyelocyte count | 1 | 0% |
| Prone position | 1 | 0% |
| Prophylaxis | 1 | 0% |
| Prophylaxis of nausea and vomiting | 1 | 0% |
| Prostate cancer | 1 | 0% |
| Prostate examination | 2 | 0% |
| Prostate infection | 1 | 0% |
| Prostatic operation | 1 | 0% |
| Prostatic specific antigen | 3 | 0.01% |
| Prostatic specific antigen decreased | 1 | 0% |
| Prostatic specific antigen increased | 1 | 0% |
| Prostatic specific antigen normal | 1 | 0% |
| Prostatitis | 3 | 0.01% |
| Prostatomegaly | 2 | 0% |
| Prosthetic cardiac valve thrombosis | 1 | 0% |
| Protein albumin ratio abnormal | 1 | 0% |
| Protein C | 6 | 0.01% |
| Protein C deficiency | 1 | 0% |
| Protein C increased | 1 | 0% |
| Protein deficiency | 1 | 0% |
| Protein S | 5 | 0.01% |
| Protein S decreased | 1 | 0% |
| Protein S deficiency | 1 | 0% |
| Protein S increased | 1 | 0% |
| Protein S normal | 1 | 0% |
| Protein total | 10 | 0.02% |
| Protein total decreased | 7 | 0.01% |
| Protein total increased | 11 | 0.02% |
| Protein total normal | 29 | 0.06% |
| Protein urine | 4 | 0.01% |
| Protein urine absent | 7 | 0.01% |
| Protein urine present | 8 | 0.02% |
| Prothrombin level | 5 | 0.01% |
| Prothrombin level increased | 1 | 0% |
| Prothrombin level normal | 4 | 0.01% |
| Prothrombin time | 55 | 0.12% |
| Prothrombin time normal | 30 | 0.06% |
| Prothrombin time prolonged | 16 | 0.03% |
| Prothrombin time ratio | 1 | 0% |
| Prothrombin time shortened | 6 | 0.01% |
| Pruritus | 1,192 | 2.52% |
| Pruritus genital | 2 | 0% |
| Pseudohyponatraemia | 1 | 0% |
| Pseudomonas infection | 1 | 0% |
| Psoriasis | 20 | 0.04% |
| Psoriatic arthropathy | 7 | 0.01% |
| Psychiatric evaluation | 1 | 0% |
| Psychiatric symptom | 2 | 0% |
| Psychogenic seizure | 3 | 0.01% |
| Psychomotor hyperactivity | 17 | 0.04% |
| Psychomotor retardation | 2 | 0% |
| Psychomotor skills impaired | 1 | 0% |
| Psychotic behaviour | 1 | 0% |
| Psychotic disorder | 6 | 0.01% |
| Pulmonary arterial hypertension | 3 | 0.01% |
| Pulmonary arterial pressure abnormal | 2 | 0% |
| Pulmonary artery compression | 1 | 0% |
| Pulmonary artery dilatation | 2 | 0% |
| Pulmonary artery thrombosis | 4 | 0.01% |
| Pulmonary calcification | 1 | 0% |
| Pulmonary congestion | 16 | 0.03% |
| Pulmonary embolism | 450 | 0.95% |
| Pulmonary fibrosis | 2 | 0% |
| Pulmonary function test | 16 | 0.03% |
| Pulmonary function test abnormal | 6 | 0.01% |
| Pulmonary function test decreased | 2 | 0% |
| Pulmonary function test normal | 3 | 0.01% |
| Pulmonary haemorrhage | 2 | 0% |
| Pulmonary hypertension | 11 | 0.02% |
| Pulmonary imaging procedure | 2 | 0% |
| Pulmonary imaging procedure abnormal | 1 | 0% |
| Pulmonary infarction | 11 | 0.02% |
| Pulmonary mass | 9 | 0.02% |
| Pulmonary microemboli | 1 | 0% |
| Pulmonary oedema | 23 | 0.05% |
| Pulmonary pain | 42 | 0.09% |
| Pulmonary physical examination | 2 | 0% |
| Pulmonary thrombosis | 86 | 0.18% |
| Pulmonary vasculitis | 1 | 0% |
| Pulmonary venous thrombosis | 2 | 0% |
| Pulpitis dental | 1 | 0% |
| Pulse abnormal | 18 | 0.04% |
| Pulse absent | 23 | 0.05% |
| Pulseless electrical activity | 11 | 0.02% |
| Pulse pressure abnormal | 1 | 0% |
| Pulse pressure increased | 1 | 0% |
| Pupil dilation procedure | 2 | 0% |
| Pupil fixed | 2 | 0% |
| Pupillary light reflex tests abnormal | 1 | 0% |
| Pupillary reflex impaired | 2 | 0% |
| Purpura | 24 | 0.05% |
| Purpura non-thrombocytopenic | 1 | 0% |
| Purulent discharge | 1 | 0% |
| Pustule | 16 | 0.03% |
| Pyelonephritis | 1 | 0% |
| Pyelonephritis acute | 1 | 0% |
| Pyloric sphincter insufficiency | 1 | 0% |
| Pyoderma gangrenosum | 1 | 0% |
| Pyrexia | 11,144 | 23.57% |
| QRS axis abnormal | 3 | 0.01% |
| Quality of life decreased | 4 | 0.01% |
| Radial nerve compression | 1 | 0% |
| Radial nerve injury | 1 | 0% |
| Radial nerve palsy | 1 | 0% |
| Radial pulse | 1 | 0% |
| Radial pulse abnormal | 1 | 0% |
| Radiculitis brachial | 1 | 0% |
| Radiculopathy | 4 | 0.01% |
| Radioactive iodine therapy | 1 | 0% |
| Radioisotope scan | 1 | 0% |
| Radiotherapy | 2 | 0% |
| Radius fracture | 1 | 0% |
| Rales | 4 | 0.01% |
| Rash | 1,814 | 3.84% |
| Rash erythematous | 287 | 0.61% |
| Rash macular | 150 | 0.32% |
| Rash maculo-papular | 14 | 0.03% |
| Rash morbilliform | 8 | 0.02% |
| Rash papular | 91 | 0.19% |
| Rash pruritic | 342 | 0.72% |
| Rash pustular | 6 | 0.01% |
| Rash vesicular | 24 | 0.05% |
| Raynaud's phenomenon | 8 | 0.02% |
| Reaction to previous exposure to any vaccine | 2 | 0% |
| Reading disorder | 3 | 0.01% |
| Rectal examination abnormal | 1 | 0% |
| Rectal haemorrhage | 31 | 0.07% |
| Rectal polypectomy | 1 | 0% |
| Red blood cell abnormality | 3 | 0.01% |
| Red blood cell agglutination | 1 | 0% |
| Red blood cell analysis | 1 | 0% |
| Red blood cell count | 13 | 0.03% |
| Red blood cell count abnormal | 3 | 0.01% |
| Red blood cell count decreased | 31 | 0.07% |
| Red blood cell count increased | 9 | 0.02% |
| Red blood cell count normal | 35 | 0.07% |
| Red blood cell enzymes abnormal | 1 | 0% |
| Red blood cell morphology | 1 | 0% |
| Red blood cell nucleated morphology | 9 | 0.02% |
| Red blood cell nucleated morphology present | 1 | 0% |
| Red blood cell scan | 1 | 0% |
| Red blood cell sedimentation rate | 48 | 0.1% |
| Red blood cell sedimentation rate abnormal | 1 | 0% |
| Red blood cell sedimentation rate decreased | 1 | 0% |
| Red blood cell sedimentation rate increased | 34 | 0.07% |
| Red blood cell sedimentation rate normal | 38 | 0.08% |
| Red blood cells urine | 1 | 0% |
| Red blood cells urine negative | 4 | 0.01% |
| Red blood cells urine positive | 5 | 0.01% |
| Red cell distribution width | 7 | 0.01% |
| Red cell distribution width decreased | 1 | 0% |
| Red cell distribution width increased | 15 | 0.03% |
| Red cell distribution width normal | 28 | 0.06% |
| Red ear syndrome | 2 | 0% |
| Reduced facial expression | 2 | 0% |
| Reduction of increased intracranial pressure | 1 | 0% |
| Reflexes abnormal | 1 | 0% |
| Reflex test | 4 | 0.01% |
| Reflex test normal | 2 | 0% |
| Reflux laryngitis | 2 | 0% |
| Refusal of treatment by patient | 5 | 0.01% |
| Refusal of vaccination | 1 | 0% |
| Regurgitation | 5 | 0.01% |
| Renal artery thrombosis | 1 | 0% |
| Renal atrophy | 2 | 0% |
| Renal cancer metastatic | 1 | 0% |
| Renal colic | 2 | 0% |
| Renal cyst | 3 | 0.01% |
| Renal disorder | 8 | 0.02% |
| Renal embolism | 1 | 0% |
| Renal failure | 15 | 0.03% |
| Renal function test | 6 | 0.01% |
| Renal function test abnormal | 3 | 0.01% |
| Renal function test normal | 15 | 0.03% |
| Renal haematoma | 1 | 0% |
| Renal haemorrhage | 3 | 0.01% |
| Renal impairment | 11 | 0.02% |
| Renal infarct | 6 | 0.01% |
| Renal pain | 78 | 0.16% |
| Renal replacement therapy | 2 | 0% |
| Renal transplant | 1 | 0% |
| Renal tubular injury | 1 | 0% |
| Renal tubular necrosis | 2 | 0% |
| Renal vein thrombosis | 1 | 0% |
| Repetitive speech | 2 | 0% |
| Respiration abnormal | 34 | 0.07% |
| Respiratory acidosis | 1 | 0% |
| Respiratory arrest | 30 | 0.06% |
| Respiratory depression | 1 | 0% |
| Respiratory disorder | 19 | 0.04% |
| Respiratory distress | 29 | 0.06% |
| Respiratory failure | 28 | 0.06% |
| Respiratory fatigue | 1 | 0% |
| Respiratory gas exchange disorder | 1 | 0% |
| Respiratory muscle weakness | 1 | 0% |
| Respiratory rate | 17 | 0.04% |
| Respiratory rate decreased | 6 | 0.01% |
| Respiratory rate increased | 56 | 0.12% |
| Respiratory symptom | 12 | 0.03% |
| Respiratory syncytial virus test | 4 | 0.01% |
| Respiratory syncytial virus test negative | 12 | 0.03% |
| Respiratory tract congestion | 140 | 0.3% |
| Respiratory tract haemorrhage | 1 | 0% |
| Respiratory tract infection | 2 | 0% |
| Respiratory tract infection viral | 1 | 0% |
| Respiratory tract inflammation | 1 | 0% |
| Respiratory tract irritation | 6 | 0.01% |
| Respiratory tract oedema | 3 | 0.01% |
| Respiratory viral panel | 13 | 0.03% |
| Respirovirus test positive | 1 | 0% |
| Restless arm syndrome | 2 | 0% |
| Restless legs syndrome | 29 | 0.06% |
| Restlessness | 123 | 0.26% |
| Resuscitation | 48 | 0.1% |
| Retained products of conception | 1 | 0% |
| Retching | 148 | 0.31% |
| Reticulocyte count | 2 | 0% |
| Reticulocyte count normal | 2 | 0% |
| Retinal artery occlusion | 12 | 0.03% |
| Retinal artery thrombosis | 1 | 0% |
| Retinal detachment | 9 | 0.02% |
| Retinal disorder | 2 | 0% |
| Retinal function test abnormal | 2 | 0% |
| Retinal function test normal | 1 | 0% |
| Retinal haemorrhage | 3 | 0.01% |
| Retinal infarction | 1 | 0% |
| Retinal migraine | 5 | 0.01% |
| Retinal oedema | 2 | 0% |
| Retinal pallor | 1 | 0% |
| Retinal pigment epitheliopathy | 1 | 0% |
| Retinal tear | 3 | 0.01% |
| Retinal vascular thrombosis | 2 | 0% |
| Retinal vein occlusion | 10 | 0.02% |
| Retinal vein thrombosis | 2 | 0% |
| Retinitis pigmentosa | 1 | 0% |
| Retinogram | 2 | 0% |
| Retinopexy | 1 | 0% |
| Retroperitoneal lymphadenopathy | 1 | 0% |
| Revascularisation procedure | 1 | 0% |
| Reversed hot-cold sensation | 1 | 0% |
| Rhabdomyolysis | 17 | 0.04% |
| Rhesus antibodies | 1 | 0% |
| Rhesus antigen | 2 | 0% |
| Rhesus antigen positive | 1 | 0% |
| Rheumatic fever | 1 | 0% |
| Rheumatoid arthritis | 25 | 0.05% |
| Rheumatoid factor | 10 | 0.02% |
| Rheumatoid factor increased | 2 | 0% |
| Rheumatoid factor negative | 11 | 0.02% |
| Rheumatoid factor positive | 2 | 0% |
| Rheumatological examination | 1 | 0% |
| Rhinalgia | 17 | 0.04% |
| Rhinitis | 1 | 0% |
| Rhinitis allergic | 1 | 0% |
| Rhinitis perennial | 1 | 0% |
| Rhinorrhoea | 318 | 0.67% |
| Rhinovirus infection | 2 | 0% |
| Rhonchi | 1 | 0% |
| Rib fracture | 3 | 0.01% |
| Right atrial dilatation | 1 | 0% |
| Right ventricular dilatation | 3 | 0.01% |
| Right ventricular dysfunction | 8 | 0.02% |
| Right ventricular enlargement | 3 | 0.01% |
| Right ventricular failure | 2 | 0% |
| Right ventricular hypertrophy | 1 | 0% |
| Right ventricular systolic pressure | 1 | 0% |
| Right ventricular systolic pressure increased | 1 | 0% |
| Road traffic accident | 22 | 0.05% |
| Rocky mountain spotted fever | 1 | 0% |
| Romberg test | 1 | 0% |
| Rosacea | 4 | 0.01% |
| Rotator cuff syndrome | 12 | 0.03% |
| Rotavirus test negative | 1 | 0% |
| Rubber sensitivity | 1 | 0% |
| Ruptured cerebral aneurysm | 1 | 0% |
| Russell's viper venom time | 1 | 0% |
| Russell's viper venom time abnormal | 1 | 0% |
| Saline infusion sonogram | 2 | 0% |
| Saliva altered | 1 | 0% |
| Salivary gland disorder | 1 | 0% |
| Salivary gland enlargement | 1 | 0% |
| Salivary gland pain | 2 | 0% |
| Salivary hypersecretion | 24 | 0.05% |
| Salmonella test | 1 | 0% |
| Salmonella test negative | 1 | 0% |
| Salpingectomy | 1 | 0% |
| Salpingitis | 1 | 0% |
| Sarcoidosis | 2 | 0% |
| SARS-CoV-1 test negative | 1 | 0% |
| SARS-CoV-2 antibody test | 134 | 0.28% |
| SARS-CoV-2 antibody test negative | 30 | 0.06% |
| SARS-CoV-2 antibody test positive | 11 | 0.02% |
| SARS-CoV-2 RNA | 3 | 0.01% |
| SARS-CoV-2 RNA increased | 3 | 0.01% |
| SARS-CoV-2 RNA undetectable | 1 | 0% |
| SARS-CoV-2 test | 563 | 1.19% |
| SARS-CoV-2 test false positive | 1 | 0% |
| SARS-CoV-2 test negative | 469 | 0.99% |
| SARS-CoV-2 test positive | 665 | 1.41% |
| Scab | 23 | 0.05% |
| Scan | 31 | 0.07% |
| Scan abdomen abnormal | 2 | 0% |
| Scan abnormal | 7 | 0.01% |
| Scan bone marrow abnormal | 1 | 0% |
| Scan brain | 14 | 0.03% |
| Scan myocardial perfusion | 2 | 0% |
| Scan myocardial perfusion abnormal | 1 | 0% |
| Scan normal | 7 | 0.01% |
| Scan spleen | 1 | 0% |
| Scan thyroid gland | 1 | 0% |
| Scan with contrast | 67 | 0.14% |
| Scan with contrast abnormal | 53 | 0.11% |
| Scan with contrast normal | 28 | 0.06% |
| Scar | 6 | 0.01% |
| Scar pain | 3 | 0.01% |
| Schistocytosis | 1 | 0% |
| Schizophrenia | 1 | 0% |
| Sciatica | 38 | 0.08% |
| Scintillating scotoma | 2 | 0% |
| Scleral discolouration | 1 | 0% |
| Scleral disorder | 1 | 0% |
| Scleritis | 1 | 0% |
| Scoliosis | 1 | 0% |
| Scratch | 7 | 0.01% |
| Screaming | 14 | 0.03% |
| Scrotal oedema | 1 | 0% |
| Seasonal allergy | 12 | 0.03% |
| Seborrhoea | 1 | 0% |
| Second trimester pregnancy | 2 | 0% |
| Secretion discharge | 27 | 0.06% |
| Sedation | 5 | 0.01% |
| Sedative therapy | 1 | 0% |
| Seizure | 523 | 1.11% |
| Seizure cluster | 2 | 0% |
| Seizure like phenomena | 51 | 0.11% |
| Semen volume decreased | 1 | 0% |
| Sensation of blood flow | 2 | 0% |
| Sensation of foreign body | 32 | 0.07% |
| Sense of oppression | 3 | 0.01% |
| Sensitisation | 1 | 0% |
| Sensitive skin | 153 | 0.32% |
| Sensory disturbance | 138 | 0.29% |
| Sensory integrative dysfunction | 1 | 0% |
| Sensory level abnormal | 2 | 0% |
| Sensory loss | 44 | 0.09% |
| Sensory overload | 2 | 0% |
| Sepsis | 32 | 0.07% |
| Sepsis syndrome | 1 | 0% |
| Septic encephalopathy | 1 | 0% |
| Septic screen | 1 | 0% |
| Septic shock | 10 | 0.02% |
| Serology test | 7 | 0.01% |
| Serotonin syndrome | 2 | 0% |
| Serum ferritin | 4 | 0.01% |
| Serum ferritin decreased | 1 | 0% |
| Serum ferritin increased | 6 | 0.01% |
| Serum ferritin normal | 1 | 0% |
| Serum serotonin | 1 | 0% |
| Serum sickness | 1 | 0% |
| Serum sickness-like reaction | 1 | 0% |
| Sexual dysfunction | 1 | 0% |
| Sexually transmitted disease test | 3 | 0.01% |
| Shift to the left | 4 | 0.01% |
| Shock | 17 | 0.04% |
| Shock haemorrhagic | 2 | 0% |
| Shock symptom | 2 | 0% |
| Shoulder arthroplasty | 1 | 0% |
| Shoulder injury related to vaccine administration | 12 | 0.03% |
| Sickle cell anaemia with crisis | 1 | 0% |
| Sick relative | 2 | 0% |
| Sigmoidoscopy | 2 | 0% |
| Similar reaction on previous exposure to drug | 1 | 0% |
| Simple partial seizures | 1 | 0% |
| Single photon emission computerised tomogram | 1 | 0% |
| Sinonasal obstruction | 4 | 0.01% |
| Sinus arrest | 1 | 0% |
| Sinus arrhythmia | 3 | 0.01% |
| Sinus bradycardia | 6 | 0.01% |
| Sinus congestion | 82 | 0.17% |
| Sinus disorder | 32 | 0.07% |
| Sinus headache | 51 | 0.11% |
| Sinusitis | 80 | 0.17% |
| Sinus node dysfunction | 1 | 0% |
| Sinus operation | 17 | 0.04% |
| Sinus pain | 49 | 0.1% |
| Sinus rhythm | 10 | 0.02% |
| Sinus tachycardia | 32 | 0.07% |
| Sitting disability | 5 | 0.01% |
| Sjogren's syndrome | 4 | 0.01% |
| Skeletal injury | 1 | 0% |
| Skin abrasion | 23 | 0.05% |
| Skin atrophy | 4 | 0.01% |
| Skin burning sensation | 132 | 0.28% |
| Skin cancer | 1 | 0% |
| Skin culture | 1 | 0% |
| Skin culture positive | 1 | 0% |
| Skin discolouration | 204 | 0.43% |
| Skin discomfort | 5 | 0.01% |
| Skin disorder | 25 | 0.05% |
| Skin exfoliation | 65 | 0.14% |
| Skin fissures | 1 | 0% |
| Skin fragility | 1 | 0% |
| Skin haemorrhage | 10 | 0.02% |
| Skin hyperpigmentation | 2 | 0% |
| Skin hypertrophy | 2 | 0% |
| Skin indentation | 1 | 0% |
| Skin induration | 5 | 0.01% |
| Skin infection | 2 | 0% |
| Skin injury | 2 | 0% |
| Skin irritation | 36 | 0.08% |
| Skin laceration | 41 | 0.09% |
| Skin lesion | 20 | 0.04% |
| Skin mass | 22 | 0.05% |
| Skin necrosis | 1 | 0% |
| Skin odour abnormal | 11 | 0.02% |
| Skin operation | 2 | 0% |
| Skin papilloma | 1 | 0% |
| Skin plaque | 2 | 0% |
| Skin reaction | 19 | 0.04% |
| Skin sensitisation | 18 | 0.04% |
| Skin swelling | 27 | 0.06% |
| Skin temperature | 1 | 0% |
| Skin test | 1 | 0% |
| Skin test negative | 1 | 0% |
| Skin test positive | 1 | 0% |
| Skin tightness | 26 | 0.05% |
| Skin ulcer | 6 | 0.01% |
| Skin warm | 345 | 0.73% |
| Skin weeping | 5 | 0.01% |
| Skin wound | 3 | 0.01% |
| Skin wrinkling | 1 | 0% |
| Skull fracture | 1 | 0% |
| Skull fractured base | 1 | 0% |
| Skull X-ray | 1 | 0% |
| Skull X-ray abnormal | 1 | 0% |
| Sleep apnoea syndrome | 4 | 0.01% |
| Sleep deficit | 4 | 0.01% |
| Sleep disorder | 831 | 1.76% |
| Sleep paralysis | 1 | 0% |
| Sleep study | 3 | 0.01% |
| Sleep talking | 3 | 0.01% |
| Sleep terror | 1 | 0% |
| Slow response to stimuli | 15 | 0.03% |
| Slow speech | 18 | 0.04% |
| Sluggishness | 58 | 0.12% |
| Small cell lung cancer | 1 | 0% |
| Small intestinal obstruction | 2 | 0% |
| Small intestinal resection | 1 | 0% |
| Small intestine gangrene | 1 | 0% |
| Smear cervix | 2 | 0% |
| Smear cervix normal | 1 | 0% |
| Smear test | 2 | 0% |
| Smear vaginal normal | 2 | 0% |
| Smooth muscle antibody negative | 1 | 0% |
| Sneezing | 91 | 0.19% |
| Snoring | 15 | 0.03% |
| Social avoidant behaviour | 1 | 0% |
| Social problem | 1 | 0% |
| Soft tissue disorder | 1 | 0% |
| Soft tissue inflammation | 1 | 0% |
| Soft tissue injury | 2 | 0% |
| Soft tissue mass | 1 | 0% |
| Soft tissue necrosis | 1 | 0% |
| Soft tissue swelling | 1 | 0% |
| Solar lentigo | 2 | 0% |
| Somatic symptom disorder | 1 | 0% |
| Somatotropin stimulation test | 2 | 0% |
| Somnambulism | 3 | 0.01% |
| Somnolence | 561 | 1.19% |
| Specialist consultation | 1 | 0% |
| Specific gravity urine | 2 | 0% |
| Specific gravity urine increased | 2 | 0% |
| Specific gravity urine normal | 7 | 0.01% |
| Speech disorder | 117 | 0.25% |
| Speech disorder developmental | 2 | 0% |
| Speech rehabilitation | 1 | 0% |
| Sperm concentration decreased | 1 | 0% |
| Spider vein | 7 | 0.01% |
| Spinal artery thrombosis | 1 | 0% |
| Spinal claudication | 1 | 0% |
| Spinal cord abscess | 1 | 0% |
| Spinal cord disorder | 3 | 0.01% |
| Spinal cord haematoma | 1 | 0% |
| Spinal cord infarction | 2 | 0% |
| Spinal cord injury | 1 | 0% |
| Spinal cord injury cervical | 1 | 0% |
| Spinal cord neoplasm | 2 | 0% |
| Spinal cord oedema | 1 | 0% |
| Spinal fracture | 2 | 0% |
| Spinal instability | 1 | 0% |
| Spinal laminectomy | 1 | 0% |
| Spinal myelogram normal | 1 | 0% |
| Spinal nerve stimulator implantation | 1 | 0% |
| Spinal osteoarthritis | 2 | 0% |
| Spinal pain | 82 | 0.17% |
| Spinal stenosis | 2 | 0% |
| Spinal X-ray | 22 | 0.05% |
| Spinal X-ray abnormal | 2 | 0% |
| Spinal X-ray normal | 6 | 0.01% |
| Spirometry | 2 | 0% |
| Spleen disorder | 2 | 0% |
| Splenectomy | 3 | 0.01% |
| Splenic artery aneurysm | 2 | 0% |
| Splenic artery thrombosis | 1 | 0% |
| Splenic haemorrhage | 3 | 0.01% |
| Splenic infarction | 6 | 0.01% |
| Splenic rupture | 3 | 0.01% |
| Splenic thrombosis | 3 | 0.01% |
| Splenic vein thrombosis | 4 | 0.01% |
| Splenomegaly | 9 | 0.02% |
| Splinter haemorrhages | 2 | 0% |
| Spondylitis | 1 | 0% |
| Spontaneous haemorrhage | 2 | 0% |
| Spontaneous penile erection | 2 | 0% |
| Sputum abnormal | 1 | 0% |
| Sputum culture | 2 | 0% |
| Sputum culture positive | 2 | 0% |
| Sputum discoloured | 8 | 0.02% |
| Squamous cell carcinoma | 1 | 0% |
| Staphylococcal infection | 8 | 0.02% |
| Staphylococcal sepsis | 2 | 0% |
| Staphylococcus test | 1 | 0% |
| Staphylococcus test negative | 3 | 0.01% |
| Staphylococcus test positive | 3 | 0.01% |
| Staring | 14 | 0.03% |
| Status asthmaticus | 1 | 0% |
| Status epilepticus | 4 | 0.01% |
| Stenosis | 1 | 0% |
| Stent placement | 10 | 0.02% |
| Sternotomy | 2 | 0% |
| Steroid diabetes | 1 | 0% |
| Steroid therapy | 2 | 0% |
| Stertor | 1 | 0% |
| Stevens-Johnson syndrome | 1 | 0% |
| Sticky skin | 4 | 0.01% |
| Stiff leg syndrome | 2 | 0% |
| Stiff tongue | 1 | 0% |
| Still's disease | 1 | 0% |
| Stillbirth | 3 | 0.01% |
| Stomatitis | 45 | 0.1% |
| Stool analysis | 8 | 0.02% |
| Stool analysis normal | 6 | 0.01% |
| Strabismus | 2 | 0% |
| Streptococcal bacteraemia | 1 | 0% |
| Streptococcal infection | 6 | 0.01% |
| Streptococcal sepsis | 1 | 0% |
| Streptococcus test | 11 | 0.02% |
| Streptococcus test negative | 44 | 0.09% |
| Streptococcus test positive | 9 | 0.02% |
| Stress | 33 | 0.07% |
| Stress at work | 1 | 0% |
| Stress cardiomyopathy | 2 | 0% |
| Stress echocardiogram | 3 | 0.01% |
| Stress fracture | 1 | 0% |
| Stridor | 2 | 0% |
| Stroke-like migraine attacks after radiation therapy | 1 | 0% |
| Subacute inflammatory demyelinating polyneuropathy | 4 | 0.01% |
| Subarachnoid haemorrhage | 22 | 0.05% |
| Subclavian vein thrombosis | 7 | 0.01% |
| Subcutaneous abscess | 1 | 0% |
| Subcutaneous haematoma | 1 | 0% |
| Subdural haematoma | 13 | 0.03% |
| Subdural haematoma evacuation | 1 | 0% |
| Subdural haemorrhage | 2 | 0% |
| Substance use | 2 | 0% |
| Sudden cardiac death | 2 | 0% |
| Sudden death | 20 | 0.04% |
| Sudden hearing loss | 13 | 0.03% |
| Sudden onset of sleep | 2 | 0% |
| Sudden visual loss | 3 | 0.01% |
| Suffocation feeling | 6 | 0.01% |
| Suicidal ideation | 12 | 0.03% |
| Suicide attempt | 1 | 0% |
| Sunburn | 8 | 0.02% |
| Superficial vein prominence | 2 | 0% |
| Superior mesenteric artery syndrome | 1 | 0% |
| Superior sagittal sinus thrombosis | 13 | 0.03% |
| Supernumerary rib | 1 | 0% |
| Supportive care | 1 | 0% |
| Suppressed lactation | 6 | 0.01% |
| Supraventricular extrasystoles | 4 | 0.01% |
| Supraventricular tachycardia | 15 | 0.03% |
| Surgery | 33 | 0.07% |
| Suspected COVID-19 | 155 | 0.33% |
| Suspected product contamination | 2 | 0% |
| Suspected product tampering | 1 | 0% |
| Suture insertion | 2 | 0% |
| Sweat discolouration | 2 | 0% |
| Sweat gland disorder | 1 | 0% |
| Sweating fever | 4 | 0.01% |
| Swelling | 382 | 0.81% |
| Swelling face | 380 | 0.8% |
| Swelling of eyelid | 47 | 0.1% |
| Swollen tongue | 187 | 0.4% |
| Symptom recurrence | 1 | 0% |
| Syncope | 2,001 | 4.23% |
| Syndactyly | 1 | 0% |
| Synovial cyst | 10 | 0.02% |
| Synovial rupture | 1 | 0% |
| Synovitis | 2 | 0% |
| Syringe issue | 97 | 0.21% |
| Systemic infection | 1 | 0% |
| Systemic inflammatory response syndrome | 11 | 0.02% |
| Systemic lupus erythematosus | 9 | 0.02% |
| Systemic lupus erythematosus rash | 1 | 0% |
| T-lymphocyte count | 2 | 0% |
| T-lymphocyte count decreased | 1 | 0% |
| T-lymphocyte count increased | 1 | 0% |
| Tachycardia | 282 | 0.6% |
| Tachycardia foetal | 1 | 0% |
| Tachyphrenia | 6 | 0.01% |
| Tachypnoea | 21 | 0.04% |
| Tardive dyskinesia | 1 | 0% |
| Taste disorder | 143 | 0.3% |
| Tearfulness | 13 | 0.03% |
| Telangiectasia | 2 | 0% |
| Temperature difference of extremities | 2 | 0% |
| Temperature intolerance | 10 | 0.02% |
| Temperature perception test decreased | 1 | 0% |
| Temperature regulation disorder | 7 | 0.01% |
| Temporal lobe epilepsy | 1 | 0% |
| Temporomandibular joint syndrome | 5 | 0.01% |
| Tenderness | 174 | 0.37% |
| Tendon disorder | 4 | 0.01% |
| Tendon injury | 1 | 0% |
| Tendonitis | 16 | 0.03% |
| Tendon pain | 18 | 0.04% |
| Tendon rupture | 1 | 0% |
| Tenosynovitis | 1 | 0% |
| Tenosynovitis stenosans | 1 | 0% |
| Tension | 34 | 0.07% |
| Tension headache | 34 | 0.07% |
| Testicular atrophy | 1 | 0% |
| Testicular disorder | 3 | 0.01% |
| Testicular mass | 1 | 0% |
| Testicular pain | 17 | 0.04% |
| Testicular swelling | 8 | 0.02% |
| Tetany | 1 | 0% |
| Thalamic infarction | 4 | 0.01% |
| Thalamus haemorrhage | 1 | 0% |
| Therapeutic product effect decreased | 1 | 0% |
| Therapeutic product effect incomplete | 1 | 0% |
| Therapeutic response changed | 1 | 0% |
| Therapeutic response decreased | 2 | 0% |
| Therapeutic response shortened | 1 | 0% |
| Therapeutic response unexpected | 86 | 0.18% |
| Therapy change | 1 | 0% |
| Therapy non-responder | 196 | 0.41% |
| Therapy partial responder | 4 | 0.01% |
| Thermal burn | 2 | 0% |
| Thermal burns of eye | 2 | 0% |
| Thinking abnormal | 31 | 0.07% |
| Third stage postpartum haemorrhage | 1 | 0% |
| Third trimester pregnancy | 2 | 0% |
| Thirst | 169 | 0.36% |
| Thirst decreased | 1 | 0% |
| Thoracic operation | 2 | 0% |
| Thought blocking | 2 | 0% |
| Throat clearing | 10 | 0.02% |
| Throat irritation | 248 | 0.52% |
| Throat lesion | 1 | 0% |
| Throat tightness | 283 | 0.6% |
| Thrombectomy | 36 | 0.08% |
| Thrombin time | 1 | 0% |
| Thrombin time normal | 1 | 0% |
| Thrombin time prolonged | 1 | 0% |
| Thrombocytopenia | 128 | 0.27% |
| Thrombocytopenic purpura | 5 | 0.01% |
| Thrombocytosis | 1 | 0% |
| Thromboelastogram | 1 | 0% |
| Thromboembolectomy | 5 | 0.01% |
| Thrombolysis | 7 | 0.01% |
| Thrombophlebitis | 9 | 0.02% |
| Thrombophlebitis superficial | 51 | 0.11% |
| Thrombosis | 676 | 1.43% |
| Thrombosis in device | 1 | 0% |
| Thrombosis mesenteric vessel | 2 | 0% |
| Thrombosis prophylaxis | 1 | 0% |
| Thrombotic cerebral infarction | 2 | 0% |
| Thrombotic microangiopathy | 1 | 0% |
| Thrombotic stroke | 1 | 0% |
| Thrombotic thrombocytopenic purpura | 7 | 0.01% |
| Thunderclap headache | 1 | 0% |
| Thyroid calcification | 1 | 0% |
| Thyroid disorder | 6 | 0.01% |
| Thyroid function test | 22 | 0.05% |
| Thyroid function test abnormal | 6 | 0.01% |
| Thyroid function test normal | 11 | 0.02% |
| Thyroid gland scan abnormal | 1 | 0% |
| Thyroid hormones increased | 1 | 0% |
| Thyroiditis | 4 | 0.01% |
| Thyroid mass | 2 | 0% |
| Thyroid pain | 2 | 0% |
| Thyroid stimulating immunoglobulin | 1 | 0% |
| Thyroid stimulating immunoglobulin increased | 1 | 0% |
| Thyroxine | 2 | 0% |
| Thyroxine decreased | 2 | 0% |
| Thyroxine free | 10 | 0.02% |
| Thyroxine free normal | 8 | 0.02% |
| Thyroxine increased | 2 | 0% |
| Thyroxine normal | 4 | 0.01% |
| Tic | 2 | 0% |
| Tilt table test | 1 | 0% |
| Tilt table test positive | 1 | 0% |
| Time perception altered | 1 | 0% |
| Tinea infection | 1 | 0% |
| Tinea versicolour | 1 | 0% |
| Tinnitus | 827 | 1.75% |
| Tissue injury | 1 | 0% |
| Tissue irritation | 1 | 0% |
| Tobacco user | 1 | 0% |
| Tongue biting | 3 | 0.01% |
| Tongue blistering | 9 | 0.02% |
| Tongue coated | 2 | 0% |
| Tongue discolouration | 10 | 0.02% |
| Tongue discomfort | 24 | 0.05% |
| Tongue disorder | 18 | 0.04% |
| Tongue dry | 8 | 0.02% |
| Tongue eruption | 4 | 0.01% |
| Tongue erythema | 8 | 0.02% |
| Tongue exfoliation | 1 | 0% |
| Tongue haemorrhage | 2 | 0% |
| Tongue injury | 1 | 0% |
| Tongue movement disturbance | 3 | 0.01% |
| Tongue oedema | 5 | 0.01% |
| Tongue pruritus | 16 | 0.03% |
| Tongue ulceration | 9 | 0.02% |
| Tonic clonic movements | 11 | 0.02% |
| Tonsillar cyst | 1 | 0% |
| Tonsillar disorder | 1 | 0% |
| Tonsillar hypertrophy | 5 | 0.01% |
| Tonsillar inflammation | 2 | 0% |
| Tonsillitis | 4 | 0.01% |
| Tonsillolith | 1 | 0% |
| Tooth abscess | 1 | 0% |
| Toothache | 71 | 0.15% |
| Tooth discolouration | 1 | 0% |
| Tooth disorder | 3 | 0.01% |
| Tooth extraction | 3 | 0.01% |
| Tooth fracture | 11 | 0.02% |
| Tooth infection | 4 | 0.01% |
| Tooth injury | 4 | 0.01% |
| Tooth loss | 1 | 0% |
| Torticollis | 2 | 0% |
| Total bile acids increased | 1 | 0% |
| Total complement activity test | 1 | 0% |
| Total lung capacity decreased | 2 | 0% |
| Toxic encephalopathy | 2 | 0% |
| Toxicity to various agents | 3 | 0.01% |
| Toxicologic test | 3 | 0.01% |
| Toxicologic test abnormal | 1 | 0% |
| Toxicologic test normal | 2 | 0% |
| Toxoplasma serology | 1 | 0% |
| Toxoplasma serology negative | 2 | 0% |
| Tracheal disorder | 1 | 0% |
| Tracheobronchitis | 1 | 0% |
| Tracheostomy | 6 | 0.01% |
| Transaminases | 2 | 0% |
| Transaminases increased | 4 | 0.01% |
| Transcranial electrical motor evoked potential monitoring | 1 | 0% |
| Transcutaneous pacing | 2 | 0% |
| Transferrin normal | 1 | 0% |
| Transferrin saturation decreased | 2 | 0% |
| Transfusion | 19 | 0.04% |
| Transient aphasia | 1 | 0% |
| Transient global amnesia | 6 | 0.01% |
| Transient ischaemic attack | 62 | 0.13% |
| Transurethral prostatectomy | 1 | 0% |
| Transverse sinus stenosis | 1 | 0% |
| Transverse sinus thrombosis | 17 | 0.04% |
| Traumatic haemorrhage | 3 | 0.01% |
| Traumatic lung injury | 3 | 0.01% |
| Treatment noncompliance | 1 | 0% |
| Tremor | 1,580 | 3.34% |
| Trendelenburg position | 1 | 0% |
| Treponema test | 5 | 0.01% |
| Treponema test negative | 12 | 0.03% |
| Tri-iodothyronine decreased | 1 | 0% |
| Tri-iodothyronine free decreased | 1 | 0% |
| Tri-iodothyronine free normal | 2 | 0% |
| Tri-iodothyronine increased | 4 | 0.01% |
| Trichoglossia | 1 | 0% |
| Trichorrhexis | 1 | 0% |
| Tricuspid valve incompetence | 7 | 0.01% |
| Trigeminal nerve disorder | 1 | 0% |
| Trigeminal nerve injection | 1 | 0% |
| Trigeminal neuralgia | 12 | 0.03% |
| Trigger finger | 5 | 0.01% |
| Trismus | 21 | 0.04% |
| Troponin | 106 | 0.22% |
| Troponin abnormal | 1 | 0% |
| Troponin I | 25 | 0.05% |
| Troponin I decreased | 1 | 0% |
| Troponin I increased | 10 | 0.02% |
| Troponin increased | 68 | 0.14% |
| Troponin I normal | 22 | 0.05% |
| Troponin normal | 51 | 0.11% |
| Troponin T | 7 | 0.01% |
| Troponin T increased | 3 | 0.01% |
| Troponin T normal | 3 | 0.01% |
| Trunk injury | 1 | 0% |
| Tryptase | 5 | 0.01% |
| Tuberculin test | 2 | 0% |
| Tuberculin test negative | 1 | 0% |
| Tuberous sclerosis complex | 1 | 0% |
| Tumefactive multiple sclerosis | 1 | 0% |
| Tumour flare | 1 | 0% |
| Tumour marker test | 1 | 0% |
| Tunnel vision | 47 | 0.1% |
| Tympanic membrane perforation | 1 | 0% |
| Tympanometry abnormal | 2 | 0% |
| Type 1 diabetes mellitus | 2 | 0% |
| Type 2 diabetes mellitus | 4 | 0.01% |
| Type IV hypersensitivity reaction | 3 | 0.01% |
| Ulcer | 3 | 0.01% |
| Ulnar nerve palsy | 1 | 0% |
| Ultrasound abdomen | 40 | 0.08% |
| Ultrasound abdomen abnormal | 7 | 0.01% |
| Ultrasound abdomen normal | 14 | 0.03% |
| Ultrasound antenatal screen | 1 | 0% |
| Ultrasound antenatal screen abnormal | 8 | 0.02% |
| Ultrasound biliary tract | 2 | 0% |
| Ultrasound biliary tract abnormal | 1 | 0% |
| Ultrasound biliary tract normal | 1 | 0% |
| Ultrasound bladder normal | 1 | 0% |
| Ultrasound breast | 5 | 0.01% |
| Ultrasound breast abnormal | 3 | 0.01% |
| Ultrasound breast normal | 1 | 0% |
| Ultrasound chest | 5 | 0.01% |
| Ultrasound Doppler | 218 | 0.46% |
| Ultrasound Doppler abnormal | 166 | 0.35% |
| Ultrasound Doppler normal | 69 | 0.15% |
| Ultrasound eye abnormal | 1 | 0% |
| Ultrasound eye normal | 2 | 0% |
| Ultrasound foetal | 1 | 0% |
| Ultrasound foetal abnormal | 1 | 0% |
| Ultrasound joint | 2 | 0% |
| Ultrasound kidney | 2 | 0% |
| Ultrasound kidney abnormal | 1 | 0% |
| Ultrasound kidney normal | 1 | 0% |
| Ultrasound liver | 3 | 0.01% |
| Ultrasound liver abnormal | 2 | 0% |
| Ultrasound pancreas | 1 | 0% |
| Ultrasound pelvis | 7 | 0.01% |
| Ultrasound pelvis abnormal | 3 | 0.01% |
| Ultrasound pelvis normal | 6 | 0.01% |
| Ultrasound scan | 436 | 0.92% |
| Ultrasound scan abnormal | 114 | 0.24% |
| Ultrasound scan normal | 104 | 0.22% |
| Ultrasound scan vagina | 14 | 0.03% |
| Ultrasound scan vagina abnormal | 3 | 0.01% |
| Ultrasound skull | 2 | 0% |
| Ultrasound spleen | 1 | 0% |
| Ultrasound thyroid | 1 | 0% |
| Ultrasound thyroid abnormal | 1 | 0% |
| Ultrasound thyroid normal | 4 | 0.01% |
| Ultrasound uterus | 4 | 0.01% |
| Ultrasound uterus normal | 1 | 0% |
| Umbilical hernia | 1 | 0% |
| Underdose | 140 | 0.3% |
| Underweight | 1 | 0% |
| Unevaluable event | 222 | 0.47% |
| Unresponsive to stimuli | 511 | 1.08% |
| Upper-airway cough syndrome | 34 | 0.07% |
| Upper gastrointestinal haemorrhage | 2 | 0% |
| Upper limb fracture | 2 | 0% |
| Upper motor neurone lesion | 3 | 0.01% |
| Upper respiratory tract congestion | 1 | 0% |
| Upper respiratory tract infection | 19 | 0.04% |
| Upper respiratory tract irritation | 1 | 0% |
| Ureteral disorder | 1 | 0% |
| Ureteral stent insertion | 1 | 0% |
| Ureteric obstruction | 1 | 0% |
| Ureteritis | 1 | 0% |
| Ureterolithiasis | 1 | 0% |
| Ureteroscopy | 1 | 0% |
| Urethral haemorrhage | 1 | 0% |
| Urethral pain | 1 | 0% |
| Urinary bladder haemorrhage | 3 | 0.01% |
| Urinary casts | 2 | 0% |
| Urinary hesitation | 1 | 0% |
| Urinary incontinence | 96 | 0.2% |
| Urinary retention | 29 | 0.06% |
| Urinary sediment present | 3 | 0.01% |
| Urinary stone analysis | 1 | 0% |
| Urinary straining | 1 | 0% |
| Urinary system X-ray | 1 | 0% |
| Urinary tract discomfort | 1 | 0% |
| Urinary tract disorder | 5 | 0.01% |
| Urinary tract infection | 77 | 0.16% |
| Urinary tract obstruction | 1 | 0% |
| Urinary tract pain | 2 | 0% |
| Urine abnormality | 7 | 0.01% |
| Urine analysis | 301 | 0.64% |
| Urine analysis abnormal | 19 | 0.04% |
| Urine analysis normal | 71 | 0.15% |
| Urine electrolytes normal | 1 | 0% |
| Urine flow decreased | 1 | 0% |
| Urine ketone body | 1 | 0% |
| Urine ketone body absent | 7 | 0.01% |
| Urine ketone body present | 6 | 0.01% |
| Urine leukocyte esterase | 11 | 0.02% |
| Urine leukocyte esterase positive | 1 | 0% |
| Urine odour abnormal | 7 | 0.01% |
| Urine output decreased | 5 | 0.01% |
| Urine output increased | 4 | 0.01% |
| Urobilinogen urine | 4 | 0.01% |
| Urobilinogen urine decreased | 2 | 0% |
| Urobilinogen urine increased | 4 | 0.01% |
| Urogram | 1 | 0% |
| Urogram normal | 1 | 0% |
| Urticaria | 994 | 2.1% |
| Urticaria aquagenic | 1 | 0% |
| Urticaria chronic | 1 | 0% |
| Urticaria papular | 1 | 0% |
| Urticaria thermal | 1 | 0% |
| Uterine contractions during pregnancy | 1 | 0% |
| Uterine cyst | 1 | 0% |
| Uterine dilation and curettage | 7 | 0.01% |
| Uterine haemorrhage | 5 | 0.01% |
| Uterine leiomyoma | 4 | 0.01% |
| Uterine pain | 3 | 0.01% |
| Uterine polyp | 2 | 0% |
| Uterine spasm | 5 | 0.01% |
| Uveitis | 3 | 0.01% |
| Vaccination complication | 99 | 0.21% |
| Vaccination error | 12 | 0.03% |
| Vaccination failure | 172 | 0.36% |
| Vaccination site atrophy | 1 | 0% |
| Vaccination site bruising | 3 | 0.01% |
| Vaccination site discomfort | 1 | 0% |
| Vaccination site erythema | 8 | 0.02% |
| Vaccination site haematoma | 1 | 0% |
| Vaccination site induration | 1 | 0% |
| Vaccination site inflammation | 2 | 0% |
| Vaccination site mass | 6 | 0.01% |
| Vaccination site oedema | 1 | 0% |
| Vaccination site pain | 53 | 0.11% |
| Vaccination site paraesthesia | 1 | 0% |
| Vaccination site pruritus | 1 | 0% |
| Vaccination site rash | 3 | 0.01% |
| Vaccination site reaction | 7 | 0.01% |
| Vaccination site swelling | 11 | 0.02% |
| Vaccination site warmth | 2 | 0% |
| Vaccine breakthrough infection | 31 | 0.07% |
| Vaccine positive rechallenge | 4 | 0.01% |
| Vaginal dilation procedure | 1 | 0% |
| Vaginal discharge | 3 | 0.01% |
| Vaginal haemorrhage | 92 | 0.19% |
| Vaginal infection | 1 | 0% |
| Vaginal lesion | 2 | 0% |
| Vaginal ulceration | 5 | 0.01% |
| Vaginitis gardnerella | 1 | 0% |
| Varicella | 1 | 0% |
| Varicella virus test | 1 | 0% |
| Varicella virus test negative | 4 | 0.01% |
| Varicella virus test positive | 2 | 0% |
| Varicella zoster virus infection | 1 | 0% |
| Varicophlebitis | 1 | 0% |
| Varicose vein | 19 | 0.04% |
| Vascular access malfunction | 1 | 0% |
| Vascular access site bruising | 1 | 0% |
| Vascular access site thrombosis | 1 | 0% |
| Vascular calcification | 1 | 0% |
| Vascular catheterisation | 1 | 0% |
| Vascular device user | 1 | 0% |
| Vascular graft occlusion | 1 | 0% |
| Vascular graft thrombosis | 1 | 0% |
| Vascular imaging | 4 | 0.01% |
| Vascular injury | 2 | 0% |
| Vascular occlusion | 3 | 0.01% |
| Vascular pain | 15 | 0.03% |
| Vascular purpura | 2 | 0% |
| Vascular rupture | 1 | 0% |
| Vascular stent thrombosis | 1 | 0% |
| Vascular test | 2 | 0% |
| Vascular test abnormal | 1 | 0% |
| Vascular test normal | 1 | 0% |
| Vasculitic rash | 1 | 0% |
| Vasculitis | 19 | 0.04% |
| Vasoconstriction | 1 | 0% |
| Vasodilatation | 40 | 0.08% |
| Vasogenic cerebral oedema | 3 | 0.01% |
| Vasopressive therapy | 3 | 0.01% |
| Vasospasm | 2 | 0% |
| Vein discolouration | 7 | 0.01% |
| Vein disorder | 21 | 0.04% |
| Vein rupture | 1 | 0% |
| Vena cava filter insertion | 8 | 0.02% |
| Vena cava thrombosis | 1 | 0% |
| Venogram | 29 | 0.06% |
| Venogram abnormal | 21 | 0.04% |
| Venogram normal | 29 | 0.06% |
| Venous angioplasty | 1 | 0% |
| Venous haemorrhage | 1 | 0% |
| Venous injury | 1 | 0% |
| Venous occlusion | 9 | 0.02% |
| Venous thrombosis | 13 | 0.03% |
| Venous thrombosis limb | 8 | 0.02% |
| Venous valve ruptured | 1 | 0% |
| Ventilation/perfusion scan | 8 | 0.02% |
| Ventilation/perfusion scan abnormal | 2 | 0% |
| Ventilation/perfusion scan normal | 3 | 0.01% |
| Ventricular arrhythmia | 3 | 0.01% |
| Ventricular assist device insertion | 1 | 0% |
| Ventricular cisternostomy | 1 | 0% |
| Ventricular drainage | 2 | 0% |
| Ventricular dysfunction | 1 | 0% |
| Ventricular dyskinesia | 1 | 0% |
| Ventricular extrasystoles | 20 | 0.04% |
| Ventricular fibrillation | 8 | 0.02% |
| Ventricular hypertrophy | 1 | 0% |
| Ventricular hypokinesia | 3 | 0.01% |
| Ventricular remodelling | 1 | 0% |
| Ventricular septal defect | 1 | 0% |
| Ventricular tachyarrhythmia | 1 | 0% |
| Ventricular tachycardia | 4 | 0.01% |
| Ventriculo-peritoneal shunt | 1 | 0% |
| Vertebral artery dissection | 5 | 0.01% |
| Vertebral artery hypoplasia | 2 | 0% |
| Vertebral artery occlusion | 1 | 0% |
| Vertebral artery stenosis | 2 | 0% |
| Vertebral artery thrombosis | 2 | 0% |
| Vertebral foraminal stenosis | 3 | 0.01% |
| Vertebral lesion | 1 | 0% |
| Vertebral osteophyte | 2 | 0% |
| Vertigo | 475 | 1% |
| Vertigo positional | 15 | 0.03% |
| Very low density lipoprotein normal | 2 | 0% |
| Vessel puncture site bruise | 1 | 0% |
| Vestibular disorder | 2 | 0% |
| Vestibular function test | 1 | 0% |
| Vestibular function test normal | 1 | 0% |
| Vestibular migraine | 3 | 0.01% |
| Vestibular neuronitis | 2 | 0% |
| Vibratory sense increased | 2 | 0% |
| Victim of abuse | 1 | 0% |
| Violence-related symptom | 1 | 0% |
| Viral infection | 12 | 0.03% |
| Viral myocarditis | 1 | 0% |
| Viral pericarditis | 2 | 0% |
| Viral rash | 1 | 0% |
| Viral sepsis | 1 | 0% |
| Viral test | 10 | 0.02% |
| Viral test negative | 15 | 0.03% |
| Viral test positive | 1 | 0% |
| Viral titre | 1 | 0% |
| Visceral pain | 2 | 0% |
| Visceral venous thrombosis | 1 | 0% |
| Vision blurred | 827 | 1.75% |
| Visual acuity reduced | 6 | 0.01% |
| Visual acuity reduced transiently | 1 | 0% |
| Visual acuity tests | 3 | 0.01% |
| Visual acuity tests normal | 1 | 0% |
| Visual brightness | 2 | 0% |
| Visual field defect | 25 | 0.05% |
| Visual field tests | 1 | 0% |
| Visual impairment | 390 | 0.82% |
| Visual pathway disorder | 2 | 0% |
| Visual perseveration | 1 | 0% |
| Visual snow syndrome | 2 | 0% |
| Visuospatial deficit | 1 | 0% |
| Vital functions abnormal | 1 | 0% |
| Vital signs measurement | 282 | 0.6% |
| Vitamin A | 1 | 0% |
| Vitamin B6 | 1 | 0% |
| Vitamin B6 normal | 1 | 0% |
| Vitamin B12 | 15 | 0.03% |
| Vitamin B12 decreased | 5 | 0.01% |
| Vitamin B12 deficiency | 3 | 0.01% |
| Vitamin B12 increased | 1 | 0% |
| Vitamin B12 normal | 19 | 0.04% |
| Vitamin C | 2 | 0% |
| Vitamin D | 13 | 0.03% |
| Vitamin D decreased | 13 | 0.03% |
| Vitamin D deficiency | 5 | 0.01% |
| Vitamin E | 2 | 0% |
| Vitamin K | 2 | 0% |
| VIth nerve paralysis | 2 | 0% |
| Vitiligo | 1 | 0% |
| Vitrectomy | 1 | 0% |
| Vitreous degeneration | 1 | 0% |
| Vitreous detachment | 6 | 0.01% |
| Vitreous floaters | 36 | 0.08% |
| Vitreous haemorrhage | 1 | 0% |
| Vocal cord disorder | 2 | 0% |
| Vocal cord paralysis | 3 | 0.01% |
| Vocal cord paresis | 1 | 0% |
| Volume blood decreased | 1 | 0% |
| Vomiting | 2,531 | 5.35% |
| Vomiting projectile | 18 | 0.04% |
| Von Willebrand's factor activity test | 1 | 0% |
| Vulval disorder | 2 | 0% |
| Vulval ulceration | 3 | 0.01% |
| Vulvovaginal discomfort | 2 | 0% |
| Vulvovaginal mycotic infection | 2 | 0% |
| Vulvovaginal pain | 6 | 0.01% |
| Vulvovaginal pruritus | 2 | 0% |
| Vulvovaginal swelling | 1 | 0% |
| Vulvovaginitis trichomonal | 1 | 0% |
| Walking aid user | 26 | 0.05% |
| Walking disability | 1 | 0% |
| Water pollution | 2 | 0% |
| Weaning failure | 2 | 0% |
| Weight | 15 | 0.03% |
| Weight bearing difficulty | 12 | 0.03% |
| Weight decreased | 104 | 0.22% |
| Weight fluctuation | 1 | 0% |
| Weight increased | 20 | 0.04% |
| West Nile virus test | 2 | 0% |
| West Nile virus test negative | 2 | 0% |
| Wheelchair user | 10 | 0.02% |
| Wheezing | 117 | 0.25% |
| White blood cell count | 56 | 0.12% |
| White blood cell count abnormal | 2 | 0% |
| White blood cell count decreased | 44 | 0.09% |
| White blood cell count increased | 107 | 0.23% |
| White blood cell count normal | 73 | 0.15% |
| White blood cell disorder | 4 | 0.01% |
| White blood cell scan | 1 | 0% |
| White blood cells urine negative | 6 | 0.01% |
| White blood cells urine positive | 4 | 0.01% |
| White coat hypertension | 1 | 0% |
| White matter lesion | 12 | 0.03% |
| Wisdom teeth removal | 2 | 0% |
| Withdrawal bleed | 1 | 0% |
| Withdrawal of life support | 2 | 0% |
| Withdrawal syndrome | 1 | 0% |
| Wound | 15 | 0.03% |
| Wound haemorrhage | 1 | 0% |
| Wound infection | 1 | 0% |
| Wound treatment | 1 | 0% |
| Wrist fracture | 1 | 0% |
| Wrong patient | 1 | 0% |
| Wrong product administered | 40 | 0.08% |
| Wrong technique in product usage process | 27 | 0.06% |
| X-ray | 291 | 0.62% |
| X-ray abnormal | 19 | 0.04% |
| X-ray dental | 1 | 0% |
| X-ray dental normal | 2 | 0% |
| X-ray gastrointestinal tract normal | 1 | 0% |
| X-ray limb | 30 | 0.06% |
| X-ray limb abnormal | 12 | 0.03% |
| X-ray limb normal | 11 | 0.02% |
| X-ray normal | 58 | 0.12% |
| X-ray of pelvis and hip | 4 | 0.01% |
| X-ray of pelvis and hip abnormal | 3 | 0.01% |
| X-ray of pelvis and hip normal | 5 | 0.01% |
| X-ray therapy to blood | 1 | 0% |
| X-ray therapy to lung | 1 | 0% |
| X-ray with contrast | 1 | 0% |
| Yawning | 6 | 0.01% |
| Yellow skin | 6 | 0.01% |
| TOTAL | † 223,468 | † 472.66% |
| † Because some cases have multiple vaccinations and symptoms, a single case can account for multiple entries in this table. This is the reason why the Total Count is greater than 47279 (the number of cases found), and the Total Percentage is greater than 100. | ||
| Case Details |
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: None stated. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Severe headache 10/10, nausea, vomiting, temp of 99 degrees F x 24 hours. waning at this time | ||||||||||||||||
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: Immediate burning in both arms. Unable to hold a pencil to fill out card after receiving vaccine. Weakness in upper extremities. Tingling, pain and numbness in both arms, red streaks appeared on the left arm going further up on to the shoulder, the were visible and painful for about 90 mins. Sweating. Nausea. Blurred vision. Loss of consciousness. Headache behind the eyes. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: 15 minutes after vaccine, c/o scratchy throat. RN on site gave benadryl 25mg. BP 134/84, o2sat 98, pulse 90. Lungs clear, no wheezing. No hives. Monitored an hour and 15 minutes. No change in throat, no difficulty swallowing. Released to home, instructed if change in symptoms or develops hives or respiratory symptoms to call 911. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Patient was given the vaccination and then waited seated for 15 minutes. At 15 minutes patient started to stand and then fainted. Patient was breathing and had a pulse. Patient was placed on back and feet elevated and 991 was called. Patient was coming too as paramedics arrived. paramedics checked vitals. Eventually patient was able to walk out on her own and did not want to go to hospital. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Fever (100) and chills all night, headache, and painful injection site. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: About 4:30, 6 hours after receiving vaccination I felt nauseated, muscle aches, horrific headache, and weak. By 6:30 I felt like my body was burning up on the inside but had no fever. My muscles in my neck became extremely tight and my ears aches. The injection site is extremely tender and hurts to lift my arm. As of 11 am the next day I have also added diarrhea to the list of symptoms. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: nausea, headache, lethargic, chills | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Client received an unknown dosage due to improper vaccine draw. Nurse administered 7 doses in one vial - Janssen vial contains only 5 doses, 6 doses maximum. Other client''s dosage verified by myself or other nurse leads. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Client received an unknown dosage due to improper vaccine draw. Nurse administered 7 doses in one vial - Janssen vial contains only 5 doses, 6 doses maximum. Other client''s dosage verified by myself or other nurse leads. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Client received an unknown dosage due to improper vaccine draw. Nurse administered 7 doses in one vial - Janssen vial contains only 5 doses, 6 doses maximum. Other client''s dosage verified by myself or other nurse leads. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Client received an unknown dosage due to improper vaccine draw. Nurse administered 7 doses in one vial - Janssen vial contains only 5 doses, 6 doses maximum. Other client''s dosage verified by myself or other nurse leads. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: couple of hours after receiving the injection, I had a large hive on my mid chest area. Later I had one on my hip. I was not concerned as I have them on occasion. I felt fine. Went to bed that evening and woke up with extreme burning and itching in my index finger and thumb of my right hand. Also a very large hive on the inside of my arm about 2 1/2 inches from my wrist bend. Intense itching. I took a Benadryl tablet and felt better almost immediately. Later in the day about 6 1/2 hours later, I had more itching on my hip where the high was located. I took another Benadryl. I am fine. I also call my doctor and reported it. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: GIVEN THE JANSSEN VACCINE. EUA. THE PATIENT STARTED DEVELOPING A RASH IMMEDIATELY AFTER VACCINATION AND SHE STARTED TO FEEL ITCHY. SHE WAS GIVE 25MG OF BENADRYL ORALLY AND WATCHED FOR 30 MINUTES. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: PT ARRIVED IN OBSERVATION AREA, AND STATED THAT SHE FELT TINGLING AROUND HER LIPS. VS WERE INITIATED. 3:52PM HR 90 BP 126/64 O2 96%. MONITIORED VS EVERY TEN MINUTES. PT WAS ADMINESTERED 25 MG OF DIPHEHYDRAMINE 0.5 ML AT 4:05PM. AT 4:30 PT STATED THAT THEY STILL FELT TINGLING. ANOTHER DOSE OF 25MG OF DIPHENHYDRAMINE WAS ADMINESTERED. MONITORED PATIENT FOR AN ADDITIONAL 30 MINUTES. PT WAS ESCORTED BY SPOUSE STABLE. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Patient arrived at observation area after getting vaccine at 5:40 PM. Patient complained of SOB and feeling unwell. V/S taken. Patient feels fine after sitting for 10 minutes. | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: 13 minutes after injection- tongue tingling and numbness for 3 hours. Hot flashes, feeling hot, headache, and extreme fatigue. | ||||||||||||||||
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: Started to experience anxiety and dizziness approx 1 hour after receiving vaccine. BP elevated at time of observation (168/102). Obesrvation time extended to 1.5 hours. Provided hydration and light meal. Discharged per team member request after she stated she felt better. Encouraged to take BP meds as directed per PCP. Encouraged to go to ER for symptom return or additional adverse reactions per handout/Agency guidelines. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: PATIENT RECEIVED THE VACCINE, AND WILL SITTING IN THE RECOVERY ROOM, FELT HOT, DIZZY AND SWEATY AS WELL AS OBTUNDED. BP 90/42, HR 55 SAT 97 RR12 DIAPHORETIC, AROUSABLE, COHERENT CV PULSE DIFFICULT TO PALPATE, BRADYCARDIC PHYSICAL EXAM OTHERWISE UNREMARKABLE PLACED ON STRETCHER. MENTAL STATUS IMPROVED. VS 115/97, 75, 12, SAT 98 TRASNFERRED TO EMERGENCY ROOM FOR EVALUATION | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Approximately 12 hours after getting the vaccine, I began shivering uncontrollably for about an hour and felt hot (like a fever) at the same time. I also ached all over. I took 2 Tylenol and was able to fall back asleep. I woke up sweaty, but the chills and fever were gone. I?m now just stiff, with some mild pain at the injection site. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: woke up with fever, chills, joint aches, headache, general malaise | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Extreme muscle aches and joint pain to the point of barely being able to move Chills Sweats Burning/Irritated Skin Nausea Thirst | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Severe chills, headache, and body aches starting approximately 5.5 hours post-vaccination. Treated with acetaminophen 1g PO. Fatigue, headache, and dizziness beginning the following morning and persisting until approximately 9pm on 3/4/21. Treatment with acetaminophen every 6 hours as needed. After 9pm on 3/4/21, complete resolution of symptoms. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Itchiness all over the body | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Little chills - fatigue nothing severe but there | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: within a minute of receiving the vaccine I started feeling dizzy and woozy and like I was floating. Then my blood pressure went up and my heart started beating faster. I had tightness in my chest and I got a tickle like feeling at the top of my chest. I got nauseous. BP was elevated (140/85) normal 107/65. I stayed for an hour. I was very very sleepy the whole time. 3/5/21 I still have the tickle and tightness and pressure on my chest and I am having vertigo attacks. I got a headache and pain and stiffness in my neck where I have had nerve pain injections and ablations. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: 8 hours after getting the vaccine I started feeling very cold. It came on me all of a sudden. Shaking, shivering, teeth chattering ensued along with generally feeling very unwell. (Similar to how I felt years ago after having surgery) This progressed during the night to fever, chills, extreme body aches, stabbing pains in the head, heart racing, dizziness and nausea. After 12 hours I started to feeling improvement. At the 16 hour mark I am really tired and nauseous but feel like I''m coming back. Probably the worst I''ve ever felt. We considered going to the ER in the night. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Pt received J/J vaccine at location yesterday (3/4/21) at 11am. She noticed a fever at around 3pm. She had a fever to 104-105 all during the night, she was 99 this am. | ||||||||||||||||
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: Dizziness, lightheadedness, chest pain, increased respiration, gagging | ||||||||||||||||
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: Later in the evening after receiving the vaccine, I experienced a very strong and pounding headache. I took some Ibuprofens and went to sleep around 9pm and the headache was resolved around 11:30pm. However, later during the night the headache came back. Also, my body aches all over and just generally uncomfortable feelings. The injection site felt warm to the touch and sore. | ||||||||||||||||
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: Janssen COVID-19 Vaccine EUA Injection @ 1130a 1hr after - diarrhea 5hrs after- Rt Arm (opposite arm of shot) tingling sensitive to touch 7hrs after- Skin Crawling painful to touch - low back,thighs, arms, scalp 9hrs after- Freezing and fever sweating 12hrs after- 102 fever, racing BP about 180 high for me, Wrist and Elbows Ached terribly, Lower legs - knee down felt swollen but no sign of swelling. Low back Ached with Pain in Right rear side. Felt like I needed to stretch back and legs tight/anxious. slight Headache 14hrs after- took 2 Tylenol PM & slept restlessly until 8:30 a (12hrs later) 8:30a - Much better with slightly achey back and forearms and occasional headache ting... not constant. Moving slow Had Covid Nov11 2020. Symptoms lasted 6week, each week one symptom would go away and a new would arise- -fever 2days -intensively painful skin crawling 2days -loss of taste and smell -diarrhea (still have loose stools and occasional watery) had diarrhea morning of shot -eyes painfully itchy irritated dry - still occurs most days about 3p -extreme exhaustion in afternoon about 1-3p still | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Patient vomited 2 min after receiving vaccine. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: PATIENT FELT LIGHT HEADED A FEW MINUTES AFTER INJECTION. BLOOD PRESSURE WAS CHECKED AND SHOWN TO BE SLIGHTLY ELEVATED. PATIENT DRANK SOME WATER AND AFTER A FEW MINUTES BLOOD PRESSURE WAS CHECKED AGAIN AND WAS IN NORMAL RANGE. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: (3) syncopal episodes following vaccination, one of which resulted in a fall with direct injury to the base of neck, head, and right flank. Pt reported chest pain prior to syncope. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: PATIENT RECEIVED VACCINATION AND WAS THEN ASKED TO SIT IN LOBBY. AFTER BEING SEATED PATIENT PASSED OUT AND FELL OUT OF CHAIR, HITTING HIS HEAD AND BITING HIS LIP IN THE PROCESS. 911 WAS CALLED AND EPI PEN WAS RETRIEVED. PATIENT CAME TO AND WAS PALE, SWEATY, AND HAD CLAMMY HANDS. PATIENT REPORTED NO DIFFICULTY IN BREATHING OR FEELING OF THROAT SWELLING SO EPI PEN WAS NOT ADMINISTERED. BP WAS CHECK AND WAS EXTREMELY ELEVATED. AMBULANCE ARRIVED A FEW MOMENTS LATER AND EMTS ASSESSED PATIENT. PATIENTS BP HAD RETURNED TO NORMAL RANGE, COLOR WAS IMPROVED AND HE WAS NO LONGER SWEATING. EMTS ASKED PATIENT IF HE WANTED TO BE TAKEN TO THE ER FOR FURTHER EVALUATION AND PATIENT REFUSED. PATIENT SAT IN THE PHARMACY FOR A FEW MORE MINUTES AND WAS THEN DRIVEN BACK TO WORK. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: March 5,2021 at 3:30 am approximately I woke up trembling severely ( entire body ) and intense internal spasms :, high fever : could not grab or hold bottle of water ; tried to get up and and could not stand trembling so bad : I covered up and it lasted till 7:30 am. Now bad headache and back ache | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Patient was being monitored for 30 minutes by EMS due to anaphylaxis to Shrimp. About 15 minutes into monitoring, the patient reported to EMS that he was feeling sweaty and had some shortness of breath. EMS reported BP to be 171/89 and pulse of 88. Patient stated that he does take blood pressure medication and reported that BP was elevated for him. EMS contacted ambulance for transport to Emergency room, patient in agreement to transport. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: 14:59 - RN responded to waiting lot. Pt c/o sensation of facial swelling and heart racing. Denied other complaints. At 1500 BP 110/80, HR 140, R 12. 1503: Pt helt HR slowing down. No further feeling of swelling in face, throat, or elsewhere. 1505: HR 128. 1510: Pt talking, breathing without difficulty. Advised to seek medical attention if s/sx worsen. 3/5/21 @ 1040: Another RN followed up with ph call. Pt reported that after leaving site, she felt HR beginning to speed up. Went to ED and was monitored x 2 hrs. Systolic pressure there was 161. HR was in 140''s. No interventions. After 2 hrs VS stabilized and pt was discharged home. Is fine today. | ||||||||||||||||
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: Janssen COVID-19 Vaccine EUA Beginning morning of 3/4/21. Nausea, extreme fatigue, body ache, severe headache, chills, fever, coughing. Beginning morning of 3/5/21. Nausea, body ache, mild headache, coughing, chills, mild fatigue | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Dizziness felt like fainting | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: 15 minutes after injection, customer complained about metallic taste, tongue slightly swollen with small bubbles on each side of tongue. No difficulty in breathing. We asked to stay 15 minutes more for observation. Had tightness in the chest 5 minutes later. Called 911. Operator asks not to give water/benadryl/epipen. EMT arrived 5 minutes later and assessed. Watch 15-20 minutes later walked her out to car. We checked 6:45 pm still have metallic taste and just little swollen on tongue. Called 3/5/21 @ 2:30pm no more symptoms., only from the JNJ shot. tiredness | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Blurred vision, dizziness, itching, tightness of chest, headache.1340 c/o itching nose/chest tightness along with anxiousness BP 124/80, HR 60, RR 18, SpO2 98% RA. Resp. easy/even. Denies difficulty with swallowing. C/o Blurred vision at this time. 1349 States that chest tightness is resolved. Continue to c/o blurred vision. States that after receiving vaccination she almost immediately had an instant headache. 1356 States that itching is now resolved, along with tightness of chest/blurred vision. States that her headache remains. 1408: BP 116/76, HR 68, RR 18, Continue c/o headache. No other complaints at this time. Staff nurse suggested pt get a ride home. Pt denied need for a ride stating that she was fine other than the headache. 1413 Pt released to go home. Pt reminded to call PCP for any further adverse reactions. | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: Fast heart rate. Thought it was going to shock me from defibrillator. | ||||||||||||||||
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: Client stated her lips felt tingly and her throat felt itchy. Airway clear, respirations even and unlabored, heart rate within normal limit. Patient in no acute distress. No angioedema noted. Patient was administed Benadryl 25mg PO X 1 dose. | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: 65m received J&J vaccine, 10 minutes after admit c/o a gripping pain mid sternum, a 2 on scale of 1-10. Pt brought ot observation area, pain non changing after 15 minutes, eval''d by on site EMS. Transferred to ED for eval. Pt notified his daughter prior to leaving vaccine clinic. He had no complaints of other symptoms. Per electronic health records, pt drove himself to ED. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Pt feels dizzy, hot, headache. VS BP 122/80, HR 75, RR 18, Osat 98% Left arm numb from elbow down. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: blood pressue 96/42. patient sweating. feeling dizzie like he was about to pass out. provided food/water and constant monitoring until symptoms resolved | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Pt was released after 15 min of monitoring. As soon as pt got in her car 9Parking lot is 3 minutes away from vaccination site) Pt developed palpitations (HR:156/min) Pt drove to the ER (3 blocks away from parking lot) Pt is currently in the ER, HR between 107-119. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: The patient has had no problems with the vaccine. We were finishing vials of both Janssen and Pfizer at the same time at the end of the evening. He received a dose of Janssen when he should have received Pfizer since he will not be 18 years old for 4 months. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: patient c/o chest pain with EKG changes 90 min. after vaccine administered. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: When I got the vaccine I got an instant pain in my arm and into my neck, then an intense headache between my eyes above my nose, I was flush and sweaty, nauseous. Then had a bad headache on the top of my head, then soon I had left side facial numbness . Light sensitivity | ||||||||||||||||
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: Headache. Hives started around 4:00PM on Friday March52021 | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Achy, fever of 100, chills fatigue | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Fever, chills, stomach pain, muscle pain, headache, nausea, soft stool, fatigue. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Fever onset (100F) along with chills uncontrollable shivering and teeth chattering around 8 PM. Around 5 Am, fever had hit 103F and body temperature (measured by an Oura ring) recorded average body temperature increase of +5.6F while sleeping compared to baseline. Fever remained intermittently throughout the next day, as well as headache, sore throat, chills. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Slight headache mid afternoon. Chills about 6pm. Fever of 100.8 around 7:30pm. Unsure whet OTC med to take. At 9pm, fever 101.6. Took ibuprofen with PowerAde around 9:15pm. What should I take and how much? | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Nausea-Mild, Systemic: Shakiness-Medium, Systemic: Weakness-Medium, Additional Details: Patient recovered after surpine positing for 15 minutes and water | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: About 6 hours after shot, began having chills. Chills lasted 12 plus hours. Fever followed chills. Couldn?t get warm enough but fever was high. Mouth thermometer indicated fever of 101.5* for several hours (24 plus); non oral thermometer indicate parts of body were 105.0*. Despite chills. Terrible headache and aches so bad I couldn?t sleep. Finally took some Advil PM so I could finally sleep. Next day, still have fever, aches, and headache. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Temp of 99.6 Muscle aches Chills Rigors Uncontrolled shaking | ||||||||||||||||
Administered by: School Purchased by: ?
Life Threatening? No Write-up: Feet & calves extremely warm, no fever. Upset stomach, malaise, slight difficulty breathinh | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Aches in both arms (mostly in arm that was vaccinated), backache, restlessness, insomnia, headache, overall body fatigue. All of these things caused me to wake up in the middle of the night around 3:30 AM the day after vaccination. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Body feels heavy like lead Very tired Minimal pain at injection site 2:18pm hands twitching and my right eye feels like it''s swollen and burning closer to my cheek and then started twitching uncontrollably. Very dry mouth. Moments later body tremors and vomiting. Ended up being taken to the emergency room will elaborate later. Drink Sprite on the way home vomited it up as soon as I walked in the door. Not the feeling of nausea just the vomiting is coming. Took temperature have a fever of 101.0 DAY 2 Tremors while walking Headache Body aches Minimal taste Tingling around eye No real desire to eat Managed to keep some noodles down Today is Day 3 5:00am Still unsteady on feet when walking Still have headache and body aches | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: Patient had sudden onset of sensation of palpations and light headedness "lasting one second" in middle of night on the day after receipt of COVID-19 vaccine. Felt urgent need for medical treatment & came to our ER. Has had similar episodes previously that have been partly diagnosed as anxiety though without light-headedness. Vitals in ER HR 141, BP 147/101. Believed to be sinus tachycardia. Has been prescribed venlafaxine, lorazepam, and metoprolol previously for this. Has seen cardiologist but per patient no specific diagnosis. As yet, patient has received a fluid bolus in ER. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: day 1 severe hot and cold flashes bad headache and severe arm pain today could not stand up sat down felt Like I was going to pass out sat on floor bad cold sweats feeling nauseous bad diarrhea | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Starting approx 7 hours after injection I started to feel run down. I then played tennis for about 45 minutes. I got home around 8:30 and started to experience extreme chills, fever of 100.4, joint aches in feet, hands, neck, wrists, shoulders, hips. Headache. I did not take any additional medication - toughed it out. This morning is approx 22 hours after vaccine. I could not sleep more than an hour or so, I was very chilled and achy. I am currently feeling a little better but still have aches in my back and wrists and ankles, have a headache | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: Started shaking inside my body 8 hours after the shot plus a fever of 100. Shaking then turned violent on outside of my body. Took 2 Motrin (225) each. Shaking stopped after 30 minutes, fever disappeared overnight. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Headache/ achy bones, painful movement in most joints | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Started with fever of 99.4 which rose to 101.4 at about 2:30 am. I ended up taking tylenol at about 2:30 am and my fever broke by time I woke up at 6:30 am | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Headaches, chills, fatigue | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Fever started 10 hours post injection. Fever was 99.1. Also body aches. Next day was fatigued and had small rash at the base of my neck in front. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: severe headache, chills for about 6 hours; flushed cheeks; body aches | ||||||||||||||||
Administered by: Senior Living Purchased by: ?
Life Threatening? No Write-up: 6 hours in: feeling cold, muscle aches 7 hours in: extreme chills and nausea 8 hours in: extreme chills, muscle aches, feverish 13-14 hours: chills subside, muscle aches, hot/feverish 20 hours: muscle aches, fatigue | ||||||||||||||||
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: Muscle aches in armpits began a few hours after receiving the dose. Within 8 hours of dose, a mild fever and chills began (around 100 degrees F). I attempted to take a bath to soothe aches but it did not help, and instead tried to go to sleep at 8:30 pm. A slight red rash appeared on chest and arms around this time. I was woken up at 10:30 pm feeling disoriented and hot, with a fever of 104.5 degrees F. My wife noticed slurring of words and that I seemed unstable and confused, and symptoms were severe enough we considered going to the emergency room. I experienced ringing in my ears and a severe headache. I took 2 extra strength Tylenol, put a cold cloth on forehead, and drank fluids to fall back asleep. Fever dropped to around 102 but continued throughout the night. I woke up at 6:30 am and took two more Tylenol. The severe headache continued and I vomited twice. I attempted to take a shower and rinse off, and continue to rest. Fever is reduced to 99 degrees F with help of Tylenol. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Severe headache, chills, body aches | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Went to bed around 10 pm. Woke up at 11:30 with moderate to severe chills and 100 degree fever. Added blankets and clothes. Took Tylenol. Drank water. Chills subsided. At 12:45am temp was 100.4 degrees F. Woke up at 6am. Temp was 98.2. Took Advil at 6am to help with muscle aches from the chills. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Fever, headache, injection site pain | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Left arm was mildly sore, as expected. Around 10 pm Thursday, I started feeling chills. During the night I felt fevers and chills alternating. Around 3 am, I was nauseous and vomited, although there wasn''t much actual vomit. I vomited again around 9 am the next morning, with even less vomit, since I hadn''t eaten any breakfast. I rested most of Friday and ate sparingly. Today (Saturday) I feel better. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Flu-like symptoms. Body aches, fever, chills, headache, nausea. Started around 8 hours after vaccination and lasted over 10 hours | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Chills, muscle fatigue | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Headache, body ache, fever, tiredness | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Intense body aches, pain and chills | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Chills, fever, headache; took 400 mg ibuprofen | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Mild fever (99.8, normal resting body temp 97.1) | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Eyes burning, fatigue, soreness at injection site, muscle aches (not manifest until following day). | ||||||||||||||||
Administered by: School Purchased by: ?
Life Threatening? No Write-up: Patient experienced dizziness, elevated blood pressure and increased heart rate. Diphenhydramine 50mg IM was administered into right deltoid. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Head ache, extreme chills, fatigue, slight nausea. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: JANSSEN COVID-19 VACCINE EUA Chills, body aches, fever | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Dizziness, headache, nauseousness to the point of having to sit still. Home treatment with Ibuprofen reduced symptoms that lasted approximately 24 hours. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Janssen COVID-19 Vaccine EUA Body aches and pains (specifically on left side of body and in lower back), lasted for ~14 hours. Migraine-like headache, currently ongoing but started 11 hours ago. Unable to sleep due to these moderate-severe amounts of pain (woke up at 3am unable to go back to sleep). | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Mega headache (I get headaches so I know it was bad) about 3 hours afterwards. Really cold and falling asleep about 5 hours after. Next day generally just cold and body tired. No arm pain. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: lymph nodes started swelling in a few hours. Woke up in middle of night with 100.3 degree fever, aches, chills, congestion, and congestion related headache | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Hives all day & night controlled by using benedryl | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: Janssen COVID-19 Vaccine EAU Headache, dizziness, and nausea starting around 2 and a half hours after vaccination. Left work early due to not feeling well enough to continue. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Janssen COVID-19 Vaccine EUA. Chills, headache, body aches, mentally fogginess, slight nausea. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: 5-6 hours after the shot I got chills and could not get warm. I went to bed and had mild aches and had to wear a jacket to keep warm. Woke up 4am because could not sleep and was ok with only mild aches | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Friday night at about 10ish I suddenly got a terrible migraine, shaking uncontrollably, and my body have stiff. I tried going to bed at 11pm, but couldn''t fall asleep. I got up sometime around 2am and I still had all of these along with extreme nausea. Check my temperature, it was 101.4 F. Got more blankets and tried to get some sleep, but took a while due to the migraine. At 7:30am, the shaking was gone and the migraine was not as bad, but I still had a temperature of 99.1 F and nausea. After calling my boss and mother, I went back to sleep. Stayed in bed until about 1:45pm Saturday. By then, the migraine was manageable and nausea was not as bad, though still had a temperature of 99.9 F. Took a shower and took 2 pills of ibuprofen. | ||||||||||||||||
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: Extreme dizziness, red face, high blood pressure, tingling tongue | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: COUGH, TINGLING THROAT AND TONGUE WITH SLIGHT SWELLING OF THROAT AND TONGUE | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Woke up at 4AM on 03/05/2021 with shaking chills, feeling very cold, couldn''t get warm. Shaking so bad I couldn''t get whole sentences out. Body aches and stiffness, affected my walking. Did not take temperature at that time. Got back into bed with 2 blankets and a comforter and still couldn''t sleep. Got up a 7AM - temp 102.2, shaking less but still feeling cold, body was hot to touch. I had a bad headache and body aches and stiffness were still there. I noticed at that time that I had a bright red flush on both cheeks and my nose that was hot to the touch. Took 600mg of Ibuprofen. Went back to bed feeling terrible. At 12 noon I got back up and temp was down to 99.7. Headache, body aches, stiffness, and "red flush" still on cheeks and nose. Went back to bed. Took more Ibuprofen at 7pm - temp was down to 98.7. Headache was better, body aches improved. Flushed hot face was still present. Went to sleep at 11:30PM and slept for 10 hours. Today, 03/06/21, all symptoms improved, no fever, redness of face is still present but less. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Patient c/o throat closing, SOB, and chest pain within minutes after receiving the vaccine. Her vital signs showed tachycardia, increased respirations, and elevated blood pressure. She had a hard time speaking in full sentences. She does have a history of anaphylaxis to certain medications. She was administered epinephrine auto injector IM and brought to the emergency department by rapid response team. | ||||||||||||||||
Link To This Search Result:
https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=SYM&EVENTS=ON&PERPAGE=100&VAX=COVID19&VAXMAN=JANSSEN
Copyright ©
2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166